EurekaMag PDF full texts Chapter 64,359

Trnková, P.; Gomà, C.; Mumot, M.; Lomax, A. 2013: OC-0160: Five years of experience with patient specific verifications of spot scanned IMPT. RadioTherapy and Oncology 106: S61-S62

Rossi, M.M.G.; Peulen, H.M.U.; Belderbos, J.S.A.; Sonke, J.J. 2013: OC-0162: An evaluation of VMAT and IMRT intrafraction motion in NSCLC patients treated with SABR. RadioTherapy and Oncology 106: S62-S63

Moser, E.C.; Vieira, S.; Mateus, D.; Soares, A.; Stroom, J.; Lebrec, J.J.P.; Greco, C. 2013: OC-0169: Intensity and volumetric modulated radiation therapy in breast cancer: tolerance versus dose constraints. RadioTherapy and Oncology 106: S65-S66

Kennedy, N A; Chang, J; Guy, M H; Smith, T; Loh, J T; Haunschmidt, D; Muscat, M; Spurio, F Fasci; Drummond, H E; Kingstone, K; Noble, C L; Shand, A G; Satsangi, J; Arnott, I D; Lees, C W 2013: OC-016Elevated Faecal Calprotectin Predicts Disease Progression in CrohnS Disease. Gut 62(Suppl 1): A7.1-A7

Le, H.; Rojas, A.; Ostler, P.; Hughes, R.; Alonzi, R.; Bryant, L.; Lowe, G.; Hoskin, P. 2013: OC-0176: Biochemical control of large prostate glands treated with HDR-BT. RadioTherapy and Oncology 106: S68-S69

Wood, D.; Baker, S.; Davidson, S.; Lane, L.; Morrissey, N.; Pooler, A.; Gillespie, W.; Hamlett, L.; Farrow, H. 2013: OC-0178: Inter-operator variation in the reconstruction of GYN brachytherapy applicators using T2 MRI only. RadioTherapy and Oncology 106: S69-S70

Huang, S.H.; O'Sullivan, B.; Xu, W.; Zhao, H.; Chen, D.; Chan, K.; Kim, J.; Bayley, A.; Goldstein, D.; Waldron, J. 2013: OC-017: Temporal Regression and Regional Control Following Primary Radiotherapy for HPV(+) vs. HPV(-) Head & Neck Cancers. RadioTherapy and Oncology 106: S5-S6

Hedin, C; McCarthy, N E; Louis, P; Farquharson, F; McCartney, S; Taylor, K; Prescott, N; Murrells, T; Stagg, A J; Whelan, K; Lindsay, J O 2013: OC-017A Discriminant Analysis Demonstrates that Siblings of Patients with CrohnS Disease have a Distinct Microbiological and Immune Phenotype Compared with Healthy Controls: Insights into Disease Pathogenesis. Gut 62(Suppl 1): A7.2-A8

Landry, G.; Reniers, B.; Vigneault, E.; Beaulieu, L.; Wildberger, J.; Verhaegen, F. 2013: OC-0181: Dual energy CT facilitates LDR brachytherapy seed metal artefact reduction. RadioTherapy and Oncology 106: S70-S71

Franich, R.D.; Smith, R.L.; Taylor, M.L.; Haworth, A.; McDermott, L.N.; Millar, J.L. 2013: OC-0183: Independent validation of high dose rate (HDR) brachytherapy source localisation using an EPID. RadioTherapy and Oncology 106: S71-S72

Brooks, A J; Wood, E M; Robinson, K; Wright, A; McAlindon, M E; Lobo, A J 2013: OC-018Limited long Term Tolerance of Methotrexate For Inflammatory Bowel Disease: 11 Years Experience from a Single Centre. Gut 62(Suppl 1): A8.1-A8

Viertl, D.; Perillo-Adamer, F.; Rigotti, S.; Maby El Hajjami, H.; Vaslin, A.; Vuagniaux, G.; Zanna, C.; Matzinger, O. 2013: OC-019: Preclinical Rationale for Combining the Smac-Mimetic Debio 1143 with Concurrent Chemio-Radiotherapy In La-SCCHN. RadioTherapy and Oncology 106: S6-S7

O'Shea, N R; Smith, A M; Chew, T; Dunne, J; Segal, A W 2013: OC-019Adamdec1: A Novel Molecule Linked to CrohnS Disease, is Associated with an Increased Susceptibility to Citrobacter Rodentium Colitis in the knock out Mouse. Gut 62(Suppl 1): A8.2-A9

Coles, C.E.; Mukesh, M.; Barnett, G.C.; Wilkinson, J.S.; Moody, A.M.; Wilson, C.B.; Dorling, L.; Qian, W.; Twyman, N.; Burnet, N.G. 2013: OC-0202: A randomised controlled trial of intensity modulated radiotherapy (IMRT) for early breast cancer: results at 5 years. RadioTherapy and Oncology 106: S79-S80

Burgess, S L; Caamaño, J; Pritchard, D M; Burkitt, M 2013: OC-020The Murine Gastric Microbiome is Influenced Both by Helicobacter Felis Infection and Somatic Deletion of NF-Kappab Family Members. Gut 62(Suppl 1): A9.1-A9

Vogelius, I.R.; Håkansson, K.; Due, A.K.; Aznar, M.C.; Berthelsen, A.K.; Kristensen, C.A.; Specht, L.; Bentzen, S.M. 2013: OC-021: Failure-Probability Driven Dose Painting. RadioTherapy and Oncology 106: S7-S8

Rostami, K; Villanacci, M Rostami Nejad Vincenzo; Kollars, S Hogg-; Volta, U; Manenti, S; Zali, M Reza; Caio, G; Giovenali, P; Barakauskiene, A; Kazenaite, E; Becheanu, G; Diculescu, M; Pellegrino, S; Magazzù, G; Cas, G 2013: OC-022Endoscopy Pitfalls in Celiac Disease Diagnosis; a Multicentre Study. Gut 62(Suppl 1): A10.1-A10

Tobias, J.; Vaidya, J. 2013: OC-0236: The TARGIT-A trial of intra-operative radiotherapy for breast cancer: Updated recurrence and survival. RadioTherapy and Oncology 106: S91-S92

Ishay, J.S.; Ganor, E. 1992: External micromorphology of the frons plate and its adjacent areas in workers of the oriental hornet. Journal of Morphology 213(1): 1-13

Koetsveld, F.; Schaake, E.E.; Milder, M.; Buijs, M.; Remeijer, P.; Sonke, J.J. 2013: OC-0241: Validation of an average patient model to account for differential motion in locally advanced lung cancer patients. RadioTherapy and Oncology 106: S93-S94

Yenice, K.; Li, J. 2013: OC-0246: Dosimetric characterization of a new commercial plastic scintillation detector in FFF MV photon beams. RadioTherapy and Oncology 106: S95-S96

Wootton, L.; Beddar, A.S. 2013: OC-0248: Characterization of the temperature dependence of BCF plastic scintillation detectors. RadioTherapy and Oncology 106: S96-S97

Richard, N.M.; O'Connor, C.; Dey, A.; Robertson, I.H.; Levine, B. 2018: External modulation of the sustained attention network in traumatic brain injury. Neuropsychology 32(5): 541-553

Mast, M.; Vredeveld, E.; Credoe, H.; Kalk, P.; Korevaar, E.; van der Laan, H.P.; Rozema, H.; Petoukhova, A.; Struikmans, H.; Maduro, J. 2013: OC-0255: Protons enable cardiac dose reduction in left sided breast conserving RT even without breath hold. RadioTherapy and Oncology 106: S99-S100

Speleers, B.; Rossi, M.; van Os, M.J.H.; van der Laan, H.P.; Duppen, J.; Duclos, F. 2013: OC-0257: Delineation of organs-at-risk in the pelvic area: developing guidelines for RTTs. RadioTherapy and Oncology 106: S100-S101

Derakhshan, M H; Robertson, E V; Lee, Y Y; Wirz, A A; Going, J J; McColl, K E 2013: OC-025Expanded Cardia Mucosa Associated with Central Obesity Immunohistochemically Resembles Non-Im BarrettS Mucosa. Gut 62(Suppl 1): A11.1-A11

Boerma, M.; Sridharan, V.; Tripathi, P.; Sharma, S.; Moros, E.G.; Aykin-Burns, N.; Hauer-Jensen, M. 2013: OC-0260: Effects of a tocotrienol-enriched formulation in a rat model of local heart irradiation. RadioTherapy and Oncology 106: S101-S102

Hoskin, P.; Rojas, A.; Ostler, P.; Hughes, R.; Bryant, L.; Lowe, G. 2013: OC-0263: HDR brachytherapy dosimetric predictors of biochemical control of prostate cancer. RadioTherapy and Oncology 106: S102-S103

Kumar, M; Khan, F; Sweis, R; Wong, T 2013: OC-026Eosinophilic Oesophagitis in Patients Presenting with Dysphagia- a Prospective Analysis. Gut 62(Suppl 1): A11.2-A12

Varghese, S; Newton, R; Ross-Innes, C S; Krishnadath, K K; Lao-Sirieix, P; O'Donovan, M; Wernisch, L; Bergman, J J; Fitzgerald, R C 2013: OC-027Defining Cancer Risk in BarrettS Oesophagus using a 90-Gene Signature. Gut 62(Suppl 1): A12.1-A12

Sobotta, B.; Alber, M. 2013: OC-0287: Beyond VMAT - high speed delivery of rotational IMRT with conebeam tomotherapy. RadioTherapy and Oncology 106: S111-S112

Alexandre, L; Clark, A; Bhutta, H; Lewis, M P; Holt, S; Hart, A R 2013: OC-028Statin use is Associated with Improved Survival in Patients with Oesophageal Cancer: a Survival Analysis using the UK General Practice Research Database and National Cancer Registry. Gut 62(Suppl 1): A12.2-A13

Haidry, R J; Banks, M; Butt, M; Gupta, A; Louis-Auguste, J; Dunn, J; Smart, H L; Bhandari, P; Smith, L-A; Willert, R; Fullarton, G; Pietro, M di; Penman, I; Narayanasamy, R; Morris, J; O'Toole, D; Novelli, M; Gordon, C; Lovat, L 2013: OC-029Radiofrequency Ablation (Rfa) Confers Sustained Benefit for Squamous High Grade Dysplasia (Hgd) and Early Squamous Cell Carcinoma (Scc) in Patients who do not Progress following First Treatment. Gut 62(Suppl 1): A13.1-A13

Lavery, D; Nicholson, A; Jeffery, R; Poulsom, R; Barr, H; Jankowski, J; Novelli, M; Shepherd, N; Rodriguez-Justo, M; Jansen, M; Wright, N A; Mcdonald, S A C 2013: OC-030BarrettS Epithelium Shows Evidence of Gastric and Intestinal Differentiation Programmes but Preserves the Proliferative and Stem Cell Architecture of Gastric Glands. Gut 62(Suppl 1): A13.2-A13

Wiseman, E F; Han, N; Ang, Y S; Sharrocks, A S 2013: OC-031Using Genome-Wide Studies to Identify Novel Foxm1 Transcription Factor Target Genes in Oesophageal Cancer. Gut 62(Suppl 1): A13.3-A14

Jackson, J.; Wada, M.; Lee, S.T.; Gan, H.; Poon, A.; Gong, S.; Gunawardana, D.; Joon, D.L.; Khaw, P.; Scott, A.M. 2013: OC-0325: Pre-Radiotherapy 18Fluoromisonidazole PET Predicts for Long Term Local Control and Survival in Head and Neck Cancer. RadioTherapy and Oncology 106: S125-S126

Carvalho, S.; Leijenaar, R.; Rios, E.; Oberije, C.; Reymen, B.; Troost, E.; Oellers, M.; Dekker, A.; Aerts, H.; Lambin, P. 2013: OC-0327: Predicting overall survival in NSCLC patients with metabolic metrics derived from baseline PET: a prospective study. RadioTherapy and Oncology 106: S126-S127

Lam, C; Chaddock, G; Hoad, C; Costigan, C; Cox, E; Marciani, L; Gowland, P; Spiller, R 2013: OC-032A New Validated whole Gut Transit Time (WGTT) Measurement using Magnetic Resonance Imaging (Mri-Wgtt) Technique. Gut 62(Suppl 1): A14.1-A14

Poulsen, P.R.; Worm, E.S.; Petersen, J.B.B.; Grau, C.; Fledelius, W.; Høyer, M. 2013: OC-0332: Kilovoltage intrafraction motion monitoring and target dose reconstruction for liver SBRT delivered by VMAT. RadioTherapy and Oncology 106: S128-S129

Fast, M.F.; Oelfke, U.; Nill, S. 2013: OC-0334: Actively triggered cone-beam CT acquisition based on electromagnetic respiratory motion tracking. RadioTherapy and Oncology 106: S129-S130

Fledelius, W.; Worm, E.; Grau, C.; Høyer, M.; Poulsen, P.R. 2013: OC-0336: Inter- and intrafractional relative motion of implanted fiducial markers in the liver. RadioTherapy and Oncology 106: S130-S131

Akimoto, M.; Nakamura, M.; Mukumoto, N.; Tanabe, H.; Yamada, M.; Matsuo, Y.; Monzen, H.; Mizowaki, T.; Kokubo, M.; Hiraoka, M. 2013: OC-0338: Accuracy of a predictive model in IR-marker-based dynamic tumour tracking for lung cancer. RadioTherapy and Oncology 106: S132-S133

Aziz, I; Smillie, D M; Sanders, D S 2013: OC-033Is Lymphocytic Duodenosis a Marker for Irritable Bowel Syndrome?. Gut 62(Suppl 1): A14.2-A15

Santiago, A.; Jelen, U.; Ammazzalorso, F.; Engenhart-Cabilic, R.; Fritz, P.; Mühlnickel, W.; Enghardt, W.; Baumann, M.; Wittig, A. 2013: OC-0340: Reproducibility of target coverage in stereotactic proton lung irradiation under high frequency jet ventilation. RadioTherapy and Oncology 106: S132-S133

Lorentini, S.; Fava, G.; Vitali, P.; Fellin, F.; Tonoli, S.; Amichetti, M.; Schwarz, M. 2013: OC-0342: Anatomical changes in mesothelioma patients: effect on proton dose distributions and benefits of early replanning. RadioTherapy and Oncology 106: S133-S134

Gora, J.; Johannes Hopfgartner, J.H.; Peter Kuess, P.K.; Brigita Paskeviciute, B.P.; Dietmar Georg, D.G. 2013: OC-0344: Is there room for combined modality treatments - Comparison of boost strategies for advanced H&N and prostate cancer. RadioTherapy and Oncology 106: S134-S135

Chan, J.M.T.; Wu, V.W.C.; Chiu, G. 2013: OC-0346: Dosimetric evaluation of Tomo Direct, helical tomotherapy and field-in-field techniques in breast radiotherapy. RadioTherapy and Oncology 106: S135-S136

Fargier, O.; Grozema, F.; Laouiti, M.; Delorme, H.; Rossi, S.; Mary-Bruttin, M.; Vinh-Hung, V. 2013: OC-0349: DVH comparison of whole breast radiotherapy (WBRT) in prone and supine position. RadioTherapy and Oncology 106: S136-S137

Michou, E; Harris, L; Hamdy, S 2013: OC-034Cortical and Brainstem Neurophysiological Mechanisms underlying Dysphagia in ParkinsonS Disease: A Transcranial Magnetic Stimulation Study On and Off Levodopa. Gut 62(Suppl 1): A15-A16

Zhuang, M.; Zhang, T.; Chen, Z.; Lin, Z.; Peng, X.; Li, D.; Qiu, Q.; Wu, R. 2013: OC-0351: Volumetric modulated arc radiotherapy with flattening filter-free beams for advanced nasopharyngeal carcinoma. RadioTherapy and Oncology 106: S138-S139

Aagaard, T.; Mohamed, S.; Fokdal, L.; Morre, E.; Lindegaard, J.; Tanderup, K. 2013: OC-0357: Dose contribution from PDR BT to the para-aortic, pelvic and inguinal lymph nodes for locally advanced cervix cancer. RadioTherapy and Oncology 106: S139-S140

Gaudet, M.; Lim, P.; Spadinger, I.; Yuen, C.; Zhang, S.; Dubash, R.; Wong, F.; Lester, B.; Bachand, F.; Aquino-Parsons, C. 2013: OC-0359: Bladder volume variation reduces long-term toxicity of imageguided brachytherapy for cervical cancer. RadioTherapy and Oncology 106: S140-S141

Long, Y; Yang, J; Zhu, Y; Cong, Y; Chu, H; Dai, N; Fried, M; Fox, M 2013: OC-035Mechanism of Lactose Intolerance in Irritable Bowel Syndrome: Role of Anxiety, Mucosal Immunity and Visceral Hypersensitivity. Gut 62(Suppl 1): A16.1-A16

Guinot, J.L.; Santos, M.; Soler, P.; Jimenez, E.; Lopez-Campos, F.; Mut, A.; Arregui, E.; Moreno, A.; Arribas, L. 2013: OC-0362: HDR brachytherapy boost with a single fraction: is it useful to preserve the breast in young woman with early cancer?. RadioTherapy and Oncology 106: S141-S142

Barton, M.B.; Shafiq, R.J.; Jacob, S.; Wong, K.; Delaney, G.P.; Hanna, T.P. 2013: OC-0367: New evidence-based benchmarks for radiotherapy service provision. RadioTherapy and Oncology 106: S143-S144

Lønbro, S.; Dalgas, U.; Primdahl, H.; Overgaard, J.; Overgaard, K. 2013: OC-036: Resistance Training and Dietary Supplements in Radiotherapy Treated Head and Neck Cancer Patients (DAHANCA 25A). RadioTherapy and Oncology 106: S14-S15

Vasant, D H; Mistry, S; Jayasekeran, V; Michou, E; Hamdy, S 2013: OC-036Neuronavigated Repetitive Cerebellar Stimulation Produces Long-Lasting Activation of Human Cortical Swallowing Projections. Gut 62(Suppl 1): A16.2-A17

Bland, R.G.; Rentz, D.C.F. 1994: External morphology and abundance of antennal sensilla in australian gryllacrididae. Journal of Morphology 222(1): 11-18

Lynch, J.; Lal, P.; Nutting, C.M.; Harrington, K.J.; Newbold, K.L.; Bhide, S.A. 2013: OC-038: Node Stage/Extracapsular Spread Predict Contralateral Node Failure After Unilateral Irradiation of Tonsil Cancer. RadioTherapy and Oncology 106: S15-S16

Zabron, A; Frampton, A; Krell, J; Stebbing, J; Castellano, L; Khan, S; Jiao, L 2013: OC-038Specific Microrna Markers are Identified in Bile in Pancreatic Ductal Adenocarcinoma. Gut 62(Suppl 1): A17.2-A18

Tod, J; Jenei, V; Chrzan, M; Johnson, C; Fine, D; Thomas, G J 2013: OC-039Eps8: A Master Regulator of Integrin-Dependent Pancreatic Cancer Invasion. Gut 62(Suppl 1): A18.1-A18

van Hagen, P.; van Rij, C.M.; van der Sangen, M.J.C.; Beukema, J.C.; Rutten, H.; Reinders, J.G.; van Berge Henegouwen, M.I.; van der Gaast, A.; Hulshof, M.C.C.M.; van Lanschot, J.J.B. 2013: OC-0417: Effect of preoperative chemoradiotherapy on recurrence pattern in esophageal tumors. RadioTherapy and Oncology 106: S160-S161

Joye, I.; Lambrecht, M.; Jegou, D.; Hortobágyi, E.; Pelgrims, A.; Scalliet, P.; Haustermans, K. 2013: OC-0420: Improving quality of care in rectal cancer:the role of a central review platform in CTV delineation. RadioTherapy and Oncology 106: S161-S162

van Stiphout, R.; Lammering, G.; Gambacorta, M.A.; Meldolesi, E.; Souvatzoglou, M.; Herrmann, K.; Valentini, V.; Lambin, P. 2013: OC-0422: Towards a validated decision tool for rectal cancer based on sequential PETCT imaging before and during treatment. RadioTherapy and Oncology 106: S162-S163

Hopper, A D; Vinayagam, R; Dube, A 2013: OC-042Endoscopic Ultrasound Guided Fine Needle Aspiration of Pancreatic Mass Lesions can be Less Accurate with a Metallic Stent in Situ but should not Delay Treatment of Obstructive Jaundice. Gut 62(Suppl 1): A18.3-A19

Håkansson, K.; Specht, L.; Aznar, M.C.; Rasmussen, J.; Bentzen, S.M.; Vogelius, I.R. 2013: OC-0430: A novel concept for history based evaluation of target dose distribution in multiple dose level treatment plans. RadioTherapy and Oncology 106: S165-S166

Werner, R.; Gauer, T.; Petersen, C.; Wilms, M.; Handels, H. 2013: OC-0433: Respiratory motion and its variability in lung and liver SBRT: DVH analysis exploiting 4DCT-based dose accumulation. RadioTherapy and Oncology 106: S166-S167

Carver, A.; Gately, A.; Clements, R.; Nahum, A. 2013: OC-0435: Monte Carlo dosimetry for the Papillion P50 contact radiotherapy and IORT device. RadioTherapy and Oncology 106: S167-S168

Bueno, M.; Schümann, J.; Duch, M.A.; Paganetti, H. 2013: OC-0437: An algorithm to assess the need for clinical Monte Carlo dose calculations for proton therapy fields. RadioTherapy and Oncology 106: S168-S169

Fix, M.K.; Frei, D.; Volken, W.; Born, E.J.; Aebersold, D.M.; Manser, P. 2013: OC-0439: Proton dose calculation using the macro Monte Carlo method. RadioTherapy and Oncology 106: S169-S170

Kiely, P; Tod, J; Jenei, V; Johnson, C; Thomas, G J 2013: OC-043The Role of the EPS8 Binding Partners Sos1 and Abi1 in Pancreatic Cancer. Gut 62(Suppl 1): A19.1-A19

Bruin, N.M.; Kruis, M.F.; Rossi, M.M.G.; Vogel, W.V.; Takken, S.L.; Vijlbrief-Bosman, M.; Houweling, A.C.; van Herk, M.; Sonke, J.J. 2013: OC-0441: Introduction of a fast 4D PET/CT protocol for radiotherapy planning a multidisciplinary approach. RadioTherapy and Oncology 106: S170-S171

Andersen, M.; Knap, M.; Hoffmann, L. 2013: OC-0444: From bone match to soft tissue match using daily CBCT for lung cancer patients. How do we implement this change?. RadioTherapy and Oncology 106: S171-S172

Hutton, N.; Carver, A.; Baker, A. 2013: OC-0446: Evaluation and development of an IGRT protocol for prostate and nodes radiotherapy. RadioTherapy and Oncology 106: S172-S173

Basford, P. J.; Longcroft-Wheaton, G. R.; Higgins, B.; Bhandari, P. 2013: OC-045 High Definition White Light Endoscopy and I-Scan for small Colonic Polyp Evaluation : Results of the Hiscope Study. Gut 62(Suppl 1): A20-A20

Bland, R.G.; Rentz, D.C.F. 1991: External morphology and abundance of mouthpart sensilla in Australian Gryllacrididae, Stenopelmatidae, and Tettigoniidae. Journal of Morphology 207(3): 315-325

Lopez-Tarjuelo, J.; Morillo-Macías, V.; Bouché-Babiloni, A.; de Marco-Blancas, N.; Santos-Serra, A.; Quirós-Higueras, J.D.; Ferrer-Albiach, C. 2013: OC-0477: Is there a role for an action level in in vivo dosimetry in IOERT? Results and proposals?. RadioTherapy and Oncology 106: S185-S186

Gérard, J.P.; Flipo, B.; Raoust, I.; Marcié, S.; Croce, O.; Trimaud, R.; Leysalle, A.; Hannoun-Lévi, J.M. 2013: OC-0479: A new breast applicator for iort using x-ray brachytherapy (xrb)with 50kv : the Nice breast applicator (NBA). RadioTherapy and Oncology 106: S186-S187

Verma, A M; Dixon, A; Chilton, A 2013: OC-047Correlation of Caecal Intubation Rate to Volume Colonoscopists should Undertake at least 120 Procedures per Year. Gut 62(Suppl 1): A21.1-A21

Krengli, M.; Calvo, F.; Sedlmayer, F.; Wenz, F.; Litoborski, M.; Pisani, C.; Ciabattoni, A.; Polkowski, W.; Kuten, A.; Dubois, J.B. 2013: OC-0483: ISIORT-Europe Data Registry: main characteristics of IORT treatments. RadioTherapy and Oncology 106: S187-S188

Krengli, M.; Beldì, D.; Apicella, G.; Marchioro, G.; Ferrara, E.; Loi, G.; Volpe, A.; Terrone, C. 2013: OC-0485: Quality assurance procedures in intraoperative radioterapy (IORT) for locally advanced prostate cancer. RadioTherapy and Oncology 106: S188-S189

Cavagnetto, F.; Ferri, L.; Agostinelli, S.; Gusinu, M.; Guenzi, M.; Pupillo, F.; Corvò, R.; Taccini, G. 2013: OC-0487: In vivo dosimetry using MOSFET and radiochromic films in intraoperative radiotherapy for breast cancer treatment. RadioTherapy and Oncology 106: S189-S190

Kong, C; Young, A N; Benson, K; Keating, J J; Davies, A H 2013: OC-048Colonoscopy: What is the Number Required to Maintain Competency? a Retrospective Audit. Gut 62(Suppl 1): A21.2-A21

Brugnera, R.; Grazia, JÉlia. 2018: External morphology of immature of Tynacantha marginata Dallas, 1851 (Hemiptera, Heteroptera, Pentatomidae). Zootaxa 4378(1): 121-128

So, K; Bewshea, C; Heap, G A; Muller, A F; Daneshmend, T K; Hart, A L; Orchard, T R; Irving, P M; Russell, R K; Wilson, D C; Parkes, M; Satsangi, J; Lees, C W; Ahmad, T 2013: OC-0505-Aminosalicylate (5-Asa) Induced Nephrotoxicity in Inflammatory Bowel Disease. Gut 62(Suppl 1): A22.1-A22

Haidry, R; Banks, M; Butt, M; Gupta, A; Dunn, J; Smart, H L; Bhandari, P; Smith, L-A; Willert, R; Fullarton, G; Pietro, M di; Penman, I; Narayanasamy, R; O'Toole, D; Gordon, C; Patel, P; Barr, H; Boger, P; Kapoor, N; Mahon, B; Hoare, J; Morris, J; Cheong, E; Ang, Y; Direkze, N; Novelli, M; Lovat, L B 2013: OC-051Patients Undergoing Radiofrequency Ablation (Rfa) for BarrettS Related Neoplasia have Improved outcomes with Decreasing Lenghths of Baseline BarrettS Oesophagus (Be) & Increasing Number of RFA Sessions. Gut 62(Suppl 1): A22.2-A23

Faulkner, J; Greaves, R Ley; Hoare, J 2013: OC-052Combined EMR and Radio Frequency Ablation Leads to High BarrettS Eradication Rates following Structured Training Programme. Gut 62(Suppl 1): A23.1-A23

Basu, P.; Shah, N. J.; Farhat, S.; Siriki, R.; Mittimanj, K.; Atluri, S.; Rahaman, M. 2013: OC-053 Curcumin, Anti-Oxidant, and Pioglitazone Therapy with Inclusion of Vitamin E in Non Alcoholic Fatty Liver Disease-A Randomized open Label Placebo Controlled Clinical Prospective Trial (Captive). Gut 62(Suppl 1): A23-A23

Hedman, M.; Björk-Eriksson, T.; Brodin, O.; Toma-Dasu, I. 2013: OC-0543:Patient-specific in vitro measurements of SF2 and Tpot - how well do they predict the tumour control probability?. RadioTherapy and Oncology 106: S207-S208

Reid, D; Lai, V; Weston, C; Vo, T; Peters, M; Adams, D; Eksteen, B 2013: OC-054Hepatic Expression of CCl25 Mediates Recruitment of Plasmacytoid Dendritic Cells to Limit Liver Injury. Gut 62(Suppl 1): A23.3-A24

Kruis, M.; van de Kamer, J.; Jansen, E.; Sonke, J.J.; van Herk, M. 2013: OC-0555: Deformable registration accuracy of respiratory motion compensation in 4D CT and contrast enhanced CT of the liver. RadioTherapy and Oncology 106: S212-S213

Katzman, T.; Shelly, E.; Luxenburg, O.; Ziv, A.; Lan, R.; Ben David, M.; Symon, Z. 2013: OC-0557: A new model for RTT education in small and mid-size countries. RadioTherapy and Oncology 106: S213-S214

Brigic, A; Southgate, A; Sibbons, P D; Fraser, C; Clark, S K; Kennedy, R H 2013: OC-055A Novel Technique for full Thickness Laparoendoscopic Excision of Colonic Lesions: an Experimental Pilot Study. Gut 62(Suppl 1): A24.1-A24

Hutton, D.; Probst, H.; Patel, I.; Eddy, A.; Wong, H.; Massey, J. 2013: OC-0560: Job satisfaction of the UK radiotherapy workforce: physics and radiography, a strategy to improve satisfaction. RadioTherapy and Oncology 106: S214-S215

Cash-Clark, C.E.; Bradley, T.J. 1994: External morphology of the larvae of Ephydra (Hydropyrus) hians (Diptera: Ephydridae). Journal of Morphology 219(3): 309-318

Tsiamoulos, Z P; Hancock, C; Bourikas, L A; Sibbons, P D; Saunders, B P 2013: OC-057The Speedboat: a New Multi-Modality Instrument for Endoscopic Resection in the Gastrointestinal Tract. Gut 62(Suppl 1): A25.1-A25

Phillips, F; Muls, A; Andreyev, J 2013: OC-058Bile Acid Malabsorption: The Unusual Suspect. A very Frequent Cause for Diarrhoea after Treatment for many different Cancer Types. Gut 62(Suppl 1): A25.2-A26

Childers, C.C.; de Lillo, E.; Bauchan, G.R.; Rogers, M.E.; Ochoa, R.; Robinson, C. 2018: External morphology of the mouthparts and observations on behavior of Tuckerella japonica on Camellia sinensis in the continental USA. Experimental and Applied Acarology 74(1): 55-71

Cadamuro, M.; Spirlì, C.; Beretta, I.; Fabris, L.; Strazzabosco, M. 2013: OC-06 Rac1 and Cdc42 activation regulates PDGF-D-mediated CAF recruitment by cancer cells in cholangiocarcinoma. Digestive and Liver Disease 45: S2-S3

Elsayed, A.Ibrahim.; Fouad, Y.Ahmed.; El Malt, A.; Sweed, A.Hassan. 2018: External Nasal Valve Repair in Children: Alar Batten Graft Reinforced by External Temporary Suspensory Suture. Annals of Otology Rhinology and Laryngology 127(9): 598-603

Broekx, S.; Weyns, F. 2018: External neurolysis as a treatment for foot drop secondary to weight loss: a retrospective analysis of 200 cases. Acta Neurochirurgica 160(9): 1847-1856

Mohamed, O; Stapely, C; Gunston, H; Gregory, L; Smith, L; Rogers, S; Clark, J; Pratt, J; Trebble, T M; Pearl, D S 2013: OC-062Low Incidence of Aspiration Events during Home Nasogastric Feeding: A Safe Strategy for Long Term Feeding?. Gut 62(Suppl 1): A27.1-A27

Wang, Y.B.; Dong, J.H.; Ren, X.M.; Xu, O.; Shan, C.G. 2017: External nose eccrine poroma：a case report. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 31(13): 1041-1042

Pirie, S; Boussioutas, A; Stacey, R 2013: OC-064Pet Scanning in Gastric Cancer: a Comparison Of Avid Versus Non Avid Cancers. Gut 62(Suppl 1): A28.1-A28

Mukai, H.; Kobayashi, K. 1988: External observations on the formation of statoblasts in Plumatella emarginata (Bryozoa, Phylactolaemata). Journal of Morphology 196(2): 205-216

Weaver, J; Shannon, N; Ross-Innes, C; Lynch, A; Forshew, T; Barbera, M; Ong, C-A; Lao-Sirieix, P; Dunning, M; Smith, L; Smith, M; Carvalho, B; O'Donovan, M; Underwood, T; Murtaza, M; May, A; Grehan, N; Hardwick, R; Davies, J; Oloumi, A; Aparicio, S; Rosenfeld, N; Eldridge, M; Caldas, C; Edwards, P; Tavare, S; Fitzgerald, R 2013: OC-066The Cancer Research UK (Cruk) Funded ICGC Oesophageal Adenocarcinoma Project: MRC Research Centre and Cruk Cambridge Research Institute. Gut 62(Suppl 1): A29.1-A29

Andreyev, H J; Benton, B; Lalji, A; Pennert, K; Lindsay, J O; Gage, H; Norton, C 2013: OC-068Algorithmic Management of Radiation-Induced Gi Symptoms is Highly Effective: the Orbit Randomised Controlled Trial. Gut 62(Suppl 1): A29.3-A30

Dobson, C; Rubin, G 2013: OC-070Perceived Delay among Patients with Colorectal, Stomach and Oesophageal Cancer: Analysis of Data from a National GP Audit. Gut 62(Suppl 1): A30.2-A30

Leen, R; Shearer, N; O'Morain, C; McNamara, D 2013: OC-071Comparison of Faecal M2-PK and Fit in Screening for Colonic Polyps in an average Risk Population. Gut 62(Suppl 1): A30.3-A31

Hansen, R; Berry, S; Mukhopadhya, I; Thomson, J; Saunders, K; Nicholl, C; Bisset, M; Russell, R; El-Omar, E; Hold, G 2013: OC-072The Microaerophilic Microbiota of De-Novo Paediatric Inflammatory Bowel Disease: the Biscuit Study. Gut 62(Suppl 1): A31.1-A31

Ban, L; Tata, L J; Card, T 2013: OC-073Risks of Major Congenital Anomalies in Children Born to Women with Inflammatory Bowel Disease: a United Kingdom Population-Based Cohort Study. Gut 62(Suppl 1): A31.2-A32

Hansen, R.; Mukhopadhya, I.; Meharg, C.; Russell, R.; Berry, S.; El-Omar, E.; Hold, G. 2013: OC-074 The Role of the Fungal Microbiota in the Pathogenesis of De-Novo Paediatric Inflammatory Bowel Disease using next Generation Sequencing. Gut 62(Suppl 1): A32-A32

Kallis, Y; Phillips, N; Steel, A; Kaltsidis, H; Nicholls, J; Jiao, L; Vlavianos, P; Habib, N; Westaby, D 2013: OC-075Analysis of Long-Term outcomes after Endoscopic Radiofrequency Ablation for Bile Duct Strictures in Pancreatic Malignancy Suggests Potential Survival Benefit. Gut 62(Suppl 1): A32.2-A32

Rao, S.; Radhakrishnasetty, N.; Chadalavada, H.; Hiremath, C. 2018: External ophthalmomyiasis by Oestrus ovis : A case report from Davangere. Journal of Laboratory Physicians 10(1): 116-117

Jones, J; Dunkley, I; Maddocks, J 2013: OC-077Is the Referral Appropriate?. Gut 62(Suppl 1): A33-A34

Serra Moltó, A.; Molina Martín, J.C.; Mengual Verdú, E.; Hueso Abancens, J.R. 2018: External ophthalmomyiasis due to Dermatobia hominis. A case report. Archivos de la Sociedad Espanola de Oftalmologia 93(8): 402-405

Alrubaiy, L. 2013: OC-079 Development and Validation of New Clinical Disease Severity Index for Patients with Inflammatory Bowel Disease: a Prospective Multicentre Study. Gut 62(Suppl 1): A34-A34

Johnson, M W; Lithgo, K; Price, T 2013: OC-080Ibd-Sshamp (Supported, Self help and Management Programme); UKS first Internet based Remote Management System for Managing Stable IBD. Gut 62(Suppl 1): A34.3-A35

Canavan, C; Corey, K; Hur, C 2013: OC-081Defining Cirrhosis with Fibroscan for entry to Hepatocellular Carcinoma Surveillance in Chronic Hepatitis C: a UK Cost Effectiveness Analysis. Gut 62(Suppl 1): A35.1-A35

Calvert, C R; Lal, S; Stansfield, C; McLaughlin, J; Robinson, A 2013: OC-082The Development of a Web-Based System to Enhance Care in Inflammatory Bowel Disease. Gut 62(Suppl 1): A35.2-A36

Geraghty, J; Snowball, J; Butler, P; Sarkar, S; Blanks, R; Halloran, S; Rees, C 2013: OC-083Faecal Occult Blood test Analysis in the United Kingdom Bowel Cancer Screening Programme. Gut 62(Suppl 1): A36.1-A36

White, I; Jenkins, J T; Coomber, R; Clark, S K; Phillips, R K S; Kennedy, R H 2013: OC-084A Comparative Study of Clinical outcomes after Laparoscopic or Open Restorative Proctocolectomy. Gut 62(Suppl 1): A36.2-A37

Wright, E; McAteer, C C; McMillan, D C; Horgan, P G; Foulis, A K; Roxburgh, C S 2013: OC-085Predicting Local or Systemic Recurrence after Curative Resection for Colorectal Cancer: the Role of Elastica Stains to Optimise Detection of Venous Invasion. Gut 62(Suppl 1): A37.1-A37

Ishikawa, H; Watanabe, A; Mukogawa, T; Nakatani, M; Nishiguchi, Y; Matsusaka, M; Ko, S 2013: OC-086Survival Benefit of FDG-Pet Oriented Surgery for Recurrent Colorectal Cancer. Gut 62(Suppl 1): A37.2-A38

Yurko, E.O.; Gryaznova, T.V.; Kholin, K.V.; Khrizanforova, V.V.; Budnikova, Y.H. 2017: External oxidant-free cross-coupling: electrochemically induced aromatic C-H phosphonation of azoles with dialkyl-H-phosphonates under silver catalysis. Dalton Transactions 47(1): 190-196

Thomas, G; Norton, C; Nicholls, R J; Vaizey, C 2013: OC-088Prospective Pilot Study to Investigate Transcutaneous Sacral Nerve Stimulation for Faecal Incontinence. Gut 62(Suppl 1): A38.2-A38

Jones, G-R; Cook, P; Webb, L; MacDonald, A 2013: OC-089Epigenetic Control of GI Inflammation Via the Methyl-Binding Protein MBD2. Gut 62(Suppl 1): A38.3-A39

Mezzabotta, L.; Vanni, E.; Rosso, C.; Carenzi, S.; Gambino, R.; Gaggini, M.; Lucarelli, D.; Faletti, R.; Cassader, M.; Smedile, A.; Rizzetto, M.; Gastaldelli, A.; Bugianesi, E. 2013: OC-09 Contribution of visceral fat and hepatic fat to metabolic derangements and liver damage in NAFLD patients. Digestive and Liver Disease 45: S3-S4

Nejad, M Rostami; Rostami, K; Romanos, J; Zojaji, H; Zali, M R; Wijmenga, C 2013: OC-090Correlation between Distribution of HLA Haplotypes and Severity of Mucosal Damages. Gut 62(Suppl 1): A39.1-A39

Marsh, A; Majumdar, D; Corfe, B; Lobo, A; Evans, C 2013: OC-091Are There Changes in Keratin Expression Profile in Active Colitis and in Colitis Phenotypes Associated with Increased Cancer Risk?. Gut 62(Suppl 1): A39.2-A40

Majumdar, D; Evans, C; Corfe, B; Lobo, A 2013: OC-092Alteration in Mucosal Keratin 8 Level, Phosphorylation and Relative Ratio to Vimentin Associate with development of Colitis-Associated Cancer. Gut 62(Suppl 1): A40.1-A40

Landy, J; Al-Hassi, H O; Mann, E R; Peake, S T; McLaughlin, S D; Perry-Woodford, Z L; Ciclitira, P J; Nicholls, J; Clark, S K; Knight, S C; Hart, A L 2013: OC-093The Effects of Faecal Microbiota Transplantation on the Innate Immune System and Epithelial Tight Junction Expression in Chronic Refractory Pouchitis. Gut 62(Suppl 1): A40.2-A41

Lee, L; Geevarghese, R; Heidtbreitch, F; Dockrell, M 2013: OC-094TGF Beta1 Mediated EMT in CACO2BBE Gut Cells. Gut 62(Suppl 1): A41.1-A41

Halimeh, S.; Rott, H. 2013: OC-11 Is a PBAC-score a good tool to quantify menorrhagia in women with von Willebrand disease and rare bleeding disorders?. Thrombosis Research 131: S73-S74

Gori, M.; Barbaro, B.; Arciello, M.; Longo, A.; Viscomi, C.; Balsano, C. 2013: OC-12 P53 and hepatic lipid metabolism: a new interesting connection. Digestive and Liver Disease 45: S4-S5

Pecorelli, A.; Piscaglia, F.; Venerandi, L.; Farinati, F.; Del Poggio, P.; Rapaccini, G.L.; Di Nolfo, M.A.; Benvegnù, L.; Zoli, M.; Borzio, F.; Giannini, E.G.; Caturelli, E.; Chiaramonte, M.; Trevisani, F.; Bolondi, L. 2013: OC-15 Clinical validation of a sub-staging proposal of patients with intermediate HCC (BCLC-B). Digestive and Liver Disease 45: S5-S6

Dall'Agata, M.; Biselli, M.; Gramenzi, A.; Gitto, S.; Liberati, C.; Ravaioli, M.; Gambato, M.; Montalti, R.; Burra, P.; Cillo, U.; Gerunda, G.E.; Pinna, A.D.; Andreone, P.; Bernardi, M. 2013: OC-18 Liver transplantation in cirrhotic patients with MELD score <18: a new model to predict drop-out from the waiting list. Digestive and Liver Disease 45: S6-S7

Tinholt, M.; Viken, M.K.; Børresen-Dale, A.L.; Kristensen, V.; Kåresen, R.; Schlichting, E.; Øystein, G.; Lie, B.A.; Dahm, A.E.; Skretting, G.; Sandset, P.M.; Iversen, N. 2013: OC-18 The link between the hemostatic system and cancer: A genotypephenotype study in breast cancer patients. Thrombosis Research 131: S75-S76

Di Maio, V.C.; Cento, V.; Di Paolo, D.; Armenia, D.; De Luca, F.; Bellocchi, M.C.; Carioti, L.; Tontodonati, M.; De Leonardis, F.; Antonucci, F.P.; Sarrecchia, C.; Rizzardini, G.; Babudieri, S.; Parruti, G.; Angelico, M.; Perno, C.F.; Ceccherini Silberstein, F. 2013: OC-24 Genotype analysis, at baseline and early time-points, by population and ultra-deep sequencing in HCV patients treated with BOC/TVR-based therapy. Digestive and Liver Disease 45: S8-S9

Santantonio, T.; Fasano, M.; Sagnelli, E.; Tundo, P.; Babudieri, S.; Fabris, P.; Toti, M.; Di Perri, G.; Marino, N.; Pizzigallo, E.; Angarano, G. 2013: OC-27 An open, randomized, multicentre trial to evaluate efficacy and safety of a 24 week-course of Peg-interferon α-2b versus a 12 week-course of Peg-Interferon α-2b alone or plus ribavirin in patients with acute hepatitis C. Digestive and Liver Disease 45: S9-S10

Viganò, M.; Lampertico, P.; Mangia, G.; Soffredini, R.; Facchetti, F.; Invernizzi, F.; Colombo, M. 2013: OC-30 Incidence and clinical consequences of reduced tubular phosphate re-absorption in nave CHB patients treated with tenofovir: a two-year field study. Digestive and Liver Disease 45: S10-S11

Colecchia, A.; Mandolesi, D.; Colli, A.; Casazza, G.; Schiumerini, R.; Marzi, L.; Bacchi Reggiani, L.; Bonato, G.; Taddia, M.; Montrone, L.; Scaioli, E.; Mazzella, G.; Festi, D. 2013: OC-33 Spleen and liver stiffness measurement can predict clinical complications in compensated cirrhotic patients: a prospective study. Digestive and Liver Disease 45: S11-S12

Winterfeld, U.; Buclin, T.; Klinger, G.; Panchaud, A.; Stephens, S.; Arnon, J.; Malm, H.; te Winkel, B.; Clementi, M.; Pistelli, A.; Man˘áková, E.; Eleftheriou, G.; Merlob, P.; Kaplan, Y.C.; Rothuizen, L.E. 2013: OC003Pregnancy Outcome Following Maternal Exposure To Mirtazapine: Preliminary Results Of A Collaborative Entis Study. Clinical Therapeutics 35(8): E1-E2

Perrottet Ries, N.; Brunner-Ferber, F.; Grouzmann, E.; Spertini, F.; Biollaz, J.; Buclin, T.; Widmer, N. 2013: OC005Biases On The Administered Parenteral Doses Of An Experimental Drug During Phase I Clinical Trials. Clinical Therapeutics 35(8): E2-E3

Ovesjö, M.-L.; Böttiger, Y. 2013: OC007Assessment Of Clinical Pharmacology Skills As Part Of The New Integrated Final Exam For Medical Students At Karolinska Institutet. Clinical Therapeutics 35(8): E3-E4

Bennie, M.; Dear, J.; Dunlop Corcoran, E.; Hems, S.; McTaggart, S.; Newham, R.; Waugh, C. 2013: OC009An Assessment Of The Accuracy Of Horizon Scanning Predictions Of Medicine Use In The Scottish National Health Service. Clinical Therapeutics 35(8): E4-E5

Paladini, D.; Pastore, G.; Cavallaro, A.; Massaro, M.; Nappi, C. 2013: OC01.01: Corpus callosum agenesis in the fetus: sonographic signs change with advancing gestational age. Ultrasound in Obstetrics and Gynecology 42(S1): 1-1

Pugash, D.; Mayer, C.; Hendson, G.; Dunham, C.P. 2013: OC01.04: Periventricular leukomalacia in the fetus: prenatal imaging and diagnostic features. Ultrasound in Obstetrics and Gynecology 42(S1): 2-2

Reid, S.; Lu, C.; Casikar, I.; Menakaya, U.; Phua, C.; Condous, G. 2013: OC02.01: Office sonovaginography for the prediction of deep infiltrating endometriosis. Ultrasound in Obstetrics and Gynecology 42(S1): 2-3

Reid, S.; Lu, C.; Casikar, I.; Menakaya, U.; Phua, C.; Condous, G. 2013: OC02.02: Development of new models to predict of pouch of Douglas (POD) obliteration in women with suspected endometriosis. Ultrasound in Obstetrics and Gynecology 42(S1): 3-3

Guerriero, S.; Ajossa, S.; Peddes, C.; Perniciano, M.; Soggiu, B.; Saba, L.; Alcazar, J.; Piras, A.; Melis, G.B. 2013: OC02.04: Three dimensional (3D) ultrasonography improves the accuracy of two dimensional (2D) ultrasonography in the diagnosis of deep endometriosis. Ultrasound in Obstetrics and Gynecology 42(S1): 3-4

Wozniak, S.; Czuczwar, P.; Szkodziak, P.R.; Wozniakowska, E.; Paszkowski, M.; Milart, P.; Wrona, W.; Paszkowski, T. 2013: OC02.05: Elastography is superior to ultrasound in preoperative assessment of abdominal wall endometriosis. Ultrasound in Obstetrics and Gynecology 42(S1): 4-4

Costa, F.D.; Panagodage, S.; Brennecke, S.P.; Murthi, P. 2013: OC03.01: Low-dose aspirin improves trophoblastic function in early-onset pre-eclampsia. Ultrasound in Obstetrics and Gynecology 42(S1): 5-5

Aviram, A.; Aviram, R.; Ben-Haroush, A. 2013: OC03.03: Sonographic fetal weight estimation compared with actual birth weight in two consecutive deliveries. Ultrasound in Obstetrics and Gynecology 42(S1): 5-6

Visentin, S.; Bertin, M.; Zanardo, V.; Cosmi, E. 2013: OC03.04: Aortic wall thickness and amniotic fluid albuminuria in growth restricted twin fetuses. Ultrasound in Obstetrics and Gynecology 42(S1): 6-6

Bourgeois, J.; Elseviers, M.; Van Bortel, L.; Petrovic, M.; Vander Stichele, R. 2013: OC037Sleep Quality Of Chronic Benzodiazepine Users In Nursing Homes: A Comparative Study With Non-Users. Clinical Therapeutics 35(8): E14-E15

Mathiesen, J.M.; Aksglaede, L.; Skibsted, L.; Petersen, O.; Tabor, A.; Group, D. 2013: OC04.01: Outcome of fetuses with short femur length detected at second trimester malformation scan: a national survey. Ultrasound in Obstetrics and Gynecology 42(S1): 7-7

Fanelli, T.; Costa, C.; Hall, P.; Burton, S.; Broster, S.; Ahmad, T.; Lees, C. 2013: OC04.03: Infant outcomes following antenatal detection of facial cleft. Ultrasound in Obstetrics and Gynecology 42(S1): 7-8

de Jong, E.; Vos, F.; Bakker, M.; Ribbert, L.S.; Bilardo, C.M. 2013: OC04.04: Forehead assessment in normal and pathological fetuses by the fetal profile line. Ultrasound in Obstetrics and Gynecology 42(S1): 8-8

Heron, H.; Lopes dos Santos, J.; Fontes, R.; Belmonte, S.; Daltro, P.; Scudieri Paes Werner, C.; Campbell, S. 2013: OC04.06: Additive manufacturing models of fetuses built from 3D ultrasound and magnetic resonance imaging for blind pregnant patients. Ultrasound in Obstetrics and Gynecology 42(S1): 8-9

Mahendru, A.; Everett, T.R.; McEniery, C.M.; Wilkinson, I.B.; Lees, C. 2013: OC05.01: Relationship between maternal cardiovascular adaptation fetal growth and birthweight. Ultrasound in Obstetrics and Gynecology 42(S1): 9-9

Cavalcante, R.; Barros, F.S.; Caetano, A.R.; Zamarian, A.P.; Araujo Junior, E.; Nardozza, L.; Moron, A.F. 2013: OC05.03: Assessment of fetal nutrition status through limb volume measurement by 3D ultrasound and correlated with newborn anthropometric data. Ultrasound in Obstetrics and Gynecology 42(S1): 9-10

Knight, C.L.; Rueda, S.; Ahmed, M.; Edwards, K.; Noble, J.A.; Papageorghiou, A.T. 2013: OC05.04: Fetal arm volumetry: a novel assessment of fetal body composition in the second and third trimester. Ultrasound in Obstetrics and Gynecology 42(S1): 10-10

Sasahara, J.; Ishii, K.; Taguchi, T.; Hayashi, S.; Mitsuda, N. 2013: OC05.06: Perinatal prognostic factors for outcome at 18 months of age in preterm growth-restricted infants. Ultrasound in Obstetrics and Gynecology 42(S1): 10-11

Lee, S.; Lee, S.; Lee, H. 2013: OC06.01: Ultrasound-guided transcervical forceps extraction of Cesarean scar or cervical pregnancy. Ultrasound in Obstetrics and Gynecology 42(S1): 11-11

Charan, P.; Tran, H.; Lee, S.; Palma-Dias, R.; Woodrow, N. 2013: OC06.04: Interstitial pregnancy: 10-year review of management options and outcomes at a tertiary level hospital in Australia. Ultrasound in Obstetrics and Gynecology 42(S1): 12-12

Mongelli, M.; Lu, C.; Reid, S.; Stamatopoulos, N.; Sankaralingam, K.; Casikar, I.; Hardy, N.; Condous, G. 2013: OC06.07: Is there a correlation between aberrant embryonic crown-rump length growth velocities and subsequent birth weights?. Ultrasound in Obstetrics and Gynecology 42(S1): 13-13

DeKoninck, P.; D'hooge, J.; Van Mieghem, T.; Richter, J.; De Catte, L.; Deprest, J.A. 2013: OC07.02: The use of speckle tracking in cardiac function assessment in fetuses with congenital diaphragmatic hernia. Ultrasound in Obstetrics and Gynecology 42(S1): 13-14

DeKoninck, P.; Richter, J.; Van Mieghem, T.; Van Schoubroeck, D.; Allegaert, K.; De Catte, L.; Deprest, J.A. 2013: OC07.03: Cardiac assessment in fetuses with right-sided congenital diaphragmatic hernia (RCDH): a case-controlled study. Ultrasound in Obstetrics and Gynecology 42(S1): 14-14

Sinkovskaya, E.; Klassen, A.; Abuhamad, A. 2013: OC07.05: A comparison of myocardial velocity information derived by pulsed and color Doppler techniques. Ultrasound in Obstetrics and Gynecology 42(S1): 14-15

Yilmaz, B.; Narayan, H.; Wilpers, A.; Wiess, C.L.; Fifer, W.P.; Williams, I.A. 2013: OC07.06: Differences in fetal electrocardiographic intervals among fetuses with normal cardiac anatomy and fetuses with CHD as measured using the MONICA AN24. Ultrasound in Obstetrics and Gynecology 42(S1): 15-15

Pagani, G.; Prefumo, F.; Thilaganathan, B. 2013: OC08.02: Neurodevelopmental outcome in isolated mild ventriculomegaly: systematic review and meta-analysis. Ultrasound in Obstetrics and Gynecology 42(S1): 16-16

D'Antonio, F.; Pagani, G.; Bhide, A.; Thilaganathan, B.; Khalil, A. 2013: OC09.01: Ovarian hyper stimulation syndrome and adverse obstetric outcome: systematic review and meta-analysis. Ultrasound in Obstetrics and Gynecology 42(S1): 17-17

Martins, W.P.; Vieira, C.V.; Teixeira, D.M.; Barbosa, M.A.; Dassunção, L.A.; Nastri, C.O. 2013: OC09.04: Ultrasound for monitoring controlled ovarian stimulation: a systematic review and meta-analysis of randomized controlled trials. Ultrasound in Obstetrics and Gynecology 42(S1): 18-18

Salman, M.S.; Abou Salem, N.; El Sherbiny, W.; El-Mazny, A. 2013: OC10.01: Comparative study of two- and three-dimensional sonohysterography versus office hysteroscopy for the evaluation of uterine cavity in the reproductive age. Ultrasound in Obstetrics and Gynecology 42(S1): 19-19

Eisenberg, V.H.; Weintraub, A.Y.; Bibi, G.; Zolti, M.; Schiff, E.; Goldenberg, M.; Soriano, D. 2013: OC10.04: The prevalence of sonographic signs of adenomyosis in women undergoing surgery for endometriosis. Ultrasound in Obstetrics and Gynecology 42(S1): 19-20

Installe, A.J.; Van den Bosch, T.; De Moor, B.; Timmerman, D. 2013: OC10.05: Studying inter-rater agreement of sonographic video clips using Clinical Data Miner. Ultrasound in Obstetrics and Gynecology 42(S1): 20-20

Nastri, C.O.; Ferriani, R.A.; Raine-Fenning, N.J.; Martins, W.P. 2013: OC11.01: Endometrial injury performed in the non-transfer cycle and assisted reproduction outcomes: a randomized controlled trial. Ultrasound in Obstetrics and Gynecology 42(S1): 20-21

Graupera, B.; Pascual, M.; Hereter, L.; Úbeda, B.; Pedrero, C.; Fernández-Cid, M. 2013: OC11.02: Three-dimensional ultrasound in diagnosis of congenital uterine anomalies comparing with magnetic resonance imaging. Ultrasound in Obstetrics and Gynecology 42(S1): 21-21

Valenzuela-Alcaraz, B.; Crispi, F.; Bijnens, B.; Cruz Lemini, M.; Creus, M.; Sitges, M.; Cívico, S.; Balasch, J.; Gratacós, E. 2013: OC11.03: Fetal cardiovascular dysfunction is present in pregnancies conceived by assisted reproductive technologies. Ultrasound in Obstetrics and Gynecology 42(S1): 21-22

D'Antonio, F.; Khalil, A.; Bhide, A.; Thilaganathan, B. 2013: OC11.04: Second trimester cervical length and spontaneous preterm birth in twin pregnancies. Ultrasound in Obstetrics and Gynecology 42(S1): 22-22

Cruz Lemini, M.; Crispi, F.; Valenzuela-Alcaraz, B.; Figueras, F.; Gómez, O.; Sitges, M.; Bijnens, B.; Gratacós, E. 2013: OC12.02: Fetal cardiovascular score for prediction of infant hypertension and arterial remodeling in intrauterine growth restricted infants. Ultrasound in Obstetrics and Gynecology 42(S1): 23-23

Henry, A.; Welsh, A.W. 2013: OC12.04: Monitoring cholestasis of pregnancy using the fetal modified myocardial performance index (mod-MPI). Ultrasound in Obstetrics and Gynecology 42(S1): 23-24

Dadlez, N.; Brubaker, S.G.; Yilmaz, B.; Simpson, L.; Williams, I.A. 2013: OC12.05: Should elective deliveries be delayed in pregnancies complicated by major fetal cardiac anomalies?. Ultrasound in Obstetrics and Gynecology 42(S1): 24-24

Enzensberger, C.; Tenzer, A.; Doelle, A.; Degenhardt, J.; Axt-Fliedner, R. 2013: OC12.07: Three-dimensional (3D) speckle tracking in fetal echocardiography: a new technology in assessment of fetal heart function. Ultrasound in Obstetrics and Gynecology 42(S1): 24-25

Ridding, G.; McLennan, A.; Sahota, D.S. 2013: OC13.01: Assessing quality standards in the measurement of maternal uterine artery Doppler parameters at 11-14 weeks gestation. Ultrasound in Obstetrics and Gynecology 42(S1): 25-25

Cosmi, E.; Rampon, M.; Visentin, S.; Bertin, M. 2013: OC13.03: Prenatal scale for cardiovascular risk in intrauterine growth restriction. Ultrasound in Obstetrics and Gynecology 42(S1): 25-26

Prior, T.; Mullins, E.; Bennett, P.; Kumar, S. 2013: OC13.04: Prediction of intra-partum fetal compromise in normal pregnancies: a composite risk score. Ultrasound in Obstetrics and Gynecology 42(S1): 26-26

Russo, K.; Grivell, R.; Simmons, L.; Hyett, J. 2013: OC13.07: Maternal cardiac function in women deemed high-risk for pre-eclampsia with subsequent normal and adverse outcomes. Ultrasound in Obstetrics and Gynecology 42(S1): 27-27

Ludovisi, M.; De Blasis, I.; Virgilio, B.; Giansiracusa, C.; Fischerova, D.; Franchi, D.; Pascual, M.; Savelli, L.; Epstein, E.; Van Holsbeke, C.; Guerriero, S.; Czekierdowski, A.; Jurkovic, D.; Rossi, A.; Timmerman, D.; Mascilini, F.; Valentin, L.; Testa, A. 2013: OC14.03: Clinical and ultrasound characteristics of tubal cancer. Ultrasound in Obstetrics and Gynecology 42(S1): 28-28

Alcazar, J.; Utrilla-Layna, J.; Minguez, J.; Jurado, M. 2013: OC14.05: Clinical and ultrasound features of type I and type II epithelial ovarian cancer. Ultrasound in Obstetrics and Gynecology 42(S1): 28-29

Jokubkiene, L.; Sladkevicius, P.; Valentin, L. 2013: OC14.06: The prevalence of ovarian lesions in asymptomatic postmenopausal women. Ultrasound in Obstetrics and Gynecology 42(S1): 29-29

Alcazar, J.; Pascual, M.; Olartecoechea, B.; Aubá, M.; Graupera, B.; Hereter, L.; Ajossa, S.; Julve, R.; Sedda, F.; Saba, L.; Guerriero, S. 2013: OC14.08: IOTA simple rules for discriminating between benign and malignant adnexal masses: a prospective external validation. Ultrasound in Obstetrics and Gynecology 42(S1): 30-30

D'Antonio, F.; Khalil, A.; Carvalho, J. 2013: OC15.03: Management of fetal right aortic arch without associated intracardiac abnormalities: cohort study and meta analysis. Ultrasound in Obstetrics and Gynecology 42(S1): 31-31

Sandaite, I.; Dymarkowski, S.; De Catte, L.; Moerman, P.; Gewillig, M.; Fedele, L.; Deprest, J.; Claus, F. 2013: OC15.06: Fetal heart pathology on postmortem 3-Tesla magnetic resonance imaging. Ultrasound in Obstetrics and Gynecology 42(S1): 32-32

Pugash, D.; Hendson, G.; Dunham, C.P.; Money, D.M. 2013: OC16.02: Fetal white matter abnormalities in cytomegalovirus infection. Ultrasound in Obstetrics and Gynecology 42(S1): 32-33

Deloison, B.; Salomon, L.J.; Sonigo, P.; Nicloux, M.; Millischer, A.; Magny, J.; Brunelle, F.; Ville, Y. 2013: OC16.03: Prenatal MRI hypersignal intensity of the white matter in T2 weight sequences in cytomegalovirus infection: myth or reality. Ultrasound in Obstetrics and Gynecology 42(S1): 33-33

Zhang, X.; Zheng, R.; He, X.; Mao, Y.; Huang, Z.; Xu, J. 2013: OC17.02: The use of contrast enhanced ultrasound in evaluation the effect of chemotherapy in cervical carcinoma. Ultrasound in Obstetrics and Gynecology 42(S1): 33-34

Dueholm, M.; Møller, C.; Rydbjerg, S.; Hansen, E.; Ørtoft, G. 2013: OC17.03: An ultrasound algorithm for the identification of endometrial cancer. Ultrasound in Obstetrics and Gynecology 42(S1): 34-34

van Dyk, S.; Kondalsamy-Chennakesavan, S.; Narayan, K.; Schneider, M. 2013: OC17.06: Comparison of measurements of the uterus and cervix obtained by MRI and ultrasound imaging used for planning radiotherapy for cervix cancer. Ultrasound in Obstetrics and Gynecology 42(S1): 35-35

de Jong, E.; Vos, F.; Kagan, K.; Ribbert, L.S.; Tromp, E.; Bilardo, C.M. 2013: OC18.01: The prenasal thickness to nasal bone length ratio: 2D versus 3D ultrasound. Ultrasound in Obstetrics and Gynecology 42(S1): 35-36

Lee, S.; Jun, J.K.; Kang, M.; Kim, S.; Kim, B.; Lee, J.; Park, C.; Park, J.S. 2013: OC18.02: N-terminal pro-B-type natriuretic peptide and cardiac troponin T in non-immune hydrops. Ultrasound in Obstetrics and Gynecology 42(S1): 36-36

Hartge, D.R.; Schröer, A.; Weichert, J. 2013: OC18.03: Differentiating fetal hydrops: sonographic landmarks. Ultrasound in Obstetrics and Gynecology 42(S1): 36-37

Javadian, P.; Shamshirsaz, A.A.; Cass, D.; Zamora, I.; Lee, T.; Cassady, C.; Ayres, N. A.; Mehollin-Ray, A.; Fernandes, C.; Welty, S.; Kalin, J. A.; Maskati, S. A.; Olutoye, O.; Belfort, M.; Ruano, R. 2013: OC18.04: Prenatal ultrasound and magnetic resonance imaging findings in fetuses with heart defect associated with congenital diaphragmatic hernia. Ultrasound in Obstetrics and Gynecology 42(S1): 37-37

Pilzek, A.; Shek, C.; Guzman Rojas, R.A.; Kamisan Atan, I.; Dietz, H.P. 2013: OC19.01: Recurrence after prolapse surgery: does partial avulsion matter?. Ultrasound in Obstetrics and Gynecology 42(S1): 37-38

Eisenberg, V.H.; Alcalay, M.; Bitman, G.; Achiron, R.; Schiff, E. 2013: OC19.02: Residual sphincter defects and symptoms in women examined within one year from a delivery with OASIS. Ultrasound in Obstetrics and Gynecology 42(S1): 38-38

Wong, V.; Guzman Rojas, R.A.; Shek, C.; Chou, D.; Moore, K.H.; Dietz, H.P. 2013: OC19.04: Bladder support after laparoscopic sacrocolpopexy: where is the mesh?. Ultrasound in Obstetrics and Gynecology 42(S1): 38-39

Chan, S.S.; Chung, M.; Wan, O.; Cheung, R. 2013: OC19.05: Levator ani muscle injury after instrumental delivery in Chinese primiparous women. Ultrasound in Obstetrics and Gynecology 42(S1): 39-39

Guerra, F.A.; Moore, P.; Acuña, E.N.; Mansilla, J.R. 2013: OC20.01: Who should perform obstetrics ultrasound in the primary health care centers? A need to be consequent with our reality. Ultrasound in Obstetrics and Gynecology 42(S1): 39-40

Tolsgaard, M.G.; Dreisler, E.; Klemmensen, A.; Loft, A.; Sorensen, J.; Ringsted, C.; Ottesen, B.; Tabor, A. 2013: OC20.02: Is the objective structured assessment of ultrasound skills (OSAUS) a reliable and valid tool to assess ultrasound skills?. Ultrasound in Obstetrics and Gynecology 42(S1): 40-40

Oh, S.; Yoon, S.; An, J.; Cha, H.; Oh, S.; Kim, J.; Roh, C. 2013: OC20.04: Ultrasonographic and clinical factors for the prediction of peripartum complications in pregnancies complicated by placenta previa. Ultrasound in Obstetrics and Gynecology 42(S1): 40-41

McNally, G.R.; Ngu, A. 2013: OC20.05: Survey of microbial contamination of ultrasound probe handles following high-level disinfection with ortho-phthalaldehyde. Ultrasound in Obstetrics and Gynecology 42(S1): 41-41

Salomon, L.J.; Castaing, O.; Kuleva, M.; Bernard, J.; Fries, N.; Fontanges, M.; Haddad, G.; Mangione, R.; Boukobza, P.; Combourieu, D.; Bussiere, P.; Le Gac, M.; Coquel, P.; Billen, P. 2013: OC20.07: Lower uterine segment in the first trimester of pregnancy: a quality based approach. Ultrasound in Obstetrics and Gynecology 42(S1): 41-42

Belachew, J.; Eurenius, K.; Axelsson, O.; Mulic-Lutvica, A. 2013: OC20.08: 3D ultrasound does not improve diagnosis of retained placental tissue compared to 2D ultrasound. Ultrasound in Obstetrics and Gynecology 42(S1): 42-42

Petersen, O.; Vogel, I.; Hyett, J.; Ekelund, C.K.; Tabor, A. 2013: OC21.02: Diagnostic consequences of substituting non-invasive (NIPT) for invasive prenatal testing following combined first trimester screening. Ultrasound in Obstetrics and Gynecology 42(S1): 43-43

Conner, P.; Marsk, A.; Almström, H.; Gustafsson, S.; Kublickas, M. 2013: OC21.04: First trimester serum biochemistry and screen positive rates in 3 consecutive pregnancies. Ultrasound in Obstetrics and Gynecology 42(S1): 43-44

D'Antonio, F.; Khalil, A.; Mantovani, E.; Thilaganathan, B. 2013: OC22.01: Embryonic growth discordance and early fetal loss in twins: the STORK multiple pregnancy cohort. Ultrasound in Obstetrics and Gynecology 42(S1): 44-44

De Musso, F.; Chalouhi, G.E.; Al-Ibrahim, A.; Essaoui, M.; Stirnemann, J.; Salomon, L.J.; Ville, Y. 2013: OC22.04: Laser therapy as an exclusive treatment of twin anemia-polycythemia (TAPS) sequence. Ultrasound in Obstetrics and Gynecology 42(S1): 45-45

D'Antonio, F.; Khalil, A.; Dias, T.; Bhide, A.; Thilaganathan, B. 2013: OC22.06: Third trimester weight discordance cut-offs and perinatal mortality in twins: the STORK multiple pregnancy cohort. Ultrasound in Obstetrics and Gynecology 42(S1): 45-46

DeStigter, K.; Souza, S.; Rielly, M.; Nelson, M.; Morey, G.; Silfen, E.; Kawooya, M.; Matovu, A.; Garra, B. 2013: OC23.01: The prevalence of prenatal conditions detected by ultrasound in a rural clinic in Uganda. Ultrasound in Obstetrics and Gynecology 42(S1): 46-46

Morey, G.; DeStigter, K.; Kim, P.; Rielly, M.; Souza, S.; Miele, F.; Nelson, M.; Silfen, E.; Kawooya, M.; Garra, B. 2013: OC23.03: A comparative evaluation of a simplified, low-cost ultrasound protocol with standard obstetrical ultrasonography in the recognition of common prenatal diagnoses. Ultrasound in Obstetrics and Gynecology 42(S1): 47-47

Yoshizawa, J; Abe, Y; Hozumi, Y; Oiso, N; Narita, T; Kawada, A; Fukai, K; Motokawa, T; Nakamura, T; Tamiya, G; Suzuki, T 2013: OCA2 polymorphisms are associated with skin color and risk of skin cancer in Japanese population. Journal of Dermatological Science 69(2): E90-E91

Leistner, D. M.; Fichtlscherer, S.; Thome, C.; Boeckel, N.; Roexe, T.; Ardogan, M.; Lehmann, R.; Seeger, F. H.; Dimmeler, S.; Zeiher, A. M. 2013: OCT-derived coronary plaque morphology and transcoronary concentration gradients of vessel wall-associated microRNAs. European Heart Journal 34(Suppl 1): P5445-P5445

Pérez-Suárez, A; Martínez-Trinidad, Jé F.; Carrasco-Ochoa, Jús A.; Medina-Pagola, Jé E. 2013: OClustR: A new graph-based algorithm for overlapping clustering. Neurocomputing 121: 234-247

Eastman, P 2013: ODAC Chairs Reveal Challenges, High Drama in a Decade of Service. Oncology Times 35(9): 19-20

Eastman, P 2013: ODAC Votes No on Tivozanib for Advanced Renal Cell Carcinoma. Oncology Times 35(11): 10-11

Eastman, P 2013: ODAC Votes for Accelerated Approval of Pertuzumab as First Neoadjuvant Treatment for Breast Cancer. Oncology Times 35(19): 11-12

Taji, M.; Ataei, M.; Goshtasbi, K.; Osanloo, M. 2013: ODM: a new approach for open pit mine blasting evaluation. Journal of Vibration and Control 19(11): 1738-1752

Bianchi, A.E.; Fernández, M.; Pantanetti, M.; Viña, R.; Torriani, I.; Sánchez, R.M. Torres; Punte, G. 2013: ODTMA+ and HDTMA+ organo-montmorillonites characterization: New insight by WAXS, SAXS and surface charge. Applied Clay Science 83-84: 280-285

Audouin, L.; Rigollet, L.; Prétrel, H.; Le Saux, W.; Röwekamp, M. 2013: OECD PRISME project: Fires in confined and ventilated nuclear-type multi-compartments - Overview and main experimental results. Fire Safety Journal 62: 80-101

Santa Maria, J A.; Schultz, B F.; Ferguson, J. B.; Gupta, N; Rohatgi, P K. 2013: OECD health in a nutshell. Pharmacoeconomics and Outcomes News 693(1): 2-2

Azzouz, A; Platon, N; Nousir, S; Ghomari, K; Nistor, D; Shiao, T Chieh; Roy, Ré 2013: OH-enriched organo-montmorillonites for potential applications in carbon dioxide separation and concentration. Separation and Purification Technology 108: 181-188

Gibilisco, R G.; Santiago, A N.; Teruel, M A. 2013: OH-initiated degradation of a series of hexenols in the troposphere. Rate coefficients at 298 K and 1 atm. Atmospheric Environment 77: 358-364

Ahmad, A; Ali, A; Khaliq, T; Wajid, S Aftab; Iqbal, Z; Ibrahim, M; Rashad Javeed, H Muhammad; Hoogenboom, G 2013: OILCROP-SUN Model Relevance for Evaluation of Nitrogen Management of Sunflower Hybrids in Sargodha, Punjab. American Journal of Plant Sciences 04(09): 1731-1735

Kevin, B. Smith, P K. Hatemi 2013: OLS is AOK for ACE: A Regression-Based Approach to Synthesizing Political Science and Behavioral Genetics Models. Political Behavior 35(2): 383-408

Kirwan, J R. 2013: OMERACT Where it came from and what it is trying to do. Indian Journal of Rheumatology 8: S4-S7

Vaucher, P 2013: OMT especially recommended for severe low back pain. International Journal of Osteopathic Medicine 16(4): 243-244

Ramanauskaitė, S; Radvilė, Eė; Olifer, D 2013: Ontologijos Naudojimas Informacijos Saugumo Reikalavimams Susieti; use of Ontologies in Mapping of Information Security Requirements;. Mokslas - Lietuvos Ateitis 5(2): 88-91

Wang, K; Zhu, K; Wang, Y; Yan, B; Yuan, J; Sang, X; Xin, X 2013: OOK-to-QPSK modulation-format conversion based on two gain-transparent SOAs. Optik - International Journal for Light and Electron Optics 124(20): 4486-4489

Binder, S.; Berg, K.; Gasca, F.; Born, J.; Marshall, L. 2013: OP 1. Boosting sleep slow oscillations by oscillatory transcranial direct current stimulation enhances memory consolidation in rats. Clinical Neurophysiology 124(10): E54-E55

Gundlach, C.; Müller, M.M.; Nierhaus, T.; Villringer, A.; Sehm, B. 2013: OP 10. Phasic modulation of somatosensory perception by means of transcranial alternating current stimulation. Clinical Neurophysiology 124(10): E60-E61

Rampersad, S.; Stegeman, D.; Oostendorp, T. 2013: OP 11. Optimized tDCS electrode configurations for five targets determined via an inverse FE modeling approach. Clinical Neurophysiology 124(10): E61-E62

Gonzalez-Rosa, J.J.; Soto-Leon, V.; Foffani, G.; Strange, B.; Oliviero, A. 2013: OP 12. Effects of transcranial static magnetic field stimulation (tSMS) over the human visual cortex: Behavioural and electrophysiological effects. Clinical Neurophysiology 124(10): E62-E63

Cappelletti, M.; Gessaroli, E.; Hithersay, R.; Mitolo, M.; Kanai, R.; Kadosh, R. Cohn; Walsh, V. 2013: OP 2. Transfer of cognitive training across magnitude dimensions achieved with concurrent brain stimulation of the parietal lobe. Clinical Neurophysiology 124(10): E55-E56

Karim, A.; Schneider, M.; Kipping, J.; Kotchoubey, B.; Khedr, E.; Fallgatter, A.; Birbaumer, N. 2013: OP 4. Psychopathic traits and the psychophysiology of deception: A transcranial direct current stimulation (tDCS) study. Clinical Neurophysiology 124(10): E57-E58

Looi, C.Y.; Duta, M.; Huber, S.; Nuerk, H.-C.; Kadosh, R. Cohen 2013: OP 6. Stimulating the brain while playing a computer-based maths game to enhance domain-specific and domain-general cognitive abilities. Clinical Neurophysiology 124(10): E58-E59

Márquez-Ruiz, J.; Ammann, C.; Leal-Campanario, R.; Wendling, F.; Ruffini, G.; Gruart, A.; Delgado-García, J. 2013: OP 8. Modulating tactile perception and learning processes by tCS in animal models: Hyperinteraction viability experiments (HIVE). Clinical Neurophysiology 124(10): E59-E60

Saraswati, S.; Kanaujia, P.K.; Agrawal, S.S. 2013: OP-03 α-Santalol demonstrates antitumor and antiantiangiogenic activities in models of hepatocellular carcinoma in vitro and in vivo. Digestive and Liver Disease 45: S249-S250

Korkut, S.; Sozen, S.B. 2013: OP-078 THE IMPACT OF MAD-HONEY INTOXICATION ON ELECTROCARDIOGRAPHY M.C. Sumerkan. International Journal of Cardiology 163(3): S30-S31

Lin, C.-H.; Wan, L. 2013: OP-10 Grifola frondosa water extract induces autophagy and leads to apoptotic cell death through the inhibition of PI3K/AKt and ERK pathways in human Hep3B cancer cells. Digestive and Liver Disease 45: S251-S252

Nickkholgh, A.; Mehrabi, A.; Hafezi, M.; Edalatpour, A.; Göppert, B.; Bruckner, T.; Schemmer, P.; Büchler, M.W. 2013: OP-13 Liver resection for cholangiocarcinoma: A single-center experience of the first decade of the new millennium. Digestive and Liver Disease 45: S252-S253

Fiorentini, G.; Aliberti, C.; Coschiera, P.; Tilli, M.; Mulazzani, L.; Marqués, A.; Marcos, R. García; Gómez, F.M.; Concepciòn, L.; Rizo, A.; De Simone, M.; Mambrini, A. 2013: OP-16 Chemoembolization adopting drug eluting beads preloaded with irinotecan (DEBIRI) plus cetuximab (debiritux) as second-line treatment for metastatic colorectal cancer (CRC) to the liver: Results of a clinical phase II trial. Digestive and Liver Disease 45: S253-S254

Kuhlmann, K.F.D.; Schat, E.; Hagendoorn, J.; Nijkamp, J.; Ruers, T.J.M. 2013: OP-24 Application of three-dimensional imaging on an iPad during liver surgery. Digestive and Liver Disease 45: S256-S257

Justinger, C.; Wirch, D.; Baral, J.; Gärtner, D.; Schöttler, A.; Münch, S.; Hecker, J.; Kant, D.; Rüdiger, T.; Tatsch, K.; Reimer, P.; Schön, M.R. 2013: OP-27 Liver resection after selective internal radiotherapy (SIRT) for liver metastasis of colorectal malignancies. Digestive and Liver Disease 45: S257-S258

Weiwei, W.; Dahmen, U.; Hohmann, N.; Voß-Böhme, A.; Deutsch, A.; Settmacher, U.; Dirsch, O. 2013: OP-30 Liver size remains stable when receiving regeneration and atrophy signals simultaneously: Mathematical model and experimental results. Digestive and Liver Disease 45: S258-S259

Hsu, Y.-A.; Wan, L. 2013: OP-33 STAT6 in the anti-proliferative activities of type I interferon: The roles of SP1 and BCL6. Digestive and Liver Disease 45: S259-S260

ple, 2013: OP-Tisch rächt sich mit den Jahren. Cme: Premium-Fortbildung für die Medizinische Praxis 10(9): 42-42

Ritchlin, C.; McInnes, I.; Kavanaugh, A.; Puig, L.; Rahman, P.; Li, S.; Shen, Y.; Doyle, M.; Mendelsohn, A.; Gottlieb, A. 2013: OP0001Maintenance of Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis Despite Prior Conventional Nonbiologic and Anti-TNF Biologic Therapy: 1 Yr Results of the Psummit 2 Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A48.1-A48

Kee, S.-J.; Cho, Y.-N.; Jin, H.-M.; Kim, M.-J.; Kim, J.-E.; Jung, H.-J.; Park, Y.-W. 2013: OP0002Pathomechanism of Bone Destruction in Chronic Gouty Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A48.2-A48

Nurmohamed, M.T.; Bao, Y.; Signorovitch, J.; Mulani, P.M.; Furst, D.E. 2013: OP0002Use of anti-TNF therapy is associated with reduced cardiovascular event risk in rheumatoid arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 52.2-52

Gossec, L.; Gaujoux-Viala, C.; Rat, A.-C.; Fautrel, B.; Saraux, A.; Guillemin, F.; Paternotte, S.; Dougados, M. 2013: OP0003Are patient global and fatigue predictive of structural outcomes, 3 years later, in patients in remission in early arthritis? Results from the french espoir cohort:. Annals of the Rheumatic Diseases 71(Suppl 3): 53.1-53

Meek, I.; Vonkeman, H. E.; van de Laar, M. A. 2013: OP0004Cardiovascular Risk in Intensively Treated Rheumatoid Arthritis: Comparison to an Osteoarthritis Population. First Prospective Analysis of the Act-CVD Cohort. Annals of the Rheumatic Diseases 72(Suppl 3): A49.1-A49

Solari, N.; Palmisani, E.; Consolaro, A.; Pistorio, A.; Lanni, S.; Dalprà, S.; Schiappapietra, B.; Bracciolini, G.; Frisina, A.; Martini, A.; Ravelli, A. 2013: OP0004Predictors of achievement of inactive disease in children with juvenile idiopathic arthritis treated with etanercept. Annals of the Rheumatic Diseases 71(Suppl 3): 53.2-53

Pappas, D. A.; John, A.; Kremer, J.; Reed, G.; Greenberg, J.; Shewade, A.; Solomon, D. H.; Curtis, J. R. 2013: OP0005Effect of Biologic Agents on Lipids and Cardiovascular Risk in Rheumatoid Arthritis Patients. Annals of the Rheumatic Diseases 72(Suppl 3): A49.2-A49

Roussou, E.; Thapper, M. 2013: OP0005rheumaholidays, niche speciality and womens preference is how final years medical students view rheumatology as a speciality when asked if they would consider it as part of fountation years training. Annals of the Rheumatic Diseases 71(Suppl 3): 53.3-54

Wipff, J.; Lemelle, I.; Pajot, C.; Duquesne, A.; Lorrot, M.; Faye, A.; Bader-Meunier, B.; Brochard, K.; Despert, V.; Grall-Lerosey, M.; Marot, Y.; Nouar, D.; Pagnier, A.; Quartier, P.; Deslandre, C. 2013: OP0006A Large National Cohort of French Patients with Chronic Recurrent Multifocal Osteitis. Annals of the Rheumatic Diseases 72(Suppl 3): A50.1-A50

Buch, M.H.; Carmona, L.; Silva, L.; Boers, M. 2013: OP0007Development of eular recommendations for the reporting of clinical trial extension studies. Annals of the Rheumatic Diseases 71(Suppl 3): 54.2-54

Daien, C. I.; Gailhac, S.; Combe, B.; Hahne, M.; Morel, J. 2013: OP0007Regulatory B Cells are Decreased in Patients with Rheumatoid Arthritis and Inversely Correlated with DAS28 in the First Five Years of the Disease. Annals of the Rheumatic Diseases 72(Suppl 3): A50.2-A50

Barbosa, L.; Ramiro, S.; Garcês, S.; Santos, M.J.; Canas da Silva, J. 2013: OP0008-HPRChallenges with the applicability of the eular recommendations for rheumatology nursing management in portugal. Annals of the Rheumatic Diseases 71(Suppl 3): 54.3-55

Gaugler, B.; Laheurte, C.; Bertolini, E.; Wendling, D.; Saas, P.; Toussirot, E. 2013: OP0008Peripheral Blood B Cell Subsets and BAFF/April Receptor Expression, Together with Circulating BAFF and April Levels, are Disturbed in Rheumatoid Arthritis but not in Ankylosing Spondylitis. Annals of the Rheumatic Diseases 72(Suppl 3): A50.3-A51

Thomsen, L.M. 2013: OP0009-PAREEasy-to-open packaging a practical tool developed by involving people with arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 55.1-55

Chauhan, A. K.; Moore, T. 2013: OP0009CD4+ T-Cell Differentiation by Immune Complexes and Complement. Annals of the Rheumatic Diseases 72(Suppl 3): A51.1-A51

Põldemaa, I.; Mustkivi, K.; Adler, E. 2013: OP0010-PARElife with a secret successful campaign designed by young rheumatics. Annals of the Rheumatic Diseases 71(Suppl 3): 55.2-55

Björk, M.; Skogh, T.; Husberg, M.; Thyberg, I. 2013: OP0010Reduced Sick Leave in Todays Early RA Patients Compared to 10 Years Ago, the Swedish Tira Project. Annals of the Rheumatic Diseases 72(Suppl 3): A51.2-A51

Makri, S. 2013: OP0011-PAREOn the Road to Raising Awareness and Empowering Patients. Annals of the Rheumatic Diseases 72(Suppl 3): A51.3-A51

Holch, J. A. 2013: OP0012-PAREUsing Social Costs of Msds as a Selling Point to Politicians. Annals of the Rheumatic Diseases 72(Suppl 3): A52.1-A52

Bech, A.Z.; Herlin, T.; Hansen, O.R.; Heuck, C.; Fiirgaard, B. 2013: OP0012Chronic recurrent non-bacterial osteomyelitis in danish children. Annals of the Rheumatic Diseases 71(Suppl 3): 56.1-56

Yeo, L.; Lom, H.; Buckley, C.; Filer, A.; Raza, K.; Scheel-Toellner, D. 2013: OP0013A Novel Pro-Inflammatory B Cell Population Infiltrating the Rheumatoid Synovium can be Identified by Expression of FCRL4. Annals of the Rheumatic Diseases 72(Suppl 3): A52.2-A52

van den Bosch, M.; Blom, A.; van Lent, P.; van Beuningen, H.; van de Loo, F.; Blaney Davidson, E.; van der Kraan, P.; van den Berg, W. 2013: OP0013Synovial overexpression of wnts and wisp1 induces cartilage damage by skewing of TGF-BETA signaling and reduction of the anti-hypertrophic factor SOX9. Annals of the Rheumatic Diseases 71(Suppl 3): 56.2-57

Moller Dohn, U.; Conaghan, P. G.; Eshed, I.; Boonen, A.; Boyesen, P.; Peterfy, C.; Lillegraven, S.; Ejbjerg, B.; Gandjbakhch, F.; Bird, P.; Foltz, V.; Genant, H.; Haavaardsholm, E.; Mcqueen, F.; Ostergaard, M. 2013: OP0014 The Omeract-Ramris Rheumatoid Arthritis Magnetic Resonance Imaging Joint Space Narrowing Score (RAMRIS JSN) is Reproducible and Correlates Closely with Computed Tomography Assessment. Annals of the Rheumatic Diseases 72(Suppl 3): A52-A52

Matsushita, I.; Motomura, H.; Seki, E.; Kimura, T. 2013: OP0015Evaluation of Hip and Knee Joint Damage in Patients with Rheumatoid Arthritis Using a Newly Developed Radiographic Scoring Method (ARASHI). Annals of the Rheumatic Diseases 72(Suppl 3): A53.1-A53

Beyer, C.; Reich, N.; Schindler, S.C.; Distler, A.; Dees, C.; Tomcik, M.; Hirth-Dietrich, C.; von Degenfeld, G.; Sandner, P.; Distler, O.; Schett, G.; Distler, J.H. 2013: OP0015Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis. Annals of the Rheumatic Diseases 71(Suppl 3): 57.2-57

Shaw, Y.; Chang, C.-C. H.; Eng, H.; Metes, I.; Moreland, L. W.; Wisniewski, S. R.; Roberts, M. S.; Levesque, M. C. 2013: OP0016The Influence of Patient and Physician Factors on Decisions to Adjust Therapy for Rheumatoid Arthritis Patients in Moderate to High Disease Activity. Annals of the Rheumatic Diseases 72(Suppl 3): A53.2-A53

Tomcik, M.; Palumbo-Zerr, K.; Avouac, J.; Horn, A.; Khodzighorova, A.; Zerr, P.; Dees, C.; Distler, A.; Beyer, C.; Becvar, R.; Senolt, L.; Distler, O.; Schett, G.; Distler, J.H. 2013: OP0016Tribbles homolog 3 mediates the stimulatory effects of tgf-beta on fibroblast activation and dermal fibrosis in systemic sclerosis. Annals of the Rheumatic Diseases 71(Suppl 3): 57.3-58

Cron, R. Q.; Zhang, M. 2013: OP0017 Blurring of the Distinction Between Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. Annals of the Rheumatic Diseases 72(Suppl 3): A53-A54

Trenkmann, M.; Brock, M.; Gay, R.E.; Speich, R.; Michel, B.A.; Gay, S.; Huber, L.C. 2013: OP0017The tnf-alpha-induced MIR-18A activates rheumatoid arthritis synovial fibroblast through a positive feedback loop in NF-KAPPA B signalling. Annals of the Rheumatic Diseases 71(Suppl 3): 58.1-58

Richette, P.; Ravaud, P.; Maheu, E.; Baron, G.; Rialland, A.; Vergnaud, P.; Roux, C.; Maugars, Y.; Mulleman, D.; Lukas, C.; Wendling, D.; Laforgue, P.; Loeuille, D.; Foltz, V.; Chevalier, X. 2013: OP0018A Randomized, Multicentre, Double Blind, Placebo Controlled Study of Anti Tnf Alpha (Adalimumab) in Refractory Hand Osteoarthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A54.1-A54

Vettori, S.; Brock, M.; Iwamoto, N.; Maurer, B.; Jungel, A.; Gay, R.E.; Calcagni, M.; Valentini, G.; Distler, J.J.; Gay, S.; Distler, O. 2013: OP0018Microrna-145 down-regulation in systemic sclerosis is limited to skin fibroblasts and influenced by epigenetic modifications and negative feedback loop by TGF-b. Annals of the Rheumatic Diseases 71(Suppl 3): 58.2-58

Harre, U.; Georgess, D.; Axmann, R.; Bang, H.; Toes, R.; Scherer, H.U.; Catrina, A.; Klareskog, L.; Jurdic, P.; Schett, G. 2013: OP0019Anti-citrullinated protein antibodies directly induce bone loss in rheumatoid arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 59.1-59

Lessard, C. J.; Li, H.; Ice, J. A.; Adrianto, I.; Jonsson, R.; Illei, G. G.; Rischmueller, M.; Nordmark, G.; Mariette, X.; Miceli-Richard, C.; Wahren Herlenius, M.; Witte, T.; Brennan, M.; Omdal, R.; Gaffney, P. M.; Lessard, J. A.; Rönnblom, L.; Ng, W.-F.; Rhodus, N.; Segal, B.; Scofield, R. H.; James, J. A.; Anaya, J.-M.; Montgomery, C. G.; Harley, J. B.; Moser Sivils, K. 2013: OP0020 Identification of Multiple Sjögren's Syndrome Susceptibility Loci. Annals of the Rheumatic Diseases 72(Suppl 3): A54.3-A55

Lubbers, J.; Brink, M.; van de Stadt, L.A.; Vosslamber, S.; Wesseling, J.G.; van Schaardenburg, D.; Rantapaa-Dahlqvist, S.M.; Verweij, C.L. 2013: OP0020Validation of gene signatures to predict rheumatoid arthritis development. Annals of the Rheumatic Diseases 71(Suppl 3): 59.2-59

Genovese, M.; Greenwald, M.; Cho, C.-S.; Berman, A.; Jin, L.; Cameron, G.; Wang, L.; Xie, L.; Braun, D.; Berclaz, P.-Y.; Banerjee, S. 2013: OP0021A phase 2 study of multiple subcutaneous doses of LY2439821, an anti-IL-17 monoclonal antibody, in patients with rheumatoid arthritis in two populations: Nave to biologic therapy or inadequate responders to tumor necrosis factor alpha inhibitors. Annals of the Rheumatic Diseases 71(Suppl 3): 59.3-59

De Rooy, D.; Tsonaka, R.; Andersson, M.; Forslind, K.; Zhernakova, A.; de Kovel, C.; Koeleman, B.; van der Heijde, D.; Huizinga, T.; Toes, R.; Houwing-Duistermaat, J.; Svensson, B.; van der Helm-van Mil, A. 2013: OP0021Genetic Factors for the Severity of ACPA-Negative Rheumatoid Arthritis in Two Cohorts of Early Disease: A Genome-Wide Study. Annals of the Rheumatic Diseases 72(Suppl 3): A55.1-A55

Ziegelhoeffer A.; De Jong J.W.; Ferrari R.; Turi Nagy L. 2013: OP0022-HPRDeveloping an Intervention on the Internet for Health Enhancing Physical Activity Behavior in Individuals with Rheumatoid Arthritis: Patients Experiences and Innovations. Annals of the Rheumatic Diseases 72(Suppl 3): A55.2-A55

Schiff, M.; Fleischmann, R.; Weinblatt, M.; Valente, R.; van der Heijde, D.; Citera, G.; Zhao, C.; Maldonado, M. 2013: OP0022Abatacept sc versus adalimumab on background methotrexate in RA: One year results from the ample study. Annals of the Rheumatic Diseases 71(Suppl 3): 60.1-60

Nocturne, G.; Boudaoud, S.; Miceli Richard, C.; Viengchareun, S.; Lazure, T.; Nititham, J.; Taylor, K. E.; Criswell, L. A.; Ma, A.; Busato, F.; Melki, J.; Dubost, J. J.; Hachulla, E.; Gottenberg, J. E.; Lombes, M.; Tost, J.; Mariette, X. 2013: OP0023 Germinal and Somatic Genetic Variants of TNFAIP3 Promote Lymphomagenesis Process Complicating Primary Sjögren's Syndrome. Annals of the Rheumatic Diseases 72(Suppl 3): A55.3-A56

Huizinga, T.W.; Kivitz, A.J.; Rell-Bakalarska, M.; Fleischmann, R.M.; Jasson, M.; Radin, A.R.; Genovese, M.C. 2013: OP0023Sarilumab for the treatment of moderate-to-severe rheumatoid arthritis: Results of a phase 2, randomized, double-blind, placebo-controlled, international study. Annals of the Rheumatic Diseases 71(Suppl 3): 60.2-60

Damjanov, N.; Tlustochowicz, M.; Aelion, J.; Dimic, A.; Greenwald, M.; Diehl, A.; Bhattacharya, I.; Menon, S.; Gourley, I. 2013: OP0024Safety and efficacy of SBI-087 in subjects with active rheumatoid arthritis in a phase 2 randomized, double-blind, placebo-controlled study. Annals of the Rheumatic Diseases 71(Suppl 3): 60.3-61

Fassl, S.; Holzinger, D.; Austermann, J.; Vogl, T.; Roth, J. 2013: OP0024The Function of PSTPIP1 and S100A8/S100A9 in Hyperzincaemia & Hypercalprotectinaemia and the PAPA-Syndrom. Annals of the Rheumatic Diseases 72(Suppl 3): A56.1-A56

De Lange-Brokaar, B. J. E.; Ioan-Facsinay, A.; Yusuf, E.; Visser, A. W.; Kroon, H. M.; van Osch, G. J. V. M.; Zuurmond, A.- M.; Stojanovic-Susulic, V.; Bloem, J. L.; Nelissen, R. G. H. H.; Huizinga, T. W. J.; Kloppenburg, M. 2013: OP0025 Different Patterns of Synovitis Present in OA Patients Associate Differentially with Pain. Annals of the Rheumatic Diseases 72(Suppl 3): A56-A56

Hsu, B.; Sheng, S.; Weinblatt, M.E.; Smolen, J.S. 2013: OP0025Results from a multicenter, international, randomized, double-blind, placebo-controlled, phase 2 study of sirukumab, a human anti-IL-6 monoclonal antibody, in patients with active rheumatoid arthritis despite methotrexate therapy. Annals of the Rheumatic Diseases 71(Suppl 3): 61.1-61

Shirinsky, I.; Shirinsky, V. 2013: OP0026Diabetes Effects on Pain and Physical Function in Incidence and Progression Subcohorts of the Osteoarthritis Initiative: A 5-Year Longitudinal Data Analysis. Annals of the Rheumatic Diseases 72(Suppl 3): A56.3-A57

Haugen, I. K.; Ramachandran, V.; Misra, D.; Neogi, T.; Niu, J.; Yang, T.; Zhang, Y.; Felson, D. T. 2013: OP0027Hand Osteoarthritis (OA) and the Associations to Mortality and Cardiovascular Events - Data from the Framingham Study. Annals of the Rheumatic Diseases 72(Suppl 3): A57.1-A57

Chatzidionysiou, K.; Lie, E.; Nasonov, E.; Lukina, G.; Hetland, M.; Tarp, U.; Ancuta, I.; Pavelka, K.; Nordström, D.; Gabay, C.; Canhao, H.; Tomsic, M.; van Riel, P.; Gomez-Reino, J.; Kvien, T.; van Vollenhoven, R. 2013: OP0028Efficacy of different doses of rituximab for the treatment of RA: Data from the cererra collaboration. Annals of the Rheumatic Diseases 71(Suppl 3): 62.2-62

Martel-Pelletier, J.; Roubille, C.; Raynauld, J.-P.; Abram, F.; Dorais, M.; Delorme, P.; Pelletier, J.-P. 2013: OP0028The Disease Modifying Effect of Strontium Ranelate in a Phase III Knee Osteoarthritis Study (SEKOIA) Using Quantitative Magnetic Resonance Imaging: Reduction in Bone Marrow Lesion Size Associated with Cartilage Protective Effect. Annals of the Rheumatic Diseases 72(Suppl 3): A57.2-A57

Bevers, K.; Bijlsma, J.; Vriezekolk, J.; van den Ende, E.; den Broeder, A. 2013: OP0029Ultrasonographic Determinants of Pain in Painful Osteoarthritis of the Knee. Annals of the Rheumatic Diseases 72(Suppl 3): A58.1-A58

Welsing, P.M.; Kinds, M.B.; Marijnissen, A.; Viergever, M.; Emans, P.J.; Lafeber, F.P. 2013: OP0030Identifying radiographic phenotypes of early knee osteoarthritis using separate quantitative features might improve patient selection for more targeted treatment. Annals of the Rheumatic Diseases 71(Suppl 3): 63.1-63

Ramonda, R.; Musacchio, E.; Frallonardo, P.; Lorenzin, M.; Sartori, L.; Punzi, L. 2013: OP0030Osteoarthritis and Bone Mineral Density of the Hand. Annals of the Rheumatic Diseases 72(Suppl 3): A58.2-A58

Henrotin, Y.; Kraus, V.; Huebner, J.; Helleputte, T.; Deberg, M. 2013: OP0031Baseline Measurements of Coll2-1 and Coll2-1NO2 in Urine are Highly Predictive of Joint Space Narrowing in Knee Osteoarthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A58.3-A59

Wesseling, J.; Bierma-Zeinstra, S.M.; Kloppenburg, M.; Bijlsma, J.W. 2013: OP0031Comparison between check study (cohort hip& cohort knee) and osteoartritis initiative; development of pain and function in 3 years of follow-up. Annals of the Rheumatic Diseases 71(Suppl 3): 63.2-63

Abraham, A.; Mann, K.D.; Pearce, M.S.; Francis, R.M.; Birrell, F. 2013: OP0032Ultrasound features of osteophytes and cartilage thickness at the knee are associated with pain and functional impairment: The newcastle thousand families study. Annals of the Rheumatic Diseases 71(Suppl 3): 63.3-64

Van Den Hoogen, F.; Khanna, D.; Fransen, J.; Johnson, S. R.; Baron, M.; Tyndall, A.; Matucci, M.; Naden, R.; Pope, J. 2013: OP0033 Classification Criteria for Systemic Sclerosis: Preliminary Results. Annals of the Rheumatic Diseases 72(Suppl 3): A59-A59

Wittoek, R.; Elewaut, D.; Verbruggen, G. 2013: OP0033Radiographical follow-up data of a one-year open-label extension study of treatment with adalimumab in erosive osteoarthritis of the IP joints. Annals of the Rheumatic Diseases 71(Suppl 3): 64.1-64

Jordan, S.; Maurer, B.; Toniolo, M.; Michel, B.; Distler, O. 2013: OP0034Performance of the New EULAR/ACR Classification Criteria for Systemic Sclerosis in Clinical Practice. Annals of the Rheumatic Diseases 72(Suppl 3): A60.1-A60

Englund, M.; Haugen, I.K.; Guermazi, A.; Roemer, F.W.; Niu, J.; Neogi, T.; Aliabadi, P.; Clancy, M.; Felson, D.T. 2013: OP0034The association between radiographic hand osteoarthritis and meniscal damage on MRI in the general population:. Annals of the Rheumatic Diseases 71(Suppl 3): 64.2-64

Tjärnlund, A.; Bottai, M.; Rider, L. G.; Werth, V. P.; Pilkington, C.; de Visser, M.; Alfredsson, L.; Amato, A. A.; Barohn, R. J.; Liang, M. H.; Singh, J. A.; Miller, F. W.; Lundberg, I. E. 2013: OP0035Progress Report on the Development of New Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies. Annals of the Rheumatic Diseases 72(Suppl 3): A60.2-A60

Laredo, J.-D.; Wyler, A.; Alvarez, C.; Aout, M.; Lequesne, M.; Vicaut, E. 2013: OP0035Value of bilateral standing oblique radiographs (FAUX profil de lequesne) in the diagnosis of hip osteoarthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 64.3-65

Lee, S.; Kim, T.-N.; Kim, S.-H. 2013: OP0036Sarcopenic obesity is more closely associated with radiographic knee osteoarthritis than non-sarcopenic obesity: A cross-sectional study using data from the fifth korean national health and nutrition examination survey (KNHANES V-1). Annals of the Rheumatic Diseases 71(Suppl 3): 65.1-65

Törring, O.; Brown, J.; Jensen, J.-E.B.; Gilchrist, N.; Recknor, C.; Roux, C.; Austin, M.; Wang, A.; Grauer, A.; Ho, P.-R.; Wagman, R. 2013: OP0037Denosumab discontinuation and associated fracture incidence: Analysis from the freedom trial. Annals of the Rheumatic Diseases 71(Suppl 3): 65.2-65

Abou-Raya, A.; Abou-Raya, S.; Helmii, M. 2013: OP0038Effects of Angiotensin II Receptor Blockade in Systemic Sclerosis: Randomized Controlled Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A61.2-A61

Park, J. K.; Lee, E. Y.; Yoon, M. J.; Lee, W.; Kim, Y. K.; Park, C. S.-Y.; Giles, J. T.; Park, J. W.; Shin, K. C.; Lee, J. S.; Song, Y. W.; Lee, E. B. 2013: OP0039Head to Head Comparison of Udenafil Versus Amlodipine in the Treatment of Secondary Raynauds Phenomenon: A Double-Blind, Randomized Cross-Over Study. Annals of the Rheumatic Diseases 72(Suppl 3): A61.3-A62

Dhainaut, A.; Hoff, M.; Syversen, U.; Haugeberg, G. 2013: OP0039Increased porosity in hand bones is strongly associated with distal radius fracture in elderly women. Annals of the Rheumatic Diseases 71(Suppl 3): 66.1-66

Umlauf, D.; Hidding, H.; Lindemann, L.O.; Frank, S.; Dankbar, B.; Cromme, C.; Rupp, M.; Stange, R.; Marshall, R.P.; Amling, M.; Dietrich, A.; Steiner, M.; Kornak, U.; Schwab, A.; Pap, T.; Bertrand, J. 2013: OP0041Essential role for TRPC1 channels in osteoclast fusion and in osteoporotic bone loss. Annals of the Rheumatic Diseases 71(Suppl 3): 66.3-67

Burmester, G.; Rigby, W.; van Vollenhoven, R.; Kay, J.; Rubbert-Roth, A.; Kelman, A.; Dimonaco, S.; Mitchell, N. 2013: OP0041Tocilizumab (TCZ) in Combination and Monotherapy Versus Methotrexate (MTX) in MTX-Naive Patients (PTS) with Early Rheumatoid Arthritis (RA): Clinical and Radiographic Outcomes from a Randomised, Placebo-Controlled Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A63.1-A63

Holz, J.- B.; Sargentini-Maier, L.; De Bruyn, S.; Gachalyi, B.; Udvaros, I.; Rojkovich, B.; Bruk, S.; Sramek, P.; Korkosz, M.; Krause, K.; Schoen, P.; D'Artois, J.; Verschueren, K.; Willems, W.; De Swert, K.; Arold, G. 2013: OP0043 Twenty-Four Weeks of Treatment with a Novel Anti-IL-6 Receptor Nanobody(R) (ALX-0061) Resulted in 84% ACR20 Improvement and 58% DAS28 Remission in a Phase I/Ii Study in RA. Annals of the Rheumatic Diseases 72(Suppl 3): A64-A64

Sehgal, A.; Mannalithra, A.; Mithal, A.; Singh, G.; Triadafilopoulos, G. 2013: OP0043Hip fracture in the extreme elderly: The last frontier of a growing public health problem:. Annals of the Rheumatic Diseases 71(Suppl 3): 67.2-67

Schiff, M.; Weinblatt, M.; Valente, R.; van der Heijde, D.; Citera, G.; Elegbe, A.; Maldonado, M.; Fleischmann, R. 2013: OP0044 Head-To-Head Comparison of Subcutaneous Abatacept Versus Adalimumab on Background Methotrexate in RA: Two Year Results from the Ample Study. Annals of the Rheumatic Diseases 72(Suppl 3): A64-A64

Padhi, D.; Allison, M.; Kivitz, A.J.; Gutierrez, M.J.; Stouch, B.; Wang, C.; Jang, G. 2013: OP0044The effects of multiple doses of sclerostin antibody AMG 785 in healthy men and postmenopausal women with low bone mass. Annals of the Rheumatic Diseases 71(Suppl 3): 67.3-68

Soroka, N.; Yagur, V.; Dostanko, N. 2013: OP0045Genetic markers of sulphasalazine adverse reactions in rheumatoid arthritis patients. Annals of the Rheumatic Diseases 71(Suppl 3): 68.1-68

Vital, E. M.; El-Sherbiny, Y.; Freeston, J.; Brown, A.; Reece, R.; Dass, S.; Buch, M.; Ponchel, F.; Emery, P. 2013: OP0045Synovial B Cell Status Determines Intensity of Rituximab Therapy Required in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A64.3-A65

Lahiri, M.; Morgan, C.; Luben, R.N.; Bunn, D.K.; Lunt, M.; Verstappen, S.M.; Symmons, D.P.; Khaw, K.-T.; Wareham, N.J.; Bruce, I.N. 2013: OP0046A risk score to identify individuals at higher risk of inflammatory polyarthritis: Results from the european prospective investigation of cancer (norfolk) and the norfolk arthritis register (the EPIC-2-NOAR study):. Annals of the Rheumatic Diseases 71(Suppl 3): 68.2-69

Genovese, M.; van Vollenhoven, R.; Wilkinson, B.; Wang, L.; Zwillich, S.; Gruben, D.; Benda, B.; Jones, T.; Bradley, J. 2013: OP0046Tofacitinib, an Oral Janus Kinase Inhibitor, in a Rheumatoid Arthritis Open-Label Extension Study Following Adalimumab Therapy in a Phase 3 Randomised Clinical Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A65.1-A65

Taylor, P.; Genovese, M. C.; Keystone, E.; Schlichting, D.; Beattie, S.; Macias, W. 2013: OP0047Baricitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Study. Annals of the Rheumatic Diseases 72(Suppl 3): A65.2-A66

Listing, J.; Pattloch, D.; Kekow, J.; Kaufmann, J.; Burmester, G.-R.; Zink, A.; Strangfeld, A. 2013: OP0047Successful control of disease activity and treatment with biologics increase the life expectancy in rheumatoid arthritis patients:. Annals of the Rheumatic Diseases 71(Suppl 3): 69.1-69

Taylor, P. C.; Genovese, M. C.; Greenwood, M.; Ho, M.; Nasonov, E.; Oemar, B.; Stoilov, R.; Vencovsky, J.; Weinblatt, M. 2013: OP0048OSKIRA-4: A Phase IIB Randomised, Placebo-Controlled Study of the Efficacy and Safety of Fostamatinib Monotherapy. Annals of the Rheumatic Diseases 72(Suppl 3): A66.1-A66

Nikiphorou, E.; Carpenter, L.; James, D.; Kiely, P.; Walsh, D.; Williams, R.; Young, A. 2013: OP0048Orthopaedic interventions for RA have changed over the period 1986-2011. An evaluation of joint surgery rates and DMARD/anti-TNF treatment patterns in two UK inception cohorts. Annals of the Rheumatic Diseases 71(Suppl 3): 69.2-69

De Rooy, D.; Zhernakova, A.; Tsonaka, R.; Willemze, A.; Kurreeman, F.; Trynka, G.; van Toorn, L.; Toes, R.; Huizinga, T.; Houwing-Duistermaat, J.; Gregersen, P.; van der Helm-van Mil, A. 2013: OP0049A Genetic Variant in the Region of MMP-9 is Associated with Serum Levels and Progression of Joint Damage in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A66.2-A66

Aguilar-Lozano, L.; Padilla-Ibarra, J.; Sandoval-Castro, C.; Castillo-Ortiz, J.D.; Morales-Torres, J.; Hernandez, C.; Burgos-Vargas, R.; Pacheco-Tena, C.; Ramos-Remus, C. 2013: OP0049The lenght of remission and rate of relapse after tocilizumab withdrawal in rheumatoid arthritis patients. Annals of the Rheumatic Diseases 71(Suppl 3): 69.3-70

Ruyssen-Witrand, A.; Gourraud, P.-A.; Nigon, D.; Lukas, C.; Miceli-Richard, C.; Jamard, B.; Cantagrel, A.; Cambon-Thomsen, A.; Dieudé, P.; Constantin, A. 2013: OP0050Evolution of the alternative classification of HLA-DRB1 alleles in rheumatoid arthritis: Impact on the production of the anti-citrullinated protein antibodies and structural progression, data from the ESPOIR cohort. Annals of the Rheumatic Diseases 71(Suppl 3): 70.1-70

Jiang, X.; Källberg, H.; Ärlestig, L.; Rantapää-Dahlqvist, S.; Klareskog, L.; Alfredsson, L.; Padyukov, L. 2013: OP0052A Dense Mapping of HLA Region for Study of Interaction with Smoking in the Development of Rheumatoid Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A67.2-A67

Filer, A.; Cader, M.Z.; Abhishek, A.; Allen, G.; Buckley, C.; de Pablo, P.; Raza, K. 2013: OP0052Use of ultrasound to predict persistence in patients with very early synovitis. Annals of the Rheumatic Diseases 71(Suppl 3): 70.3-71

Ohl, K.; Rauen, T.; Tenbrock, K. 2013: OP0053Cremalpha destabilizes FOXP3 expression in regulatory T cells. Annals of the Rheumatic Diseases 71(Suppl 3): 71.1-71

Tost, J.; Touleimat, N.; Boudaoud, S.; Miceli, C.; Mariette, X. 2013: OP0054High-Throughput DNA Methylation Analysis of Cell Sorted Blood Cell Populations Reveals Widespread Epigenetic Deregulation in Sjogrens Syndrome. Annals of the Rheumatic Diseases 72(Suppl 3): A68.1-A68

De Jager, W.; Vastert, S.J.; Noordman, B.J.; Prakken, B.J.; Wulffraat, N.M. 2013: OP0055IL-1 receptor antagonist restores IL-18 nk cell axis in systemic JIA. Annals of the Rheumatic Diseases 71(Suppl 3): 71.3-72

McAllister, K.; Eyre, S.; Bowes, J.; Plenge, R.; Greenburg, J.; Pappas, D.; Worthington, J. 2013: OP0055Immunochip Validation Study Confirms Two Novel RA Susceptibility Loci, BACH2 and RAD51L1. Annals of the Rheumatic Diseases 72(Suppl 3): A68.2-A68

Fleischer, Y.; Barczyk, K.; Klotz, L.; Wiendl, H.; Roth, J. 2013: OP005612/15-lipoxygenase mediates GC-induced anti-inflammatory mechanisms in monocytes. Annals of the Rheumatic Diseases 71(Suppl 3): 72.1-72

Serrano, A.; Carmona, D.; Marquez, A.; Solans, R.; Hernández-Rodríguez, J.; Cid, M. C.; Castañeda, S.; Morado, I. C.; Narvaez, J.; Sopeña, B.; Garcia-Villanueva, M. J.; Tío-Barrera, L.; Ortego-Centeno, N.; Unzurrunzaga, A.; Marí-Alfonso, B.; Sanchez-Martin, J.; de Miguel, E.; Magro, C.; Raya, E.; Hidalgo-Conde, A.; Martinez, L.; Fanlo-Mateo, P.; Gonzalez-Gay, M. A.; Martin, J. 2013: OP0056The PTPN22/CSK Signalling Pathway is Involved in Susceptibility to Develop Giant Cell Arteritis. Annals of the Rheumatic Diseases 72(Suppl 3): A68.3-A69

Wehrens, E. J.; Vastert, S. J.; Mijnheer, G.; Meerding, J. M.; Klein, M.; Wulffraat, N. M.; Prakken, B. J.; van Wijk, F. 2013: OP0057Anti-TNF Therapy Targets PKB/C-AKT Induced Resistance of Effector Cells to Suppression in Juvenile Idiopathic Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A69.1-A69

Costa-Reis, P.; Russo, P.; Sullivan, K. E. 2013: OP0058 MIR-26A and MIR-30B Dysregulation in Pediatric Lupus Nephritis. Annals of the Rheumatic Diseases 72(Suppl 3): A69-A69

Sustal, K.N.; Almanzar, G.; Trippen, R.; Höfner, K.; Prelog, M. 2013: OP0058CCR6+ T-cells in children with juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 72.3-72

Kaneko, T.; Saito, Y.; Kotani, T.; Ohnishi, H.; Murata, Y.; Yonemoto, Y.; Okamura, K.; Matozaki, T.; Takagishi, K. 2013: OP0059Importance of the protein tyrosine phosphatase SHP1 in dendritic cells for prevention of TH1 cell differentiation and autoimmunity: A potential target for the therapy. Annals of the Rheumatic Diseases 71(Suppl 3): 73.1-73

Meroni, P.L.; Raschi, E.; Chighizola, C.; Grossi, C.; Ronda, N.; Gatti, R.; Borghi, M.O. 2013: OP0060Beta2GPI and TLR4 interaction on endothelial cells: A bridge between innate and adaptive immunity in APS. Annals of the Rheumatic Diseases 71(Suppl 3): 73.2-73

De Benedetti, F.; Ruperto, N.; Zuber, Z.; Keane, C.; Harari, O.; Kenwright, A.; Cuttica, R.; Keltsev, V.; Xavier, R.; Calvo, I.; Nikishina, I.; Rubio-Pérez, N.; Alekseeva, E.; Chasnyk, V.; Chavez, J.; Horneff, G.; Opoka-Winiarska, V.; Quartier, P.; Silva, C.; Silverman, E.; Spindler, A.; Martini, A.; Lovell, D.; Brunner, H. 2013: OP0060Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data from a Phase 3 Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A70.1-A70

Olivecrona, H.; Alden Raboisson, M.; Soderberg, K.; Hallen, B.; Leinonen, M.; Sibley, C.; Plass, N.; Brewer, C.; King, K.; Zalewski, C.; Kim, J.; Bishop, R.; Hill, S.; Paul, S.; Stone, D.; Chapelle, D.; Butman, J.; Goldbach-Mansky, R. 2013: OP0061 Kineret(R) (Anakinra) Controls Disease Symptoms in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS): Up to 5-Year Follow-Up Data. Annals of the Rheumatic Diseases 72(Suppl 3): A70-A71

Hanly, J.G. 2013: OP0061Seizures in systemic lupus erythematosus: A prospective study of predictors and outcomes in a large, international, disease inception cohort. Annals of the Rheumatic Diseases 71(Suppl 3): 73.3-73

Windschall, D.; Horneff, G. 2013: OP0062Safety and Efficacy of Etanercept in Children with the JIA Categories Extended Oligoarthritis, Enthesitis Related Arthritis and Psoriasis Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A71.1-A71

Schmeling, H.; Horneff, G. 2013: OP0063Efficacy and Safety of Adalimumab in Children with Juvenile Idiopathic Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A71.2-A71

Seyhan, A.; O'Toole, M.; Zhang, Y.; Immermann, F.W.; Hill, A.; Reddy, P.; Masferrer, J.; Zhou, T.; Mounts, W.; Whitley, M.; Walker, T.; Kamp, S.; James, J.; Sridharan, S.; Merrill, J.T.; Honczarenko, M. 2013: OP0063Impact of baseline interferon pathway activation on widespread gene expression changes with disease flare in lupus patients: Interim report from the bold (biomarkers of lupus disease) study:. Annals of the Rheumatic Diseases 71(Suppl 3): 74.2-74

Strand, V.; Williams, S.; Miller, P. S. J.; Saunders, K.; Grant, S.; Kremer, J. M. 2013: OP0064Discontinuation of Biologic Therapy in Rheumatoid Arthritis (RA): Analysis from the Consortium of Rheumatology Researchers of North America (CORRONA) Database. Annals of the Rheumatic Diseases 72(Suppl 3): A71.3-A72

Heather, E. M.; Payne, K.; Harrison, M. J.; Hyrich, K. L.; Symmons, D. P. 2013: OP0065Quantifying the Economic Impact of Serious Infections from Anti-TNFS for Rheumatoid Arthritis: Results from the BSRBR-RA. Annals of the Rheumatic Diseases 72(Suppl 3): A72.1-A72

Fautrel, B.; Gandjbakhch, F.; Foltz, V.; Pham, T.; Morel, J.; Alfaiate, T.; Dernis, E.; Gaudin, P.; Mariette, X.; Tubach, F. 2013: OP0066 Targeting the Lowest Efficacious Dose for Rheumatoid Arthritis Patients in Remission: Clinical and Structural Impact of a Step-Down Strategy Trial Based on Progressive Spacing of TNF-Blocker Injections (Strass Trial). Annals of the Rheumatic Diseases 72(Suppl 3): A72-A72

Cinquetti, G.; Larroche, C.; Combe, B.; Hachulla, E.; Meyer, O.; Pertuiset, E.; Kaplanski, G.; Mariette, X.; Gottenberg, J.-E. 2013: OP0066Efficacy of rituximab in systemic manifestations of patients with primary sjgrens syndrome: Results from the air registry. Annals of the Rheumatic Diseases 71(Suppl 3): 75.2-76

Docampo, E.; Escaramis, G.; Rabionet, R.; Carbonell, J.; Rivera, J.; Alegre, J.; Vidal, J.; Estivill, X.; Collado, A. 2013: OP0067Cluster analysis of clinical data identifies fibromyalgia subgroups. Annals of the Rheumatic Diseases 71(Suppl 3): 76.1-76

Burmester, G.; Kivitz, A.; Kupper, H.; Arulmani, U.; Florentinus, S.; Goss, S.; Rathmann, S.; Fleischmann, R. 2013: OP0067Efficacy, Pharmacokinetics, and Safety of Different Doses of Methotrexate in Combination with Adalimumab: Results from the Concerto Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A72.3-A73

Yoo, D. H.; Racewicz, A.; Brzezicki, J.; Yatsyshyn, R.; Tobias Arteaga, E.; Baranauskaite, A.; Abud-Mendoza, C.; Navarra, S.; Eullaran, R.; Kadinov, V.; Goecke Sariego, I.; Byrne, P.; Park, W.; Lee, S. J.; Kim, H. U.; Muller-Ladner, U. 2013: OP0068 A Phase 3 Randomised Controlled Trial to Compare CT-P13 with Infliximab in Patients with Active Rheumatoid Arthritis: 54 Week Results from the Planetra Study. Annals of the Rheumatic Diseases 72(Suppl 3): A73-A73

Bossema, E.; van Middendorp, H.; Jacobs, J.W.; Bijlsma, J.W.; Geenen, R. 2013: OP0069-HPRThe influence of weather on daily pain and fatigue in female patients with fibromyalgia. Annals of the Rheumatic Diseases 71(Suppl 3): 76.3-77

Manders, S.; Kievit, W.; Jansen, T.; Stolk, J.; Visser, H.; Bos, R.; van de Laar, M.; van Riel, P. 2013: OP0069Significantly Better Results for TNFI Combination Therapy with MTX Than TNFI Mono- and Combination Without MTX Therapy in Patients with RA: Results from the Dream Registry. Annals of the Rheumatic Diseases 72(Suppl 3): A73.2-A74

Bruzzese, V.; Lorenzetti, R.; Zullo, A.; Hassan, C.; Campo, S. M. 2013: OP0070Anti-TNF Therapy and Tuberculosis Risk in Rheumatic Diseases, Psoriasis, and IBD: A Pooled-Data Analysis of Randomized Controlled Trials. Annals of the Rheumatic Diseases 72(Suppl 3): A74.1-A74

Häuser, W.; Kopp, I. 2013: OP0070Update of the german evidence-based guideline on the management of fibromyalgia syndrome. Annals of the Rheumatic Diseases 71(Suppl 3): 77.1-77

Predel, H.G.; Giannetti, B.; Burnett, I.; Hug, A.M. 2013: OP0071Efficacy and safety of diclofenac diethylamine 1.16% gel in the treatment of acute neck pain: A randomized, double-blind, placebo-controlled study. Annals of the Rheumatic Diseases 71(Suppl 3): 77.2-77

Singh, J. A.; Wells, G.; Christensen, R.; Ghogomu, E.; Macdonald, J.; Maxwell, L.; Tarp, S.; Buchbinder, R.; Tugwell, P. 2013: OP0071Risk of Cancer, Serious Lung Infections and Death with Biologics: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (RCTS). Annals of the Rheumatic Diseases 72(Suppl 3): A74.2-A74

Krogh, T.; Bartels, E.M.; Ellingsen, T.; Stengaard-Pedersen, K.; Buchbinder, R.; Fredberg, U.; Bliddal, H.; Christensen, R. 2013: OP0072Comparative effectiveness of injection therapies in lateral epicondylitis: A systematic review and network meta-analysis of randomized controlled trials. Annals of the Rheumatic Diseases 71(Suppl 3): 77.3-78

Arai, Y.; Yamashita, K.; Mizugishi, K.; Takaori-Kondo, A. 2013: OP0072Plasmacytoid Dendritic Cells Activated by Neutrophil Extracellular Traps Contribute to the Pathogenesis of IGG4-Related Disease. Annals of the Rheumatic Diseases 72(Suppl 3): A74.3-A75

Saidenberg-Kermanac'h, N.; semerano, L.; Nunes, H.; Sadoun, D.; Guillot, X.; Boubaya, M.; Naggara, N.; Valeyre, D.; Boissier, M.-C. 2013: OP0073High Risk Fracture in Sarcoidosis Patients Despite Not Lowered Bone Mineral Density: Implication of Serum 25(OH) Vitamin D Levels. Annals of the Rheumatic Diseases 72(Suppl 3): A75.1-A75

Grøvle, L.; Brox, J.I.; Haugen, A.J.; Keller, A.; Natvig, B.; Grotle, M. 2013: OP0073Prognostic factors for return to work in patients with sciatica. Annals of the Rheumatic Diseases 71(Suppl 3): 78.1-78

Baerlecken, N.T.; Stoll, M.; Witte, T.; Schmidt, R.E.; Meyer-Olson, D. 2013: OP0074Clinical study: Frequency and manifestations of joint disease in HIV-infected patients. Annals of the Rheumatic Diseases 71(Suppl 3): 78.2-78

Galeazzi, M.; Obici, L.; Ferracin, M.; Fulci, V.; McDermott, M. F.; Lucherini, O. M.; Merlini, G.; Dickie, L.; Muscari, I.; Frediani, B.; Negrini, M.; Cimaz, R.; Cantarini, L. 2013: OP0074First Report of Circulating Micrornas in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS). Annals of the Rheumatic Diseases 72(Suppl 3): A75.2-A75

Stukstette, M.J.; Dekker, J.; den Broeder, A.A.; Noort van der Laan, W.; Bijlsma, J.W.; van den Ende, C.H. 2013: OP0075-HPRA multidisciplinary and multidimensional program for hand osteoarthritis is not effective: Results of a randomized controlled study:. Annals of the Rheumatic Diseases 71(Suppl 3): 78.3-79

Brik, R.; Butbul Aviel, Y.; Lubin, S.; Ben Dayan, E.; Tseng, L.; Hashkes, P. J. 2013: OP0075A 6-Month, Phase 2, Open Label, Single-Arm Study to Evaluate the Safety and Efficacy of Treatment with Canakinumab of Pediatric Patients with Colchicine Resistant Familial Mediterranean Fever. Annals of the Rheumatic Diseases 72(Suppl 3): A75.3-A76

Koyama, Y.; Tanino, M.; Shiraishi, H.; Nagano, S.; Ota, T.; Uchino, A.; Nakagawa, J.; Higuchi, T. 2013: OP0076Difference in the Expression of Long Intergenic Non-Coding RNA Between Polymyalgia Rheumatica and Rheumatoid Arthritis Might Be Important for Understanding and Discriminating these Diseases. Annals of the Rheumatic Diseases 72(Suppl 3): A76.1-A76

Peter, W.F.; van der Wees, P.H.; Verhoef, J.; de Jong, Z.; van Bodegom-Vos, L.; Hilberdink, W.K.; Fiocco, M.; VlietVlieland, T.P. 2013: OP0077-HPRThe effect of an interactive workshop on the adherence with the dutch physical therapy practice guideline for hip and knee osteoarthritis: A randomised controlled trial. Annals of the Rheumatic Diseases 71(Suppl 3): 79.2-79

Kjeken, I.; Bø, I.; Rønningen, A.; Spada, C.; Mowinckel, P.; Hagen, K.B.; Dagfinrud, H. 2013: OP0078-HPRA three week rehabilitation program had positive long term effects in patients with ankylosing spondylitis: Results from a randomised controlled trial. Annals of the Rheumatic Diseases 71(Suppl 3): 79.3-80

Cosan, F.; Emrence, Z.; Pişkinpaşa, S. V.; Odabas, A. R.; Ustek, D.; Cefle, A. 2013: OP0078The TNFRSF1A and MEFV Gene Mutations in the Secondary Amyloidosis Without FMF and HPFS Symptoms. Annals of the Rheumatic Diseases 72(Suppl 3): A76.3-A77

Morva, A.; Kapsogeorgou, E. K.; Konsta, O. D.; Moutsopoulos, H. M.; Tzioufas, A. G. 2013: OP0079Salivary Gland Epithelial Cells (SGECS) Promote the Differentiation of B Cells. Annals of the Rheumatic Diseases 72(Suppl 3): A77.1-A77

Murray-Brown, W.; Croia, C.; Sutcliffe, N.; Tappuni, A.; Vartoukian, S.; Fortune, F.; Pitzalis, C.; Bombardieri, M. 2013: OP0080 Lesional IL-21 Expression Correlates with Functional Germinal Center Formation and T Follicular Helper Cell Infiltration in the Salivary Glands of Sjögren's Syndrome. Annals of the Rheumatic Diseases 72(Suppl 3): A77.2-A77

Guggino, G.; Ciccia, F.; Rizzo, A.; Raimondo, S.; Giardina, A.; Carubbi, F.; Cipriani, P.; Sireci, G.; Giacomelli, R.; Alessandro, R.; Triolo, G. 2013: OP0081Aberrant Expression of IL-22RA1 on Hematopoietic Cells as Immunologically Signature of Primary Sjogrens Syndrome and Sjogren-Associated Non-Hodgkin Lymphomas. Annals of the Rheumatic Diseases 72(Suppl 3): A77.3-A78

Meesters, J.; Pont, W.; Beaart-van de Voorde, L.; Stamm, T.; Vliet Vlieland, T. 2013: OP0081Concepts important to patients with rheumatoid arthritis in rehabilitation and their coverage by rehabilitation tools. Annals of the Rheumatic Diseases 71(Suppl 3): 80.3-81

Astorri, E.; Scrivo, R.; Bombardieri, M.; Picarelli, G.; Pecorella, I.; Porzia, A.; Valesini, G.; Priori, R. 2013: OP0082 Expression of Fractalkine in Sjögren's Syndrome Patients: Cellular and Molecular Characterization of CX3CL1 and CX3CR1 in Sera and Salivary Glands. Annals of the Rheumatic Diseases 72(Suppl 3): A78.1-A78

Eppeland, S.G.; Diamantopoulos, A.; Soldal, D.M.; Haugeberg, G. 2013: OP0082Short term effect of 2-weeks rehabilitation on disease activity and health status in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases 71(Suppl 3): 81.1-81

Yeo, L.; Filer, A.D.; Buckley, C.D.; Scheel-Toellner, D.; Raza, K. 2013: OP0083Comparison of synovial tissue cytokine mrna profiles in very early arthritis patients with divergent outcomes. Annals of the Rheumatic Diseases 71(Suppl 3): 81.2-81

Kyriakidis, N. C.; Kapsogeorgou, E. K.; Gourzi, V. C.; Moutsopoulos, H. M.; Tzioufas, A. G. 2013: OP0083RO52/TRIM21 Expression in Salivary Gland Epithelial Cells (SGECS) is Upregulated by TLR3-Signaling. Annals of the Rheumatic Diseases 72(Suppl 3): A78.2-A78

Hoxha, A.; Ruffatti, A.; Ottosson, V.; Ottosson, L.; Hedlund, M.; Del Ross, T.; Punzi, L.; Sonesson, S.-E.; Wahren-Herlenius, M. 2013: OP0084Cardiopathogenic Role of Human RO/SSA and LA/SSA Antibodies Demonstrated in a Novel Animal Model of Congenital Heart Block. Annals of the Rheumatic Diseases 72(Suppl 3): A78.3-A79

Turesson, C.; Hansson, M.; Bergström, U.; Jacobsson, L.T.; Mathsson, L.; Klareskog, L.; Jakobsson, P.-J.; Holmdahl, R.; Rönnelid, J. 2013: OP0084Patterns of circulating antibodies in the pre-clinical phase of rheumatoid arthritis suggest epitope spreading in the immune reaction against citrullinated peptides. Annals of the Rheumatic Diseases 71(Suppl 3): 81.3-82

Brink, M.; Hansson, M.; Mathsson, L.; Nogueira, L.; Serre, G.; Jakobsson, P.-J.; Holmdahl, R.; Rönnelid, J.; Klareskog, L.; Rantapää Dahlqvist, S. 2013: OP0085Multiplex analysis of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 82.1-82

Wang, L. C.; Perper, S.; Perron, D.; Tarcsa, E.; Bardwell, P.; Mozaffarian, N.; Souers, A.; Elmore, S.; Ghayur, T.; Olson, L. 2013: OP0085Therapeutic Inhibition of Anti-Apoptotic BCL-2 Family Proteins in a Murine Model of Lupus Nephritis. Annals of the Rheumatic Diseases 72(Suppl 3): A79.1-A79

Spies, C.M.; Gaber, T.; Hoff, P.; Mazuch, J.; Maier, B.; Hahne, M.; Strehl, C.; Tran, C.L.; Soboleva, N.; Stoehr, A.; Wagegg, M.; Fangradt, M.; Jakstadt, M.; Huscher, D.; Burmester, G.-R.; Detert, J.; Kramer, A.; Buttgereit, F. 2013: OP0086Alterations of immune cellular circadian rhythms in rheumatoid arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 82.2-82

Ruiz-Limon, P.; Pérez-Sánchez, C.; Messineo, S.; Aguirre, M. Á.; Carretero, R. M.; Rodriguez-Ariza, A.; Barbarroja, N.; Khamashta, M.; Collantes, E.; Cuadrado, M. J.; López-Pedrera, C. 2013: OP0086Gene Profiling Reveals Specific Molecular Pathways in the Pathogenesis of Atherosclerosis and Cardiovascular Disease in Primary Antiphospholipid Syndrome, Systemic Lupus Erythematosus and Lupus with Antiphospholipid Syndrome. Annals of the Rheumatic Diseases 72(Suppl 3): A79.2-A79

Lin, N.Y. 2013: OP0087Autophagy contributes to TNFa-mediated joint destruction. Annals of the Rheumatic Diseases 71(Suppl 3): 82.3-83

Diffin, J.; Lunt, M.; Marshall, T.; Chipping, J.; Symmons, D.; Verstappen, S. 2013: OP0088Changes in Baseline Severity of Inflammatory Polyarthritis Over Time. Annals of the Rheumatic Diseases 72(Suppl 3): A80.1-A80

Kato, Y.; Morikawa, N.; Hamachi, E.; Nakayama, H.; Takata, Y.; Tamaki, K.; Mizuhara, H.; Nishimura, K.; Akamatsu, H.; Taguchi, Y.; Yamaguchi, T.; Miyata, J.; Higashi, Y. 2013: OP0088Discovery of a novel anti-bone resorption compound, AS2690168, which inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappa B ligand (RANKL). Annals of the Rheumatic Diseases 71(Suppl 3): 125.3-126

Diffin, J.; Marshall, T.; Chipping, J.; Symmons, D.; Verstappen, S. 2013: OP0089Disease Severity in Patients with Inflammatory Arthritis who Persistently, Intermittently, or Never Achieve Remission. Annals of the Rheumatic Diseases 72(Suppl 3): A80.2-A80

de Rooy, D.; Yeremenko, N.; Knevel, R.; Brouwer, E.; Wilson, G.; Lindqvist, E.; Saxne, T.; Krabben, A.; Leijsma, M.; Tsonaka, R.; Daha, N.; Zhernakova, S.; Houwing-Duistermaat, J.; Huizinga, T.; Baeten, D.; Toes, R.; van der Helm-van Mil, A. 2013: OP0089Genetic studies on DICKKOPF-1, sclerostin and the severity of joint destruction in rheumatoid arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 83.1-83

Sørensen, J.; Hetland, M. L. 2013: OP0090Duration of Symptoms Before Diagnosis in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis. Annals of the Rheumatic Diseases 72(Suppl 3): A80.3-A81

de Munter, W.; Walgreen, B.; Helsen, M.M.; Sloetjes, A.W.; van den Berg, W.B.; van Lent, P.L. 2013: OP0090LDL receptor deficiency results in osteophyte formation during experimental osteoarthritis which is increased under high cholesterol conditions. Annals of the Rheumatic Diseases 71(Suppl 3): 83.2-83

Poddubnyy, D.; Conrad, K.; Ruiz-Heiland, G.; Syrbe, U.; Haibel, H.; Appel, H.; Rudwaleit, M.; Schett, G.; Sieper, J. 2013: OP0091Prediction of radiographic spinal progression using biomarkers in patients with ankylosing spondylitis who are at high risk for progression:. Annals of the Rheumatic Diseases 71(Suppl 3): 83.3-84

Van Nies, J. A. B.; Krabben, A.; Schoones, J. W.; Huizinga, T. W. J.; Kloppenburg, M.; van der Helm-van Mil, A. H. M. 2013: OP0091What is the Evidence for the Presence of a Therapeutic Window of Opportunity in Rheumatoid Arthritis? A Systematic Literature Review. Annals of the Rheumatic Diseases 72(Suppl 3): A81.1-A81

Syrbe, U.; Scheer, R.; Wu, P.; Sieper, J. 2013: OP0092Differential systemic and synovial TH1 cell reactivity towards escherichia coli antigens in patients with ankylosing spondylitis and rheumatoid arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 84.1-84

Ambarus, C.A.; van Duivenvoorde, L.M.; Masdar, H.; van Melsen, T.K.; van Tok, M.N.; Tak, P.P.; Yeremenko, N.G.; Baeten, D.L. 2013: OP0093Relative overexpression of transmembrane versus soluble TNF in human and experimental spondyloarthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 84.2-84

Eriksson, J.; Karlsson, J. A.; Bratt, J.; Petersson, I. F.; van Vollenhoven, R. F.; Ernestam, S.; Geborek, P.; Neovius, M. 2013: OP0094Cost-Effectiveness of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: 2-Year Results of the Randomised Controlled Swefot Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A82.1-A82

Nocturne, G.; Pavy, S.; Goupille, P.; Dougados, M.; Roux, C.; Mariette, X.; Miceli-Richard, C. 2013: OP0094DKK1 serum level is increased in recent spondyloarthritis and is associated with higher prevalence of syndesmophytes. Data from the desir cohort. Annals of the Rheumatic Diseases 71(Suppl 3): 84.3-85

Christie, A.; Dagfinrud, H.; Dale, Ø.; Schulz, T.; Hagen, K. B. 2013: OP0095-HPRWhy Use Pen and Paper in Data Collection when you can Use a Mobile Phone? - Comparison of the Two Methods. Annals of the Rheumatic Diseases 72(Suppl 3): A82.2-A82

Uddin, M.; O'Reilly, D.D.; Inman, R.D.; Maksymowych, W.P.; Gladman, D.D.; Hamilton, S.; Yazdani, R.; Rahman, P. 2013: OP0095Customized CNV microarray identified UGT2B17 as a novel susceptibility gene associated with familial ankylosing spondylitis. Annals of the Rheumatic Diseases 71(Suppl 3): 85.1-85

Ciurea, A.; Scherer, A.; Weber, U.; Nissen, M.; Exer, P.; Bernhard, J.; Tamborrini, G.; Mueller, R.; Weiss, B.; Kissling, R.; Michel, B.A.; Finckh, A. 2013: OP0096Tobacco smoking is associated with increased disease activity in HLA-B27 positive axial spondyloarthritis patients, but does not alter the course of disease activity. Annals of the Rheumatic Diseases 71(Suppl 3): 85.2-85

Nikolaus, S.; Bode, C.; Taal, E.; Oostveen, A.; Glas, C.; van de Laar, M. 2013: OP0097-HPRThe Challenge to Develop a Multidimensional Computerized Adaptive Test for Fatigue in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A83.1-A83

Heine, P.; Williams, M. A.; McConkey, C.; Lord, J.; Dosanjh, S.; Williamson, E.; Adams, J.; Underwood, M.; Lamb, S. E. 2013: OP0098-HPRSarah: Strengthening and Stretching for People with Rheumatoid Arthritis of the Hands: A Randomised Controlled Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A83.2-A83

Mchugh, K.; Shaw, J.; Kollnberger, S.; Utriainen, L.; Firmin, D.; Milling, S.; Renner, C.; Bowness, P. 2013: OP0098The detection of a potentially pathogenic subset of HLA-B27 conformers at the cell surface in a rat model of SPA. Annals of the Rheumatic Diseases 71(Suppl 3): 86.1-86

Crins, M.; Roorda, L. D.; Beuving, W.; Boshuizen, H. C.; Dekker, J. 2013: OP0099Somatic Comorbidity in Patients with Chronic Widespread Pain in an Outpatient Secondary Care Center for Rheumatology and Rehabilitation in the Netherlands. Annals of the Rheumatic Diseases 72(Suppl 3): A83.3-A84

Holzinger, D.; Nippe, N.; Marketon, K.; Dalbeth, N.; Merriman, T.; Baeten, D.; Busso, N.; Vogl, T.; Foell, D.; Gabay, C.; Roth, J. 2013: OP0099Toll-like receptor 4 agonists MRP 8 and MRP 14 act as endogenous enhancers of MSU-crystal induced IL-1 secretion in vitro and reflect disease activity in gout patients in vivo. Annals of the Rheumatic Diseases 71(Suppl 3): 86.2-86

Schroeer, A.; Brandt, P.; Hartge, D. R.; Weichert, J. 2013: OP01.01: Prevalence, clinical impact and recurrence risk of genetic disorders in prenatal medicine: lessons from our unit over 15 years. Ultrasound in Obstetrics and Gynecology 42(S1): 48-48

Aviram, A.; Steinberg, M.; Fishman, A.; Tepper, R.; Solt, I.; Lifshitz Aviram, P.; Aviram, R. 2013: OP01.04: Late termination of pregnancy in Israel: the effect of a policy change. Ultrasound in Obstetrics and Gynecology 42(S1): 49-49

Mano, Y.; Tsuda, H.; Sumigama, S.; Kotani, T.; Kikkawa, F. 2013: OP01.07: Prenatal diagnosis of congenital diarrhea using color Doppler ultrasonography. Ultrasound in Obstetrics and Gynecology 42(S1): 50-50

Willems, L. M.; Redmond, A. C.; Braschi, F.; Stamm, T. A.; Boström, C.; Decuman, S.; Tyrrell Kennedy, A.; Brozd, J.; Roškar, S.; Smith, V.; van den Ende, C. H. 2013: OP0100-HPREducational Needs Among Health Professionals Working with Systemic Sclerosis: An International Survey Conducted on Behalf of the Eular Scleroderma Health Professionals Network (EUSHNet). Annals of the Rheumatic Diseases 72(Suppl 3): A84.1-A84

Rothenbacher, D.; Kleiner, A.; Koenig, W.; Primatesta, P.; Breitling, L.P.; Brenner, H. 2013: OP0100Gout in patients with stable coronary heart disease and the impact of serum uric acid levels on adverse cardiovascular outcomes: A long-term follow-up study. Annals of the Rheumatic Diseases 71(Suppl 3): 86.3-87

Van Den Ende, C.; Stukstette, M.; Hoogeboom, T.; Noort, W.; Bijlsma, J. W.; Dekker, J. 2013: OP0101-HPRIn Patients with Hand OA there is no Evidence that a Booster Session after Multidisciplinary Treatment is Effective; Results of a Randomised Controlled Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A84.2-A84

Loeppenthin, K.; Esbensen, B. A.; Østergaard, M.; Jennum, P.; Thomsen, T.; Midtgaard, J. 2013: OP0102-HPRSedentary Behaviour in Danish Patients with Rheumatoid Arthritis - What is the Association to Pain, Fatigue, Sleep and Physical Function? A Cross-Sectional Study. Annals of the Rheumatic Diseases 72(Suppl 3): A85.1-A85

Kuo, C.-F.; Yu, K.-H.; Luo, S.-F.; See, L.-C. 2013: OP0103Risk of end-stage renal disease associated with gout: A nationwide population study. Annals of the Rheumatic Diseases 71(Suppl 3): 87.3-88

Birbara, C.; Blanco, F. J.; Crowley, J. J.; Hu, C.; Stevens, R.; Edwards, C. J. 2013: OP0104 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis Including Current Skin Involvement: Results of a Phase 3, Randomized, Controlled Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A85-A86

Hoff, P.; Gaber, T.; Hahne, M.; Strehl, C.; Fangradt, M.; Schmidt-Bleek, K.; Burmester, G.R.; Schmidmaier, G.; Duda, G.N.; Perka, C.; Buttgereit, F. 2013: OP0105Accumulation of CD34+ hematopoietic stem cells in the initial inflammatory human fracture hematoma is driven by rantes and eotaxin. Annals of the Rheumatic Diseases 71(Suppl 3): 88.2-88

Mease, P. J.; Rao, S.; Betts, K. A.; Lu, M.; Fan, L.; Pangan, A. L.; van der Heijde, D.; Cifaldi, M. A. 2013: OP0105Effect of Adalimumab on Physical Function, Health-Related Quality of Life, and Work Productivity in Patients with Peripheral Spondyloarthritis: Results from the Ability-2 Clinical Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A86.1-A86

Bantia, S.; Parker, C.; Harman, L.; Papac, D.; Hollister, A. 2013: OP0106Effect of BCX4208 add-on therapy to allopurinol 300 mg on plasma hypoxanthine and xanthine concentrations in gout patients:. Annals of the Rheumatic Diseases 71(Suppl 3): 89.1-89

Landewé, R.; Rudwaleit, M.; van der Heijde, D.; Dougados, M.; Maksymowych, W. P.; Braun, J.; Deodhar, A.; Stach, C.; Hoepken, B.; Coteur, G.; Kielar, D.; Fichtner, A.; Arledge, T.; Sieper, J. 2013: OP0106Effect of Certolizumab Pegol on Signs and Symptoms of Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 24-Week Results of Rapid-Axspa Study. Annals of the Rheumatic Diseases 72(Suppl 3): A86.2-A87

Lachmann, H.J.; Touitou, I.; Obici, L.; Woo, P.; Naselli, A.; Berendes, R.; Anton, J.; Modesto, C.; Quartier, P.; Merino, R.; Ozen, S.; Cimaz, R.; Meini, A.; Ruperto, N.; Gattorno, M. 2013: OP0107Clinical features at presentation in a series of 86 patients with genetically confirmed traps and 33 patients with inflammatory symptoms and the r92q variant from the eurofevers/eurotraps registry:. Annals of the Rheumatic Diseases 71(Suppl 3): 89.2-89

van der Heijde, D.; Braun, J.; Rudwaleit, M.; Purcaru, O.; Kavanaugh, A. 2013: OP0107Improvements in Work and Household Productivity after 24 Weeks of Certolizumab Pegol in Treatment of Axial Spondyloarthritis Patients, Including Patients with Ankylosing Spondylitis: Results of Rapid-Axspa Study. Annals of the Rheumatic Diseases 72(Suppl 3): A87.1-A87

Dougados, M.; van der Heijde, D.; Sieper, J.; Braun, J.; Maksymowych, W. P.; Citera, G.; Pedersen, R.; Bonin, R.; Bukowski, J.; Koenig, A. S.; Vlahos, B.; Alvarez, D. 2013: OP0108Clinical and Imaging Efficacy of Etanercept in Early Non-Radiographic Axial Spondyloarthritis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A87.2-A88

Colafrancesco, S.; Picarelli, G.; Gattamelata, A.; Priori, R.; Valesini, G. 2013: OP0108Clinical and laboratory findings in a cohort of italian patients with adult onset stills disease. Annals of the Rheumatic Diseases 71(Suppl 3): 89.3-90

Kasifoglu, T.; Bilge, S.; Gonullu, E.; Bekdemir, F.; Korkmaz, C. 2013: OP0109Evaluation of potential risk factors of amyloidosis in familial mediterranean fever. Annals of the Rheumatic Diseases 71(Suppl 3): 90.1-90

Sieper, J.; Baeten, D. L.; Van den Bosch, F.; Rathmann, S. S.; Anderson, J.; Pangan, A. L. 2013: OP0109Sustained Clinical Remission in Patients with Non-Radiographic Axial Spondyloarthritis after Two Years of Adalimumab Treatment. Annals of the Rheumatic Diseases 72(Suppl 3): A88.1-A88

Danjo, J.; Dobashi, H.; Kameda, T.; Susaki, K.; Yamamoto, Y.; Nakashima, S.; Shimada, H.; Izumikawa, M.; Nishiyama, Y.; Matsunaga, T. 2013: OP0110The utility of fluorodeoxyglucose-positron emission tomography for IgG4-related disease diagnosed accorgding to comprehensive diagnostic criteria. Annals of the Rheumatic Diseases 71(Suppl 3): 90.2-90

Shao, A.; Zhan, J.; Li, N.; Chiang, C.-W.; Lei, A. 2018: External Oxidant-Free Dehydrogenative Lactonization of 2-Arylbenzoic Acids via Visible-Light Photocatalysis. Journal of Organic Chemistry 83(7): 3582-3589

Gossec, L.; de Wit, M.; Heiberg, T.; Maccarone, M.; Balanescu, A.; Balint, P.; Niedermayer, D.; Cañete, J. D.; Sánchez Lombarte, A.; Helliwell, P.; Parkinson, A.; Kalyoncu, U.; Kilic, L.; Braun, J.; Kiltz, U.; Otsa, K.; Veale, D.; O'Sullivan, D.; de Vlam, K.; Scrivo, R.; Stamm, T.; Smolen, J.; Carton, L.; Bertheussen, H.; Kvien, T. K. 2013: OP0111Elaboration and Preliminary Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire. A 13-Country Eular Initiative with Involvement of Patient Research Partners from Each Country. Annals of the Rheumatic Diseases 72(Suppl 3): A89.1-A89

Meiners, P.; Vissink, A.; Kroese, F.; Spijkervet, F.; Haacke, E.; Abdulahad, W.; Sillevis Smitt-Kamminga, N.; Brouwer, E.; Arends, S.; Bootsma, H. 2013: OP0112 Abatacept Treatment Reduces Disease Activity in Early Primary Sjögren's Syndrome (Phase II Open Label Asap Study). Annals of the Rheumatic Diseases 72(Suppl 3): A89.2-A89

Hansen, I.J.W.; Noraas, S.; Skarpaas, T.; Kjelland, V.; Haugeberg, G. 2013: OP0113Lyme arthritis in southern norway - an endemic area for lyme borreliosis. Annals of the Rheumatic Diseases 71(Suppl 3): 91.2-91

Seror, R.; Lazure, T.; Desmoulins, F.; Pavy, S.; Miceli-Richard, C.; Ravaud, P.; Mariette, X. 2013: OP0113Modification of Salivary Gland Lymphocyte Pattern after Belimumab in Primary Sjogrens Syndrome: Results of the Beliss Study. Annals of the Rheumatic Diseases 72(Suppl 3): A89.3-A90

Gottenberg, J. E.; Ravaud, P.; Puechal, X.; Le Guern, V.; Sibilia, J.; Goeb, V.; Larroche, C.; Dubost, J. J.; Rist, S.; Saraux, A.; Devauchelle, V.; Morel, J.; Hayem, G.; Hachulla, E.; Perdriger, A.; Sene, D.; Zarnitsky, C.; Perrodeau, E.; Batouche, D.; Furlan, V.; Benessiano, J.; Seror, R.; Mariette, X. 2013: OP0114 Inefficacy of Hydroxychoroquine in Primary Sjögren's Syndrome: Results at 12 Months of the Randomized Placebo-Controlled Trial of Plaquenil in Primary Sjögren's Syndrome. Annals of the Rheumatic Diseases 72(Suppl 3): A90.1-A90

Primdahl, J.; Horn, H.C.; Petersen, R.; Hørslev-Petersen, K. 2013: OP0115Clinical and radiological outcome in outpatients with rheumatoid arthritis followed by medical, nursing or shared care a two year randomised controlled trial. Annals of the Rheumatic Diseases 71(Suppl 3): 92.1-92

Vermeer, M.; Kievit, W.; Kuper, I.; Braakman-Jansen, A.; Bernelot Moens, H.; Zijlstra, T.; den Broeder, A.; van Riel, P.; Fransen, J.; van de Laar, M. 2013: OP0116Cost-effectiveness and cost-utility analysis of treat-to-target versus usual care in early rheumatoid arthritis: Results of the dream registry. Annals of the Rheumatic Diseases 71(Suppl 3): 92.2-92

Furie, R.; Scheinberg, M.; Leon, G.; Ramiterre, E. B.; Thomas, M.; Chu, A. D.; Hislop, C.; Martin, R. S.; Petri, M. A. 2013: OP0116Effects of Blisibimod, a Subcutaneous Inhibitor of B Cell Activating Factor, in Patients with SLE. Annals of the Rheumatic Diseases 72(Suppl 3): A90.3-A91

Tselios, K.; Sarantopoulos, A.; Gkougkourelas, I.; Papagianni, A.; Boura, P. 2013: OP0117Cyclophosphamide Pulse Therapy Leads to T Regulatory Cells Alterations in Active Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases 72(Suppl 3): A91.1-A91

Gati, T.; Morgan, C.; Luben, R.N.; Lahiri, M.; Verstappen, S.M.; Bunn, D.K.; Lunt, M.; Symmons, D.P.; Wareham, N.J.; Khaw, K.-T.; Bruce, I.N. 2013: OP0117HDL-C and HBA1C predict the development of inflammatory polyarthritis: Results from the european prospective investigation of cancer (norfolk) and the norfolk arthritis register (EPIC-2-NOAR study). Annals of the Rheumatic Diseases 71(Suppl 3): 92.3-92

Goldenberg, D. M.; Rossi, E. A.; Michel, R.; Wallace, D. J.; Chang, C.-H. 2013: OP0118Epratuzumab Mediates BCR-Antigen Trogocytosis as Potential Mechanism of Action in Systemic Lupus Erythematosus (SLE). Annals of the Rheumatic Diseases 72(Suppl 3): A91.2-A91

Alhusain, A.Z.; Verstappen, S.M.; Lunt, M.; Mirjafari, H.; Bunn, D.; Marshall, T.; Charlton-menys, V.; Durrington, P.; Symmons, D.; Bruce, I.N. 2013: OP0118Predictors of overall/cardiovascular mortality in patients with early inflammatory polyarthritis; the lipid-paradox?. Annals of the Rheumatic Diseases 71(Suppl 3): 93.1-93

Singh, G.; Mannalithara, A.; Mithal, A.; Triadafilopoulos, G. 2013: OP0119Great progress but much more needed: Hospitalizations due to complicated gastric and duodenal ulcers in the US (1990-2009). Annals of the Rheumatic Diseases 71(Suppl 3): 93.2-93

Wofsy, D.; Gordon, C.; Licu, D.; Copt, S.; Pena Rossi, C.; Isenberg, D. 2013: OP0119Pharmacodynamic Effects of Atacicept in SLE Patients: 52-Week Data from the April-SLE Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A91.3-A92

Umeda, N.; Matsumoto, I.; Inoue, A.; Tanaka, Y.; Kondo, Y.; Tsuboi, H.; Suzuki, T.; Tsuchiya, N.; Sumida, T. 2013: OP0120Specific Identification of Anti-Citrullinated Glucose-6-Phospate Isomerase Peptide (CCG) Antibodies Associated with HLA-DRB1 SE and Disease Activity in Patients with RA. Annals of the Rheumatic Diseases 72(Suppl 3): A92.1-A92

Svendsen, A.J.; Hjelmborg, J.V.; Skytthe, A.; Houen, G.; Kyvik, K.; Junker, P. 2013: OP0120The incidence of rheumatoid arthritis and the impact of smoking. Annals of the Rheumatic Diseases 71(Suppl 3): 93.3-94

Eriksson, J.; Askling, J.; Neovius, M. 2013: OP0121Combined and specific costs for hospitalisations, drugs, and lost work days in prevalent contemporary RA: A nationwide cohort study. Annals of the Rheumatic Diseases 71(Suppl 3): 94.1-94

Binks, D.; Matzelle, M.; Bergin, D.; Hodgson, R.; Gravallese, E.; McGonagle, D.; Radjenovic, A. 2013: OP0121The Frequency of Bone Erosion and Oedema in Inflammatory and Degenerative Arthropathies Proximal to the Peri-Entheseal Cruciate Ligament Vascular Channels. Annals of the Rheumatic Diseases 72(Suppl 3): A92.2-A92

Willumsen, L.; Jeppesen, H. 2013: OP0122-PAREPauseboogie - campaign to raise awareness of the DANISH rheumatism association. Annals of the Rheumatic Diseases 71(Suppl 3): 94.2-94

van den Bosch, M. H.; Blom, A. B.; van Erp, A. E.; van de Loo, F. A.; Blaney Davidson, E. N.; van der Kraan, P. M.; van Lent, P. L.; van den Berg, W. B. 2013: OP0122Synovial WNT and WISP1 Expression Induces Expression of Cartilage-Degrading Metalloproteinases in the Synovium. Annals of the Rheumatic Diseases 72(Suppl 3): A92.3-A93

Jasinski, T.; Lemetti, H.; Käppa, I. 2013: OP0123-PARELocal government services for disabled people in tartu and the role of tartu rheumatism association in mediating the services. Annals of the Rheumatic Diseases 71(Suppl 3): 94.3-95

Akhtar, N.; Haqqi, T. M. 2013: OP0123In Human Chondrocytes DNMT-1 Plays a Key Role in the Expression of Several Genes Associated with the Pathogenesis of Osteoarthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A93.1-A93

Basu, N.; McClean, A.; Luqmani, R.; Harper, L.; Flossmann, O.; Jayne, D.; Little, M.; Amft, E.N.; Dhaun, N.; McLaren, J.; Kumar, V.; Erwig, L.; Jones, G.; Reid, D.; Macfarlane, G. 2013: OP0124Contextualising quality of life in ANCA associated vasculitis (AAV). Annals of the Rheumatic Diseases 71(Suppl 3): 95.1-95

Lin, N. Y.; Distler, A.; Luther, J.; Beyer, C.; Kagwiria, R.; Stefanica, A.; Distler, O.; Schett, G.; Distler, J. H. 2013: OP0124Inhibition of Autophagy Rescue the Bone Loss of Experimental Osteoporosis. Annals of the Rheumatic Diseases 72(Suppl 3): A93.2-A93

Luong Nguyen, L.B.; Bonitsis, N.G.; Altenburg, A.; Zouboulis, C.C.; Mahr, A. 2013: OP0125Gender-specific differences in adamantiades-behets disease presentation: Meta-analyses of combined data from the german registry for adamantiades-behets disease and from a systematic literature review. Annals of the Rheumatic Diseases 71(Suppl 3): 95.2-95

Laiguillon, M.-C.; Houard, X.; Bougault, C.; Nourissat, G.; Jacques, C.; Berenbaum, F.; Sellam, J. 2013: OP0125VISFATIN/NAMPT in Osteoarthritis: A Pro-Inflammatory Adipokine Involved in Synovium-Cartilage and Synovium-Bone Communications. Annals of the Rheumatic Diseases 72(Suppl 3): A93.3-A94

Scire', C.A.; Lunt, M.; Symmons, D.P.; Verstappen, S.M. 2013: OP0126Early and sustained remission is associated with improved survival in patients with inflammatory polyarthritis: Results from the norfolk arthritis register. Annals of the Rheumatic Diseases 71(Suppl 3): 95.3-96

Priam, S.; Bougault, C.; Gosset, M.; Houard, X.; Sellam, J.; Berenbaum, F.; Jacques, C. 2013: OP0126Secreted 14-3-3E : Discovery by Proteomics of a New Subchondral Bone Mediator Involved in Cartilage Degradation During Osteoarthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A94.1-A94

Im, G.-I.; Ko, J.-Y.; Choi, Y.-J. 2013: OP0127In Vitro Chondrogenesis and in VIVO Repair of Osteochondral Defect with Human Induced Pluripotent Stem Cells. Annals of the Rheumatic Diseases 72(Suppl 3): A94.2-A94

Kosanovic, M. 2013: OP0128-PAREMove to Improve Fashion Show Celebrating 2012 World Arthritis Day in Serbia. Annals of the Rheumatic Diseases 72(Suppl 3): A94.3-A95

Abou-Raya, A.; Abou-Raya, S.; Helmii, M.; Khadrawi, T. 2013: OP0129Effect of low dose oral prednisolone on symptoms and systemic inflammation in older adults with moderate to severe knee osteoarthritis: A randomized placebo-controlled trial. Annals of the Rheumatic Diseases 71(Suppl 3): 97.1-97

Furie, R.; Scheinberg, M.; Leon, G.; Ramiterre, E. B.; Thomas, M.; Chu, A. D.; Hislop, C.; Martin, R. S.; Petri, M. A. 2013: OP0129Effects of Blisibimod, an Inhibitor of B-Cell Activating Factor, on Markers of Renal Disease in Patients with SLE. Annals of the Rheumatic Diseases 72(Suppl 3): A95.1-A95

Eliseev, M. S.; Denisov, I. S.; Gluhova, S. I.; Barskova, V. G. 2013: OP0130Independent Risk Factors for Cardiovascular Events in Male Patients with Gout: Results of the 7-Year Prospective Follow-Up Study. Annals of the Rheumatic Diseases 72(Suppl 3): A95.2-A95

Kerkhof, H.J.; Bierma-Zeinstra, S.; Hofman, B.; Rivadeneira, F.; Uitterlinden, A.; Janssens, C.; van Meurs, J. 2013: OP0130Prediction model for knee osteoarthritis including clinical, genetic and biochemical risk factors. Annals of the Rheumatic Diseases 71(Suppl 3): 97.2-97

Tauber, M.; Avouac, J.; Benahmed, A.; Barbot, L.; Kahan, A.; Allanore, Y. 2013: OP0131 Prevalence and Predictors of Small Intestinal Bacterial Overgrowth in Systemic Sclerosis. Annals of the Rheumatic Diseases 72(Suppl 3): A95-A96

Humphreys, J.; Verstappen, S.; Lunt, M.; Hyrich, K.; Marshall, T.; Symmons, D. 2013: OP0131Incidence of rheumatoid arthritis in the UK using the 2010 ACR/EULAR classification criteria for RA; and comparison with estimates using the 1987 ACR criteria:. Annals of the Rheumatic Diseases 71(Suppl 3): 97.3-98

Callhoff, J.; Westhoff, G.; Edelmann, E.; Schett, G.; Schneider, M.; Zink, A. 2013: OP0132Remission According to the ACR/EULAR Remission Criteria in Patients with Early Arthritis is Significantly Influenced by Patient-Reported Fatigue and Well-Being. Annals of the Rheumatic Diseases 72(Suppl 3): A96.1-A96

Nicolau, J.; Boumier, P.; Daragon, A.; Mejjad, O.; Ménard, J.-F.; Pouplin, S.; Vittecoq, O.; Fardellone, P.; Le Loët, X. 2013: OP0132Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis in the very early arthritis community-based (VERA) cohort: Slight improvement after excluding erosion criterion. Annals of the Rheumatic Diseases 71(Suppl 3): 98.1-98

Castrejón, I.; Dougados, M.; Combe, B.; Guillemin, F.; Fautrel, B.; Pincus, T. 2013: OP0133Analysis of Potential Predictors for Remission in Early Rheumatoid Arthritis According to ACR/EULAR Boolean, DAS28 and RAPID3RJ1 Criteria: Results from the Espoir Cohort. Annals of the Rheumatic Diseases 72(Suppl 3): A96.2-A97

Lisbona, M.; Maymo, J.; Ares, J.; Almirall, M.; Navallas, M.; Solano, A.; Carbonell, J. 2013: OP0134Cut-Offs Values for Inflammatory H-MRI Lesions to Define Remission. Comparison Between DAS28, SDAI and New Boolean ACR/EULAR Criteria. Annals of the Rheumatic Diseases 72(Suppl 3): A97.1-A97

Krabben, A.; Abhishek, A.; Britsemmer, K.; Filer, A.; Huizinga, T.W.J.; Raza, K.; van Schaardenburg, D.; van der Helm-van Mil, A.H.M. 2013: OP0134Risk stratification in patients with undifferentiated arthritis according to the 2010 ACR/EULAR criteria. Annals of the Rheumatic Diseases 71(Suppl 3): 98.3-99

Aydin, S. Z.; Gallego, C. C.; Nam, J.; Freeston, J.; Horton, S.; Wakefield, R. J.; Emery, P. 2013: OP0135The New ACR/EULAR Criteria for Rheumatoid Arthritis is Able to Identify Patients with Same Disease Activity but Less Damage by Ultrasound. Annals of the Rheumatic Diseases 72(Suppl 3): A97.2-A97

Buttgereit, F.; Tuominen, R. 2013: OP0136Impact of morning stiffness on work performance in people with rheumatoid arthritis:. Annals of the Rheumatic Diseases 71(Suppl 3): 99.2-99

Pattloch, D.; Herzer, P.; Zinke, S.; Gräßler, A.; Zink, A.; Strangfeld, A. 2013: OP0137-PCDecreasing incidence of disability pensions in patients with rheumatoid arthritis in germany:. Annals of the Rheumatic Diseases 71(Suppl 3): 99.3-100

Bergman, S. 2013: OP0137-PCNumber of Painful Regions and their Distribution Predicts Outcome of Pain in the General Population. Annals of the Rheumatic Diseases 72(Suppl 3): A98.1-A98

Ursum, J.; Nielen, M.; Twisk, J.; Peters, M.; Schellevis, F.; Nurmohamed, M.; Korevaar, J. 2013: OP0138-PCHigh Presence of Chronic Diseases at the Onset of Inflammatory Arthritis: Results from a Population-Based Study. Annals of the Rheumatic Diseases 72(Suppl 3): A98.2-A98

Magnani, A.; Meloni, A.; Gattorno, M.; Martini, A.; Traggiai, E. 2013: OP0138B cell subsets phenotype in autoimmunity with immunodeficiency: Analysis of a large cohort of patients with apeced syndrome. Annals of the Rheumatic Diseases 71(Suppl 3): 100.1-100

Hamann, P.; Heward, J.; McHugh, N.; Lindsay, M. 2013: OP0139Next Generation Sequencing Analysis of the Transcriptome in Muscle Obtained from Anti-JO 1 Positive Idiopathic Inflammatory Myositis and Inclusion Body Myositis: A Pilot Study. Annals of the Rheumatic Diseases 72(Suppl 3): A98.3-A99

Cumming, J.; Hull, R.G. 2013: OP0140-PAREThe complexity of living with rheumatic and musculoskeletal diseases and other health problems. Annals of the Rheumatic Diseases 71(Suppl 3): 100.3-101

He, Y.; Brandt-Hansen, N.; Wang, J.; Su, D.; Zheng, Q.; Petersen, K.; Simonsen, O.; Schett, G.; Karsdal, M.; Bay-Jensen, A. C. 2013: OP0140Circulating Carboxy-Terminal Type X Collagen Fragments (C-Col10), a Measure of Skeletal Hypertrophy, are Elevated in Patients with Osteoarthritis and Ankylosing Spondylitis. Annals of the Rheumatic Diseases 72(Suppl 3): A99.1-A99

Dankers, W.; van Hamburg, J.P.; Asmawidjaja, P.S.; Davelaar, N.; Wen, K.; Mus, A.M.C.; Colin, E.M.; van Leeuwen, J.P.T.M.; Hazes, J.M.W.; Lubberts, E. 2013: OP01411,25(OH)2D3 modulates gene expression involved in cytokine production, proliferation, survival and migration of TH17 cells from patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 101.1-101

Bleil, J.; Syrbe, U.; Maier, R.; Sieper, J.; Appel, H. 2013: OP0141No Signs for Direct Bone Formation or Endochondral Ossification at the Entheses in Facet Joints from Ankylosing Spondylitis Patients. Annals of the Rheumatic Diseases 72(Suppl 3): A99.2-A99

Gijon-Nogueron, G.; Ndosi, M.; Luque-Suarez, A.; Alcacer-Pitarch, B.; Munuera, P. V.; Adam, G.; Redmond, A. 2013: OP0142-HPRPsychometric Characteristics of a Spanish Translation of the Manchester Foot Pain and Disability Index: Validation and Rasch Analysis. Annals of the Rheumatic Diseases 72(Suppl 3): A100.1-A100

Söderström, K.; Sundström, Y.; Berg, L.; Schepis, D.; Galsgaard, E.D.; Klareskog, L.; Wagtmann, N. 2013: OP0142Masking CD94/NKG2A using a novel therapeutic MAB results in significant suppression of IL-6 levels and reduced osteoclast formation in rheumatoid arthritis ex vivo cultures. Annals of the Rheumatic Diseases 71(Suppl 3): 101.2-101

Betteridge, K.; Cottle, S.; Driver, A. 2013: OP0143-PAREImproving Patient Experience in Enhanced Recovery after Surgery. Annals of the Rheumatic Diseases 72(Suppl 3): A100.2-A100

Krieckaert, C.; Nurmohamed, M.T.; Wolbink, G. 2013: OP0143Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients. Annals of the Rheumatic Diseases 71(Suppl 3): 101.3-101

Sellam, J.; Mathoret-Philibert, F.; Lebouc, D.; Sfedj, S.; Preiss, P.; Rollot, S. 2013: OP0144-PAREInvolvement of Patients with Rheumatoid Arthritis in the Choice of their Treatment: Survey Conducted in France Among a Sample of Patients Belonging to an Association of Patients. Annals of the Rheumatic Diseases 72(Suppl 3): A100.3-A101

Strangfeld, A.; Manger, B.; Eisterhues, C.; Krause, A.; Listing, J.; Zink, A. 2013: OP0144Validation of the rabbit risk score for serious infections:. Annals of the Rheumatic Diseases 71(Suppl 3): 102.1-102

Detert, J.; Bastian, H.; Listing, J.; Weiss, A.; Wassenberg, S.; Liebhaber, A.; Rockwitz, K.; Alten, R.; Krüger, K.; Rau, R.; Simon, C.; Gremmelsbacher, E.; Braun, T.; Marsmann, B.; Höhne-Zimmer, V.; Egerer, K.; Buttgereit, F.; Burmester, G.-R. 2013: OP0145Induction therapy with adalimumab plus methotrexate versus methotrexate monotherapy in recent onset rheumatoid arthritis (RA) an investigator initiated randomized controlled trial:. Annals of the Rheumatic Diseases 71(Suppl 3): 102.2-103

Cornec, D.; Jousse-Joulin, S.; Marhadour, T.; Pers, J.-O.; Renaudineau, Y.; Saraux, A.; Devauchelle-Pensec, V. 2013: OP0145 Salivary Gland Ultrasonography Improves the Diagnostic Performance of ACR 2012 Classification Criteria for Sjögren's Syndrome. Annals of the Rheumatic Diseases 72(Suppl 3): A101.1-A101

Kelly, S.; Davidson, B.; Gorman, C.; Meenagh, G.; Reynolds, P. 2013: OP0146The Impact of Ultrasound on the Diagnosis and Management of Patients with Rheumatoid Arthritis (RA) in Routine Clinical Care Within the UK. Annals of the Rheumatic Diseases 72(Suppl 3): A101.2-A101

Kuroda, T.; Kobayashi, D.; Sato, H.; Nakatsue, T.; Wada, Y.; Murakami, S.; Nakano, M.; Narita, I. 2013: OP0146Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis. Annals of the Rheumatic Diseases 71(Suppl 3): 103.1-103

Syngle, A.; Verma, I.; Garg, N. 2013: OP0147Impact of Disease Modifying Anti Rheumatic Drugs on Autonomic Neuropathy in Rheumatoid Arthritis and Ankyliosing Spondylitis Patients. Annals of the Rheumatic Diseases 72(Suppl 3): A101.3-A102

Rantalaiho, V.; Korpela, M.; Hannonen, P.; Kaipiainen-Seppänen, O.; Möttönen, T.; Kauppi, M.; Karjalainen, A.; Laiho, K.; Kautiainen, H.; Leirisalo-Repo, M. 2013: OP0147Targeted treatment with combination DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of the neo-raco trial. Annals of the Rheumatic Diseases 71(Suppl 3): 103.2-103

Peredo, R.; Impens, A.; Phillips, K. 2013: OP0148 Peripheral Neuropathy (PN) in Primary Sjögren's Syndrome: Implications of Clinical Assessment, Time of Diagnosis and Treatment. Annals of the Rheumatic Diseases 72(Suppl 3): A102.1-A102

Gibson, J.; Harris, H.; McLaren, J.; Cullinane, S. 2013: OP0148Reduced dose and frequency of anti-TNF therapy in rhemuatic diseases:. Annals of the Rheumatic Diseases 71(Suppl 3): 103.3-104

Krieckaert, C.; Nair, S.C.; Nurmohamed, M.T.; van Dongen, C.J.; Lems, W.F.; Lafeber, F.P.; Bijlsma, J.W.; Wolbink, G.; Welsing, P.M. 2013: OP0149Evaluating the cost-effectiveness of personalized treatment with adalimumab using serum drug level and anti-adalimumab antibodies in rheumatoid arthritis patients. Annals of the Rheumatic Diseases 71(Suppl 3): 104.1-104

Orellana, C.; Klareskog, L.; Alfredsson, L.; Bengtsson, C. 2013: OP0149The Association Between Parity and Rheumatoid Arthritis: Results from the Swedish Eira Study. Annals of the Rheumatic Diseases 72(Suppl 3): A102.2-A102

Andersson, M.L.; Forslind, K.; Söderlin, M.; Hafström, I. 2013: OP0150Comparison between patients included in the BARFOT study 1992-1999 and 2000-2006 - a five year follow-up. Annals of the Rheumatic Diseases 71(Suppl 3): 104.2-104

Castrejón, I.; Yazici, Y.; Pincus, T. 2013: OP0150Formal Education Level is More Explanatory of Variation in Patient Global Estimate than Age, Duration of Disease or Gender in Patients with Rheumatoid Arthritis, Osteoarthritis, Systemic Lupus Erythematosus and Gout. Annals of the Rheumatic Diseases 72(Suppl 3): A103.1-A103

Beasley, M.; Schild von Spannenberg, S.; Jones, G. T.; Macfarlane, G. J. 2013: OP0151-PCDoes Primary Care Management of Low-Back Pain Differ in Older Persons? Results from the Musician Study. Annals of the Rheumatic Diseases 72(Suppl 3): A103.2-A103

den Uyl, D.; ter Wee, M.M.; Boers, M.; Voskuyl, A.E.; Kerstens, P.J.; Nurmohamed, M.T.; Raterman, H.G.; van Schaardenburg, D.; van Dillen, N.; Dijkmans, B.A.; Lems, W.F. 2013: OP0151Cobra-light therapy is clinically non-inferior to original cobra therapy in the treatment of early rheumatoid arthritis:. Annals of the Rheumatic Diseases 71(Suppl 3): 104.3-105

Healey, E. L.; Ryan, S.; McHugh, G. A.; Main, C. J.; Porcheret, M.; Ong, B. N.; Pushpa-Rajah, A.; Dziedzic, K. S. 2013: OP0152-PCKnowledge and Confidence of Practice Nurses in the Management of Osteoarthritis (OA): Pre- and Post-Evaluation of an OA Self-Management Training Programme. Annals of the Rheumatic Diseases 72(Suppl 3): A103.3-A104

Nakajima, A.; Inoue, E.; Kobayashi, A.; Sato, E.; Shidara, K.; Hoshi, D.; Sugimoto, N.; Seto, Y.; Tanaka, E.; Taniguchi, A.; Momohara, S.; Yamanaka, H. 2013: OP0152Impact of comorbidities on both disease activity and treatment strategy in patients with rheumatoid arthritis: Analysis of the IORRA cohort database:. Annals of the Rheumatic Diseases 71(Suppl 3): 105.1-105

Roemer, F. W.; Kwoh, C. K.; Hannon, M. J.; Boudreau, R.; Hunter, D. J.; Eckstein, F.; Wang, Z.; Grago, J.; Guermazi, A. 2013: OP0153 Subchondral Bone Marrow Lesions Predict Incident Radiographic Osteoarthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A104-A104

Volkmann, E.R.; Rezai, S.; Furst, D.E.; Woodworth, T. 2013: OP0153The art of tapering glucocorticoids (GC): A systematic review of studies reporting tapering strategies and outcomes in patients with rheumatoid arthritis (RA):. Annals of the Rheumatic Diseases 71(Suppl 3): 105.2-106

Abou-Raya, S.; Abou-Raya, A.; Khadrawi, T.; Helmii, M. 2013: OP0154 Chemerin and Knee Osteoarthritis: Effects on Inflammation and Cartilage Destruction. Annals of the Rheumatic Diseases 72(Suppl 3): A104-A104

van den Broek, M.; Dirven, L.; Klarenbeek, N.; van Krugten, M.; Ronday, H.; Kerstens, P.; Huizinga, T.; Lems, W.; Allaart, C. 2013: OP0154Clinical and radiological outcomes of four disease activity driven treatment strategies: 8-year results of the best study:. Annals of the Rheumatic Diseases 71(Suppl 3): 106.1-106

Liu, S.; Leask, A. 2013: OP0155A Novel Model of Systemic Sclerosis?: Loss of PTEN in Fibroblasts Results in Lung Fibrosis in A CCN2/CTGF-Dependent Fashion. Annals of the Rheumatic Diseases 72(Suppl 3): A104.3-A105

Karlsson, J.A.; Neovius, M.; Nilsson, J.-Å.; Petersson, I.F.; Bratt, J.; van Vollenhoven, R.F.; Ernestam, S.; Geborek, P. 2013: OP0155Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality of life results of the randomised, controlled swefot trial. Annals of the Rheumatic Diseases 71(Suppl 3): 106.2-106

Dees, C.; Schlottmann, I.; Funke, R.; Distler, A.; Palumbo-Zerr, K.; Zerr, P.; Lin, N.-Y.; Beyer, C.; Distler, O.; Schett, G.; Distler, J. 2013: OP0156Epigenetic Silencing of Endogenous WNT Inhibitors Contributes to the Aberrant Activation of Canonical WNT Signaling in Systemic Sclerosis. Annals of the Rheumatic Diseases 72(Suppl 3): A105.1-A105

Nam, J.L.; Villeneuve, E.; Hensor, E.M.A.; Conaghan, P.G.; Keen, H.I.; Gough, A.K.; Green, M.J.; Helliwell, P.; Keenan, A.-M.; Morgan, A.W.; Quinn, M.; Reece, R.; van der Heijde, D.M.; Wakefield, R.J.; Emery, P. 2013: OP0156Inhibition of structural damage with two intensive treatment strategies using infliximab or high dose intravenous steroid followed by treat to target in DMARD nave rheumatoid arthritis (the idea study) a preliminary report. Annals of the Rheumatic Diseases 71(Suppl 3): 106.3-107

Horneff, G.; Minden, K.; Huppertz, H. I. 2013: OP0157Use of Biologics in Patient with Juvenile Idiopathic Arthriitis. Annals of the Rheumatic Diseases 72(Suppl 3): A105.2-A105

Degboé, Y.; Fruchon, S.; Turrin, C.-O.; Caminade, A.-M.; Poupot, R.; Cantagrel, A.; Davignon, J.-L. 2013: OP0159Monocyte and Dendritic Cell Activation Via TLR4: Anti-Inflammatory Modulation by Dendrimer ABP. Annals of the Rheumatic Diseases 72(Suppl 3): A106.1-A106

Zhang, F.; Guerin, A.; Gauthier, G.; Curtis, J. 2013: OP0159Treatment patterns in psoriatic arthritis (PSA) patients newly initiated on oral disease-modifying anti-rheumatic drugs (DMARDs). Annals of the Rheumatic Diseases 71(Suppl 3): 108.1-108

Gladue, H.; Steen, V.; Allanore, Y.; Maranian, P.; Khanna, D. 2013: OP0160Evaluation of Non-Invasive Tests as an Early Diagnostic Screen for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis. Annals of the Rheumatic Diseases 72(Suppl 3): A106.2-A106

Lόpez-Vives, L.; Estrada, P.V.; Martín-Esteve, I.; Aparicio, M.; Juanola, X.; Nolla, J.M.; Rodríguez-Moreno, J. 2013: OP0161Dose reduction and/or withdrawal of anti-TNF treatment in psoritic arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 108.3-109

Lillegraven, S.; Greenberg, J. D.; Reed, G. W.; Saunders, K.; Curtis, J. R.; Harrold, L.; Hochberg, M. C.; Pappas, D.; Kremer, J. M.; Solomon, D. H. 2013: OP0161Use of TNF Inhibitors is Associated with a Reduced Risk of Diabetes in RA Patients. Annals of the Rheumatic Diseases 72(Suppl 3): A106.3-A107

Grøn, K. L.; Ørnbjerg, L. M.; Hetland, M. L.; Sokka-Isler, T. 2013: OP0162Prevalence of Comorbidities in Rheumatoid Arthritis. Does Gross Domestic Product Matter? Results from 34 Countries in the QUEST-RA Program. Annals of the Rheumatic Diseases 72(Suppl 3): A107.1-A107

Di Minno, M.N.D.; Iervolino, S.; Peluso, R.; Lupoli, R.; Russolillo, A.; Bottiglieri, P.; Scarpa, R.; Di Minno, G. 2013: OP0163Weight loss and induction of minimal disease activity in psoriatic arthritis patients starting TNF-a blockers treatment. Annals of the Rheumatic Diseases 71(Suppl 3): 109.2-109

Myasoedova, E.; Crowson, C. S.; Green, A. B.; Matteson, E. L.; Gabriel, S. E. 2013: OP0164Long-Term Blood Pressure Variability in Patients with Rheumatoid Arthritis (RA) Vs General Population, and its Impact on Cardiovascular Events and All-Cause Mortality in RA. Annals of the Rheumatic Diseases 72(Suppl 3): A108.1-A108

de Vlam, K.; Lories, R. 2013: OP0164Long-term TNF blockade induces joint repair in psoriatic arthritis:. Annals of the Rheumatic Diseases 71(Suppl 3): 109.3-110

Poggenborg, R.P.; Eshed, I.; Pedersen, S.J.; Sørensen, I.J.; Madsen, O.R.; Møller, J.; Østergaard, M. 2013: OP0165Whole-body MRI for assessment of enthesitis in psoriatic arthritis, axial spondyloarthritis and healthy subjects a comparison with 7 clinical enthesitis indices:. Annals of the Rheumatic Diseases 71(Suppl 3): 110.1-110

Van Sijl, A. M.; van den Oever, I. A.; Peters, M. J.; van Halm, V. V.; Voskuyl, A. E.; Smulders, Y. M.; Nurmohamed, M. T. 2013: OP0166Sustained Development of Cardiovascular Disease in Rheumatoid Arthritis Despite Cardioprotective Treatment: The 10-Year Prospective Carre-Study. Annals of the Rheumatic Diseases 72(Suppl 3): A109.1-A109

Sieper, J.; Porter-Brown, B.; Thompson, L.; Harari, O.; Dougados, M. 2013: OP0166Tocilizumab (TCZ) is not effective for the treatment of ankylosing spondylitis (AS): Results of a phase 2, international, multicentre, randomised, double-blind, placebo-controlled trial:. Annals of the Rheumatic Diseases 71(Suppl 3): 110.2-111

Park, W.; Hrycaj, P.; Kovalenko, V.; Miranda, P.; Gutierrez-Ureña, S.; Lee, Y.; Lim, M.; Ahn, C.; Kim, H.; Yoo, D.; Braun, J. 2013: OP0167A randomized, double-blind, phase 1 study demonstrates equivalence in pharmacokinetics, safety, and efficacy of CT-P13 and infliximab in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases 71(Suppl 3): 111.1-111

Meissner, Y.; Kühl-Habich, D.; Kekow, J.; Rockwitz, K.; Liebhaber, A.; Gräßler, A.; Gerhold, K.; Listing, J.; Strangfeld, A.; Zink, A. 2013: OP0167Acute Myocardial Infarction is Driven by Chronic Systemic Inflammation, Irrespective of the Kind of Treatment - Data from the German Biologics Register Rabbit. Annals of the Rheumatic Diseases 72(Suppl 3): A109.2-A109

Skeoch, S.; Dobbs, M.; Hubbard, P.; Naish, J.; Woodhouse, N.; Ho, M.; Waterton, J.; Parker, G.; Bruce, I. 2013: OP0169Assessment of Lupus Nephritis Disease Activity Using Non-Contrast MRI: A Pilot Study. Annals of the Rheumatic Diseases 72(Suppl 3): A110.1-A110

Sieper, J.; Inman, R.D.; Badalamenti, S.; Radin, A.; Braun, J. 2013: OP0169Sarilumab for the treatment of ankylosing spondylitis: Results of a phase 2, randomized. Double-blind, placebo-controlled, international study (align). Annals of the Rheumatic Diseases 71(Suppl 3): 111.3-112

van der Heijde, D.; Deodhar, A.; Braun, J.; Mack, M.; Hsu, B.; Gathany, T.; Han, C.; Inman, R. 2013: OP0170Achieving ASDAS-CRP major improvement and inactive disease in patients with ankylosing spondylitis after treatment with golimumab is associated with normalized health related quality of life: Two-year results from the go-raise trial. Annals of the Rheumatic Diseases 71(Suppl 3): 112.1-112

Hammer, H. B. 2013: OP0170The Radiocarpal and MCP2 Joints Should be Included in Ultrasonographic Follow-Up of RA Patients During Biologic Treatment. Annals of the Rheumatic Diseases 72(Suppl 3): A110.2-A100

Weber, U.; Zubler, V.; Pedersen, S.J.; Rufibach, K.; Lambert, R.G.; Chan, S.; Ostergaard, M.; Maksymowych, W.P. 2013: OP0171A data driven approach to the definition of a positive MRI of the sacroiliac joints in spondyloarthritis:. Annals of the Rheumatic Diseases 71(Suppl 3): 112.2-113

Haj Hensvold, A.; Magnusson, P. K.; Israelsson, L.; Hansson, M.; Holmdahl, R.; Jakobsson, P.-J.; Askling, J.; Malmström, V.; Klareskog, L.; Catrina, A. I. 2013: OP0171Screening for Anti-CCP in a Large Population Based Cohort and its Association with Prevalent Rheumatoid Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A110.3-A111

Baraliakos, X.; Heldmann, F.; Callhoff, J.; Listing, J.; Appelboom, T.; Brandt, J.; van den Bosch, F.; Breban, M.; Burmester, G.; Dougados, M.; Emery, P.; Pappas, D.; Gaston, H.; Sieper, J.; de Vlam, K.; Braun, J. 2013: OP0172Inflammation and fatty degeneration are of similar importance for new bone formation in patients with ankylosing spondylitis treated with infliximab or other anti-TNF agents over 5 years. Annals of the Rheumatic Diseases 71(Suppl 3): 113.1-113

Bertoli, A. M.; Audisio, M. J.; Py, G. E.; Strusberg, I. 2013: OP0172The Presence and Intensity of Power Doppler Signal are not Modified by Time of Assessment: Data form Patients with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A111.1-A111

Krabben, A.; Stomp, W.; Huizinga, T. W. J.; van der Heijde, D. M. F. M.; Bloem, H. L.; Reijnierse, M.; van der Helm-van Mil, A. H. M. 2013: OP0173Concordance Between Joint Swelling or Tenderness at Physical Examination and Inflammation on MRI in Early Arthritis Patients. Annals of the Rheumatic Diseases 72(Suppl 3): A111.2-A111

Berntson, L.; Aalto, K.; Fasth, A.; Herlin, T.; Nielsen, S.; Nordal, E.; Peltoniemi, S.; Zak, M.; Rygg, M. 2013: OP0173HLA-B27 and classification of enthesitis-related arthritis in an eight year follow up study of nordic patients with juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 113.2-113

Aksentijevich, I.; Zhou, Q.; Lee, G.-S.; Katan, M.; Datta, S.; Milner, J.; Khan, J.; Kastner, D.L. 2013: OP0174Exome sequencing identifies a hypermorphic missense mutation in the PLCG2 gene as the cause of a dominantly inherited autoinflammatory disease with immunodeficiency. Annals of the Rheumatic Diseases 71(Suppl 3): 113.3-114

Gandjbakhch, F.; Foltz, V.; Renoux, J.; Costedoat, N.; SENE, D.; Mercy, G.; Amoura, Z.; Piette, J. C.; Morel, N.; Cozic, N.; Bourgeois, P.; Fautrel, B. 2013: OP0175Systemic Lupus Erythematosous and Primary Sjogrens Syndrome May Display Joint Erosions on MRI as Well as Healthy Control, but Cannot be Considered as Erosive Disease Such as Rheumatoid Arthritis: An MRI Observational Study of 90 Subjects. Annals of the Rheumatic Diseases 72(Suppl 3): A112.1-A112

Naselli, A.; Frenkel, J.; Ozen, S.; Konè-Paut, I.; Lachmann, H.; Woo, P.; De Benedetti, F.; Hofer, M.; Neven, B.; Dolezalova, P.; Kümmerle-Deschner, J.; Hentgen, V.; Touitou, I.; Simon, A.; Wouters, C.; Toplak, N.; Anton, J.; Stojanov, S.; Girschick, H.; Vesely, R.; Arostegui, J.I.; Rose, C.; Ozdogan, H.; Ruperto, N.; Martini, A.; Gattorno, M. 2013: OP0175The eurofever registry for autoinflammatory disease: Update on enrollment after 2 years. Annals of the Rheumatic Diseases 71(Suppl 3): 114.1-114

Rantapää Dahlqvist, S.; Ärlestig, L.; Brink, M.; Rönnelid, J.; Klareskog, L. 2013: OP0176Clusters of Single Nucleotide Polymorphisms Within the HLA-DRB1 Gene in Relation to Antibodies Against Citrullinated Peptides in Individuals Prior to the Development of Rheumatoid Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A112.2-A113

Raab, A.; Sengler, C.; Niewerth, M.; Klotsche, J.; Horneff, G.; Zink, A.; Girschick, H.; Minden, K. 2013: OP0176Comorbidity profiles among adult patients with JIA who were treated with etanercept results of the biologic register jumbo. Annals of the Rheumatic Diseases 71(Suppl 3): 114.2-114

De Jong, P. H. P.; Hazes, J. M.; Luime, J. J.; Weel, A. E. 2013: OP0177 Randomized Comparison of Triple Dmard Therapy with Methotrexate Mono-Therapy. Annals of the Rheumatic Diseases 72(Suppl 3): A113-A113

Tzaribachev, N.; Voellm, R.; Horneff, G. 2013: OP0177Efficacy and safety of high vs. low dose etanercept in children with JIA. Annals of the Rheumatic Diseases 71(Suppl 3): 114.3-115

Gremese, E.; Fedele, A. L.; Gigante, M. R.; Tolusso, B.; Carbonella, A.; Bosello, S. L.; Ferraccioli, G. 2013: OP0178The Body Mass Index: A Determinant of Remission in Early Rheumatoid Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A113.2-A113

Miyamae, T.; Nozawa, T.; Kikuchi, M.; Kizawa, T.; Imagawa, T.; Yokota, S. 2013: OP0178Tocilizumab-effects on growth impairment in systemic juvenile idiopathic arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 115.1-115

Molloy, D.; McCormick, J.; Connolly, M.; Haroon, M.; Veale, D.J.; Fearon, U.; Molloy, E. 2013: OP0179Angiogenesis and blood vessel stability in giant cell arteritis. Annals of the Rheumatic Diseases 71(Suppl 3): 115.2-115

De Rooy, D.; Van Nies, J.; Andersson, M.; Forslind, K.; van der Heijde, D.; Huizinga, T.; Gregersen, P.; Svensson, B.; van der Helm-van Mil, A. 2013: OP0179Smoking as a Risk Factor for the Severity of Rheumatoid Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A113.3-A113

Rakieh, C.; Nam, J. L.; Hunt, L.; Villeneuve, E.; Bissell, L.-A.; Das, S.; Conaghan, P. G.; McGonagle, D.; Wakefield, R. J.; Emery, P. 2013: OP0180Risk of Developing Clinical Synovitis in ACPA Positive Patients with Non-Specific Musculoskeletal Symptoms. Annals of the Rheumatic Diseases 72(Suppl 3): A114.1-A114

Atzeni, F.; Boiardi, L.; Vaglio, A.; Nicoli, D.; Farnetti, E.; Palmisano, A.; Pipitone, N.; Casali, B.; Martorana, D.; Moroni, G.; Gallelli, B.; Buzio, C.; Salvarani, C. 2013: OP0180TLR4 and VEGF polymorphisms in chronic periaortitis. Annals of the Rheumatic Diseases 71(Suppl 3): 115.3-116

De Winter, L.; Hansen, W.; Geusens, P.; Vanhoof, J.; Lenaerts, J.; Langenaken, C.; Stinissen, P.; Somers, V. 2013: OP0181New Autoantibodies as Biomarkers for Early and Seronegative Rheumatoid Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A114.2-A114

Maurer, B.; Akhmetshina, A.; Gay, R.E.; Schett, G.; Michel, B.A.; Gay, S.; Distler, J.H.; Distler, O. 2013: OP0181Vegf induces vasculopathy and fibrosis in vivo closely resembling human systemic sclerosis. Annals of the Rheumatic Diseases 71(Suppl 3): 116.1-116

Avouac, J.; Meune, C.; Kahan, A.; Chiocchia, G.; Allanore, Y. 2013: OP0182Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis. Annals of the Rheumatic Diseases 71(Suppl 3): 116.2-116

Wevers-De Boer, K. V. C.; Heimans, L.; Visser, K.; Schouffoer, A.; van Oosterhout, M.; van Groenendaal, H.; Speyer, I.; Huizinga, T.; Allaart, C. 2013: OP0182Drug Free Remission After One Year of Treatment in Patients with Early Rheumatoid Arthritis: Also Possible for ACPA Positive Patients?. Annals of the Rheumatic Diseases 72(Suppl 3): A114.3-A114

Van Nies, J. A. B.; Burgers, L. E.; Ho, L. Y.; de Rooy, D. P. C.; Huizinga, T. W. J.; van der Helm-van Mil, A. H. M. 2013: OP0183Long-Term Outcome of Rheumatoid Arthritis Defined According to the 2010-Classification Criteria. Annals of the Rheumatic Diseases 72(Suppl 3): A114.4-A115

Abou-Raya, A.; Abou-Raya, S.; Sallam, N. 2013: OP0183Rebamipide: A potential useful therapeutic addition in the treatment of recurrent oral ulcers in behets disease. Annals of the Rheumatic Diseases 71(Suppl 3): 116.3-117

de Garavilla, L.; Acton, P.; Lubomirski, M.; Malaviya, R.; Shen, F.; Shah, N.; Vasquez, S.; Yoder, V.; Small, D.; Weinstein, D.; Kilgore, K. 2013: OP0184 High Resolution Micro-Computerized Tomography Imaging as a Translational Tool to Quantitatively Assess Bone Damage in a Mouse Model of Collagen-Induced Arthritis in Mice: Disease Severity and Time-Course of Bone Changes. Annals of the Rheumatic Diseases 72(Suppl 3): A115-A115

Holle, J.; Voigt, C.; Nölle, B.; Both, M.; Holl-Ulrich, K.; Laudien, M.; Gross, W. 2013: OP0184Retrospective monocentric cohort of orbital masses in granulomatosis with polyangiitis (GPA, wegeners): rare disease manifestation with a refractory disease course. Annals of the Rheumatic Diseases 71(Suppl 3): 117.1-117

Kötter, I.; Nast-Kolb, B.; Riewerts, F.; Xenitidis, T.; Deuter, C.; Henes, J. 2013: OP0185Behcets disease in germany: Differences and similarities in patients of german and turkish origin a single center experience. Annals of the Rheumatic Diseases 71(Suppl 3): 117.2-117

Tengvall, S.; Eneljung, T.; Martensson, I.-L.; Gustafsson, K.; Stern, A.; Jirholt, P.; Gjertsson, I. 2013: OP0185Endogenous B Cell-Targeted Antigen Expression Induces Tolerance to Collagen Type II Arthritis in Mice. Annals of the Rheumatic Diseases 72(Suppl 3): A115.2-A115

Koffeman, A.; 't Jong, G.; Valkhoff, V.; Warlé-van Herwaarden, M.; Luijsterburg, P.; Sturkenboom, M.; Bierma-Zeinstra, S.; Bindels, P. 2013: OP0187-PCPotentially harmful prescription of NSAIDS in a primary care population with musculoskeletal complaints. Annals of the Rheumatic Diseases 71(Suppl 3): 118.1-118

Verkleij, S.P.; Luijsterburg, P.A.; Wesseling, J.; Bastick, A.N.; Koes, B.W.; Bierma-Zeinstra, S.M. 2013: OP0188-PCPain trajectories in hip osteoarthritis: Results of the dutch cohort hip and cohort knee (CHECK). Annals of the Rheumatic Diseases 71(Suppl 3): 118.2-118

Scherer, H. U.; Rombouts, Y.; Ewing, E.; van de Stadt, L. A.; Selman, M. H.; Deelder, A. M.; Huizinga, T. W.; Wuhrer, M.; van Schaardenburg, D.; Toes, R. E. 2013: OP0189 Anti-Citrullinated Protein Antibody Specific FC Glycosylation Patterns in Patients with Arthralgia. Annals of the Rheumatic Diseases 72(Suppl 3): A116-A117

Kristensen, L.; Englund, M.; Geborek, P.; Neovius, M.; Askling, J.; Jacobsson, L.T.; Petersson, I. 2013: OP0189Long term work disability in anti-TNF therapy treated patients with psoriatic arthritis: A population-based cohort study. Annals of the Rheumatic Diseases 71(Suppl 3): 118.3-119

Cavagna, L.; Trifirò, G.; Caporali, R.; Morabito, P.; Ferrajolo, C.; Pecchioli, S.; Simonetti, M.; Medea, G.; Cricelli, C.; Caputi, A.; Mazzaglia, G.; Montecucco, C. 2013: OP0190-PCPrevalence and incidence of gout in italy. Analysis of a primary care database. Annals of the Rheumatic Diseases 71(Suppl 3): 119.1-119

Muhammad, A.; van Wesemael, T.; Kochi, Y.; Mjaavatten, M.; Wevers-de Boer, K.; Allaart, C.; Trouw, L.; Suzuki, A.; Yamamoto, K.; Huizinga, T.; Toes, R.; van der Woude, D. 2013: OP0190Smoking is Not Primarily Associated with ACPA, but with the Presence of Multiple Autoantibodies in RA. Annals of the Rheumatic Diseases 72(Suppl 3): A117.1-A117

Maeda, Y.; Matsushita, M.; Yura, A.; Teshigawara, S.; Katayama, M.; Yoshimura, M.; Watanabe, A.; Tanaka, E.; Tsuji, S.; Kitatobe, A.; Harada, Y.; Ohshima, S.; Katada, Y.; Hashimoto, J.; Ogata, K.; Takahashi, T.; Tsuji, H.; Nomoto, K.; Kumanogoh, A.; Takeda, K.; Saeki, Y. 2013: OP0191 The Fecal Microbiota of Rheumatoid Arthritis Patients Differs from that of Healthy Volunteers and is Considerably Altered by Treatment with Biologics. Annals of the Rheumatic Diseases 72(Suppl 3): A117-A117

Murphy, D.J.; Kyle, S.; Manhas, R.; Mascarenhas, R.F.; Mackay, K.R. 2013: OP0191-PCPrevalence of inflammatory back pain in a UK primary care population:. Annals of the Rheumatic Diseases 71(Suppl 3): 119.2-119

Häuser, W.; Nüesch, E.; Jüni, P. 2013: OP0192Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia. Annals of the Rheumatic Diseases 71(Suppl 3): 119.3-120

Mansour, S.; Tocheva, A.; Edwards, M.; Goulston, L.; Platten, H.; Parsons, C.; Edwards, C.; Cooper, C.; Gadola, S. D. 2013: OP0192Early Treatment-Naive Rheumatoid Arthritis (RA) is Characterised by Qualitative Changes of the INKT Regulatory Cell Repertoire. Annals of the Rheumatic Diseases 72(Suppl 3): A117.3-A118

van Nies, J.A.B.; Brouwer, E.; Posthumus, M.D.; Huizinga, T.W.J.; van der Helm-van Mil, A.H.M. 2013: OP0193Motivations for seeking medical advice in arthralgia and early arthritis patients. Annals of the Rheumatic Diseases 71(Suppl 3): 120.1-120

Spengler, J.; Lugonja, B.; Creese, A.; Nicholas, A.; Milward, M.; Pearson, M.; Buckley, C.; Filer, A.; Raza, K.; Cooper, P. R.; Chapple, I. L.; Scheel-Toellner, D. 2013: OP0193Synovial Fluid Neutrophils Undergoing Netosis Contribute to Joint Inflammation by Producing Citrullinated Autoantigens. Annals of the Rheumatic Diseases 72(Suppl 3): A118.1-A118

Ndosi, M.; Lewis, M.; Hale, C.; Bird, H.; Ryan, S.; Quinn, H.; McIvor, L.; Taylor, J.; Burbage, G.; Bond, D.; White, J.; Chagadama, D.; Green, S.; Kay, L.; Pace, A.V.; Bejarano, V.; Emery, P.; Hill, J. 2013: OP0194-HPRClinical outcomes of nurse-led care for people with RA: A multicentre RCT:. Annals of the Rheumatic Diseases 71(Suppl 3): 120.2-120

Terrier, B.; Nagata, S.; Ise, T.; Rosenzwajg, M.; Klatzmann, D.; Saadoun, D.; Cacoub, P. 2013: OP0194CD21-/LO Marginal Zone-Like B Cells in HCV-Related Mixed Cryoglobulinemia Vasculitis Highly Express FCRL5 Protein and are Specifically Killed by Anti-FCRL5 Immunotoxins. Annals of the Rheumatic Diseases 72(Suppl 3): A118.2-A118

Larsson, I.; Arvidsson, B.; Fridlund, B.; Teleman, A.; Bergman, S. 2013: OP0195-HPRNurse-led rheumatology clinic versus rheumatologist clinic in monitoring of biological therapy a randomised controlled study:. Annals of the Rheumatic Diseases 71(Suppl 3): 121.1-121

Oravecz, T.; Chang, W. C.; Jhaver, K. G.; Al-Shami, A.; Jessop, T. C.; Hamman, B.; Bagdanoff, J. T.; Augeri, D. J.; Vogel, P.; Swaffield, J.; Wilson, A.; Carson, K. G.; Main, A.; Zambrowicz, B. P. 2013: OP0195Genetic and Pharmacologic Inhibition of MST1 Blocks Lymphocyte Function and Protects Against Inflammation and Autoimmunity. Annals of the Rheumatic Diseases 72(Suppl 3): A118.3-A118

Petersen, R.; Jessen, E.H.; Primdahl, J. 2013: OP0196-HPRMultidisciplinary education for people with rheumatoid arthritis a systematic literature review. Annals of the Rheumatic Diseases 71(Suppl 3): 121.2-121

Arroyo-Villa, I.; Bautista-Caro, M.-B.; Balsa, A.; Aguado, P.; Villalba, A.; Plasencia, C.; Martín-Mola, E.; Miranda-Carus, M.-E. 2013: OP0196An Alteration in Circulating CXCR5+CD4+ T Cell Subsets in RA Patients is Associated with Increased Circulating Plasmablasts. Annals of the Rheumatic Diseases 72(Suppl 3): A119.1-A119

Uhlig, T.; Austad, C.; Kvien, T.K. 2013: OP0197Many patients with rheumatoid arthritis remain physically inactive. Annals of the Rheumatic Diseases 71(Suppl 3): 121.3-121

Magnusson, K.; Østerås, N.; Mowinckel, P.; Bård, N.; Hagen, K.B. 2013: OP0198-HPRNo prospective association found between obesity and chronic, widespread musculoskeletal pain in a population based 20-year prospective follow-up study. Annals of the Rheumatic Diseases 71(Suppl 3): 122.1-122

Daridon, C.; Loddenkemper, C.; Spieckermann, S.; Kühl, A. A.; Salama, A.; Burmester, G. R.; Lipsky, P. E.; Thomas, D. 2013: OP0198Proliferative Lymphoid Nodules and not Germinal Centers are the Sites of Autoantigen Stimulation in Human Spleen. Annals of the Rheumatic Diseases 72(Suppl 3): A119.3-A119

Osborne, R.H.; Dodson, S.; Batterham, R.; Buchbinder, R.; McCabe, M.; Ginnifer, Y.; Cavill, S. 2013: OP0199-HPRChronic disease self-management (CDSM) for people with musculoskeletal and mental health problems: Steppingup - a new flexible web-based system to serve patients, clinicians and organisations. Annals of the Rheumatic Diseases 71(Suppl 3): 122.2-122

Wang, S.-P.; Iwata, S.; Yamaoka, K.; Niiro, H.; Nakayamada, S.; Tabrizi, S. J.; Kubo, S.; Kondo, M.; Akashi, K.; Tanaka, Y. 2013: OP0199Amplification of IL-21 Signaling Pathway Through Brutons Tyrosine Kinase (BTK) in Human B Cells. Annals of the Rheumatic Diseases 72(Suppl 3): A119.4-A120

Gilmore, A B; Tavakoly, B; Taylor, G; Reed, H 2013: OP01How a Detailed Understanding of Industry Activities can Inform Public Health Policy: The example of Cigarette Pricing in Britain. Journal of Epidemiology and Community Health 67(Suppl 1): A4.1-A4

Nagy, Lívia; Filotás, D; Pozsgai, G; Pintér, E; Nagy, G 2013: OP02 Amperometric microcell for subcutaneous detection of hydrogen sulfide in anesthetized experimental animals. Nitric Oxide 31: S19-S20

Barber, J.; Rumsby, E.; Parker, S.; Mohebati, L.; Venables, S.; Lawson, K.; Scanlon, T.; Memon, A. 2013: OP02 Women's Views on Smoking Cessation Services and National Tobacco Control Measures. Journal of Epidemiology and Community Health 67(Suppl 1): A4-A4

Monten, C.; Veldeman, L.; Vandecasteele, K.; Oltéanu, L.; De Gersem, W.; Vercauteren, T.; Mulliez, T.; Van Den Broecke, R.; Depypere, H.; De Neve, W.; Lievens, Y. 2018: External partial breast irradiation in prone position: how to improve accuracy?. Acta Oncologica 57(10): 1339-1345

Visentin, S.; Londero, A. P.; Grumolato, F.; Gobbo, F.; Pegoraro, B.; Cosmi, E. 2013: OP02.02: First trimester combined screening and second trimester aorta intima-media thickness: preliminary data. Ultrasound in Obstetrics and Gynecology 42(S1): 51-51

Hofstaetter, C. 2013: OP02.05: Dopplersonographic measurement of both umbilical arteries in pregnancies complicated by IUGR and/or PE. Ultrasound in Obstetrics and Gynecology 42(S1): 52-52

Araujo Junior, E.; Nardozza, L.; Moron, A. F.; Helfer, T. M.; Serni, P. O.; Barros, F. S.; Carvalho, N. S. 2013: OP02.09: Perinatal outcomes of fetuses with growth restriction: comparison between two groups with different estimated fetal weight. Ultrasound in Obstetrics and Gynecology 42(S1): 52-53

Bardien, N.; Whitehead, C.; Tong, S.; Walker, S. P. 2013: OP02.10: Slowing of fetal growth in late pregnancy is a feature of placental insufficiency among apparently well grown fetuses. Ultrasound in Obstetrics and Gynecology 42(S1): 53-53

Martin-Martin, L.; Magro-Checa, C.; Valenza, C.; Caracuel-Martinez, J.-C.; Castellote-Caballero, Y.; Fajardo-Rodriguez, M.; Valenza, G. 2013: OP0200-HPRHow many subjective measurement tools are needed in knee osteoarthritis assessment?:. Annals of the Rheumatic Diseases 71(Suppl 3): 122.3-123

Åsenlöf, P.; Demmelmaier, I.; Emilson, C.; Pettersson, S.; Bergman, S. 2013: OP0200-PCStep-Up: An Innovative Stepped-Care Protocol for Tailored Behavioral Medicine Treatment in the Management of Musculoskeletal Pain in Primary Care. Annals of the Rheumatic Diseases 72(Suppl 3): A120.1-A120

Smink, A.; Bierma Zeinstra, S.; Dekker, J.; Vliet-Vlieland, T.; Bijlsma, J.; Swierstra, B.; Kortland, J.; Voorn, T.; van den Ende, C.; Schers, H. 2013: OP0201-PCAgreement of General Practitioners with the Guideline-Based Stepped-Care Strategy for Patients with Osteoarthritis of the Hip or Knee: A Cross-Sectional Study. Annals of the Rheumatic Diseases 72(Suppl 3): A120.2-A120

Koffeman, A.; Valkhoff, V.; Çelik, S.; 't Jong, G.; Sturkenboom, M.; Bindels, P.; Van der Lei, J.; Luijsterburg, P.; Bierma-Zeinstra, S. 2013: OP0202-PCUse of Over-the-Counter Non-Steroidal Anti-Inflammatory Drugs in the General Population and in Patients with a High Risk of Adverse Drug Events. Annals of the Rheumatic Diseases 72(Suppl 3): A120.3-A121

Orr, C.; O'Connor, C.; Kavanagh, J. 2013: OP0203-PCNew Data, New Problem; Assessing the Prevalence of Nsaid Prescribing in Primary Care in Those with a Background of Ischaemic Heart Disease (IHD) or Risk Factors for IHD. Annals of the Rheumatic Diseases 72(Suppl 3): A121.1-A121

Tak, P.P.; Balanescu, A.; Tseluyko, V.; Bojin, S.; Drescher, E.; Dairaghi, D.; Miao, S.; Marchesin, V.; Jaen, J.; Schall, T.J.; Bekker, P. 2013: OP0203Orally-administered CCR1 antagonist CCX354-C in a phase 2 rheumatoid arthritis study:. Annals of the Rheumatic Diseases 71(Suppl 3): 123.3-124

Finney, A.; Healey, E. L.; Lewis, M.; Ryan, S.; Dziedzic, K. S. 2013: OP0204-PCMultisite Peripheral Joint Pain in the Community: Prevalence and Impact in the North West Midlands, United Kingdom (UK). Annals of the Rheumatic Diseases 72(Suppl 3): A121.2-A121

Powers, J.P.; Bekker, P.J.; Dairaghi, D.J.; Jennette, J.C.; Johnson, D.A.; Leleti, M.; Miao, S.; Seitz, L.C.; Wang, Y.; Xiao, H.; Schall, T.J.; Jaen, J.C. 2013: OP0204Characterization of the novel C5AR antagonist CCX168, a potential therapeutic for ANCA-vasculitis, rheumatoid arthritis, and other autoimmune disorders. Annals of the Rheumatic Diseases 71(Suppl 3): 124.1-124

Prieto-González, S.; Depetris, M.; García-Martínez, A.; Espígol-Frigolé, G.; Planas-Rigol, E.; Corbera-Bellalta, M.; Tavera-Bahillo, I.; Butjosa, M.; Alba, M. A.; Grau, J. M.; Hernández-Rodríguez, J.; Lomeña, F.; Cid, M. C. 2013: OP0206Diagnostic Performance of PET/CT in Patients with Newly Diagnosed, Biopsy-Proven, Giant-Cell Arteritis. a Prospective, Case-Control Study Using Roc Analysis at Different Vascular Territories. Annals of the Rheumatic Diseases 72(Suppl 3): A122.1-A122

Iaccarino, L.; Farina, I.; Sulli, A.; Bortoluzzi, A.; Marcassa, C.; Doria, A.; Govoni, M.; Cutolo, M. 2013: OP0206Efficacy of modified-release prednisone in patients with rheumatoid arthritis (RA) chronically treated with standard glucocorticoids: An italian multicenter survey:. Annals of the Rheumatic Diseases 71(Suppl 3): 125.1-125

Motomura, H.; Matsushita, I.; Seki, E.; Kimura, T. 2013: OP0207Inhibitory effect of tacrolimus on the progression of joint damage in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 125.2-125

Diamantopoulos, A. P.; Haugeberg, G.; Hetland, H.; Soldal, D. M.; Myklebust, G. 2013: OP0207The Fast Track Giant Cell Arteritis Outpatient Clinic: A Useful Tool to Reduce the Morbidity of Disease?. Annals of the Rheumatic Diseases 72(Suppl 3): A122.2-A122

Sifuentes Giraldo, W. A.; Boteanu, A. L.; Rodriguez Garcia, A. 2013: OP0208Diagnostic Value of the Number of Affected Branches of the Temporal Artery by Color Doppler Ultrasonography in Giant Cell Arteritis. Annals of the Rheumatic Diseases 72(Suppl 3): A122.3-A123

Eyre, S.; Bowes, J.; Diogo, D.; Raychaudhuri, S.; Stahl, E.; Zhernakova, A.; Padyukov, L.; Amos, C.; Plenge, R.; Klareskog, L.; Gregersen, P.; Worthington, J. 2013: OP0208High density fine mapping in rheumatoid arthritis indentifies 14 new loci:. Annals of the Rheumatic Diseases 71(Suppl 3): 126.1-126

Neumann, T.; Moosig, F.; Vaglio, A.; Zwerina, J.; Bremer, P.; Gioffredi, A.; Grosskreutz, J.; Kroegel, C.; Maritati, F.; Resche-Rigon, M.; Mahr, A. 2013: OP0209Cluster Analysis to Explore Subclassification of Eosinophilic Granulomatosis with Polyangiitis (Churg Strauss). Annals of the Rheumatic Diseases 72(Suppl 3): A123.1-A123

Yazici, Y.; Bata, Y.; Swearingen, C. J. 2013: OP0211A Preliminary Investigation of Treat-to-Target Criteria Using BSAS, RAPID3 and Physician Global in Behcets Syndrome. Annals of the Rheumatic Diseases 72(Suppl 3): A123.3-A124

Mæhlen, M.; Provan, S.A.; Semb, A.G.; Uhlig, T.; van der Heijde, D.; Olsen, I.C.; Kvien, T.K.; Lie, B.A. 2013: OP0211APOE genotypes are associated with reduced joint damage and increased lipid levels in patients with rheumatoid arthritis:. Annals of the Rheumatic Diseases 71(Suppl 3): 127.1-127

Roccatello, D.; Sciascia, S.; Baldovino, S.; Rossi, D. 2013: OP0212Very Long-Term Effects of the 4 Plus 2 Infusion Protocol of Rituximab Alone in Patients with HCV-Associated Mixed Cryoglobulinemia with Diffuse Membranoproliferative Glomerulonephritis, Severe Polyneuropathy and Necrotic Ulcers of Skin. Annals of the Rheumatic Diseases 72(Suppl 3): A124.1-A124

Terrier, B.; Pagnoux, C.; Karras, A.; Khouatra, C.; Aumaitre, O.; Cohen, P.; Maurier, F.; Decaux, O.; Demurs-Clavel, H.; Gobert, P.; Quemeneur, T.; Godmer, P.; Puechal, X.; Mouthon, L.; Guillevin, L. 2013: OP0213 Rituximab Versus Azathioprine for Maintenance in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis (MAINRITSAN): Follow Up at 34 Months. Annals of the Rheumatic Diseases 72(Suppl 3): A124-A124

Steel, K.J.A.; Hinks, A.; Barton, A.; Bowes, J.; Cobb, J.; Langefeld, C.; Prahalad, S.; Haas, P.; Thompson, S.D.; Thomson, W. 2013: OP0213Identification of common susceptibility loci for inflammatory arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 128.1-128

Kiltz, U.; van der Heijde, D.; Boonen, A.; Cieza, A.; Stucki, G.; Khan, M. A.; Maksymowych, W.; Marzo-Ortega, H.; Reveille, J.; Taylor, W.; Bostan, C.; Braun, J. 2013: OP0214Development of a Health Index in Patients with Ankylosing Spondylitis (ASAS HI) Final Result of a Global Initiative Based on the ICF Guided by ASAS. Annals of the Rheumatic Diseases 72(Suppl 3): A124.3-A125

Viatte, S.; Plant, D.; Lunt, M.; Fu, B.; Parker, B.; Galloway, J.; Solymossy, C.; Worthington, J.; Symmons, D.; Dixey, J.; Young, A.; Barton, A. 2013: OP0214Investigation of rheumatoid arthritis genetic susceptibility markers in the early rheumatoid arthritis study (ERAS) provides further replication of the TRAF1/C5 association with radiological damage. Annals of the Rheumatic Diseases 71(Suppl 3): 128.2-128

Berg, I. J.; Semb, A. G.; van der Heijde, D.; Dagfinrud, H.; Kvien, T. K.; Provan, S. A. 2013: OP0215Baseline ASDAS and CRP Predicts Future Cardiovascular Risk in Ankylosing Spondylitis: Results After 5-Year Follow-Up. Annals of the Rheumatic Diseases 72(Suppl 3): A125.1-A125

Alonso-Perez, E.; Gonzalez, A. 2013: OP0215Bias in effect size of systemic lupus erythematosus susceptibility loci across europe. Annals of the Rheumatic Diseases 71(Suppl 3): 128.3-128

Poddubnyy, D.; Conrad, K.; Syrbe, U.; Haibel, H.; Appel, H.; Rudwaleit, M.; Sieper, J. 2013: OP0216Elevated Serum Level of the Vascular Endothelial Growth Factor Predicts Radiographic Spinal Progression in Patients with Axial Spondyloarthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A125.2-A125

Weber, U.; Zhao, Z.; Zubler, V.; Chan, S. M.; Lambert, R. G.; Ostergaard, M.; Pedersen, S. J.; Maksymowych, W. P. 2013: OP0217Frequent Detection of Inflammation and Fat Infiltration Suggestive of Spondyloarthritis on MRI of the Entire Spine in Healthy Subjects and Patients with Mechanical Back Pain. Annals of the Rheumatic Diseases 72(Suppl 3): A125.3-A126

Yeremenko, N.; Cantaert, T.; Gofita, I.; van Tok, M.; Cañete, J.D.; Tak, P.P.; Spits, H.; Baeten, D. 2013: OP0217The role of BOB1 in rheumatoid arthritis: Potential implications for autoimmunity. Annals of the Rheumatic Diseases 71(Suppl 3): 129.2-129

Ramiro, S.; van Tubergen, A.; Stolwijk, C.; van der Heijde, D.; Dougados, M.; van den Bosch, F.; Landewé, R. 2013: OP0218Erosions and Sclerosis, but not Squaring Predict the Development of New Syndesmophytes: A 12-Year Longitudinal Analysis. Annals of the Rheumatic Diseases 72(Suppl 3): A126.1-A126

El Shikh, M.E.; Biggioggero, M.; El Sayed, R.; Kmieciak, M.; Manjili, M.; Szakal, A.; Meroni, P.L.; Pitzalis, C.; Tew, J. 2013: OP0218Regulation of auto-antibody production by auto-immune complexes on follicular dendritic cells. Annals of the Rheumatic Diseases 71(Suppl 3): 129.3-129

Rooney, P.; Gao, W.; McCormick, J.; Harty, L.; Veale, D.J.; Fearon, U.; Connolly, M. 2013: OP0219TLR2 differentially mediates A-SAA induced pro-inflammatory pathways in rheumatoid arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 130.1-130

Briot, K.; Paternotte, S.; Miceli-Richard, C.; Dougados, M.; Roux, C. 2013: OP0219Use of Non Steroidal Anti-Inflammatory Drugs and High Body Mass Index Prevent Bone Loss in Patients with Early Inflammatory Back Pain: Results from the Desir Cohort. Annals of the Rheumatic Diseases 72(Suppl 3): A126.2-A126

Presumey, J.; Courties, G.; Charbonnier, L.-M.; Escriou, V.; Scherman, D.; Pers, Y.-M.; Louis-Plence, P.; Yssel, H.; Pène, J.; Kyburz, D.; Gay, S.; Jorgensen, C.; Apparailly, F. 2013: OP0220Innovative anti-inflammatory strategy in arthritis using PBEF sirna-mediated silencing in LY-6CHIGH monocytes. Annals of the Rheumatic Diseases 71(Suppl 3): 130.2-130

De Hooge, M.; Van Den Berg, R.; van Gaalen, F.; Navarro Compán, M. V.; Reijnierse, M.; Fagerli, K. M.; Turina, M.; van Oosterhout, M.; Lorenzin, M.; Huizinga, T.; Van Der Heijde, D. 2013: OP0221Is Site of Back Pain Related to Location of Inflammatory Lesions on MRI in Patients with Chronic Back Pain?. Annals of the Rheumatic Diseases 72(Suppl 3): A127.2-A127

Manetti, M.; Rosa, I.; Milia, A. F.; Ruffo, M.; Guiducci, S.; Ibba-Manneschi, L.; Matucci-Cerinic, M. 2013: OP0222Inactivation of Urokinase-Type Plasminogen Activator Receptor Induces Dermal and Pulmonary Fibrosis and Peripheral Microvasculopathy in Mice Closely Resembling Human Systemic Sclerosis. Annals of the Rheumatic Diseases 72(Suppl 3): A127.3-A127

Moret, F.M.; van der Wurff-Jacobs, K.M.; Hack, C.E.; Lafeber, F.P.; van Roon, J.A. 2013: OP0222TSLP expression is increased in RA joints and causes increased activation of intra-articular myeloid dendritic cells with enhanced stimulation of TH1 and TH17 activity. Annals of the Rheumatic Diseases 71(Suppl 3): 130.4-131

Zhang, Y.; Dees, C.; Beyer, C.; Lin, N.-Y.; Distler, O.; Schett, G.; Distler, J. 2013: OP0223Inhibition of Casein Kinase-2 Alleviates the Profibrotic Effects of Transforming Growth Factor in Systemic Sclerosis. Annals of the Rheumatic Diseases 72(Suppl 3): A128.1-A128

Ammitzbøll, C.G.; Jensenius, J.C.; Ellingsen, T.; Thiel, S.; Hørslev-Petersen, K.; Hetland, M.; Junker, P.; Johansen, J.; Østergaard, M.; Pødenphant, J.; Stengaard-Pedersen, K. 2013: OP0223M-ficolin, an activator of the complement system, predicts DAS28 remission in early DMARD nave rheumatoid arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 131.1-131

Kill, A.; Günther, J.; Becker, M. O.; Dragun, D.; Burmester, G.-R.; Riemekasten, G. 2013: OP0224Anti-AT1R and Anti-ETAR Autoantibodies from Patients with SSC and their Agonistic Effects. Annals of the Rheumatic Diseases 72(Suppl 3): A128.2-A128

Smith, V.; Decuman, S.; Sulli, A.; Riccieri, V.; Bonroy, C.; Piette, Y.; Deschepper, E.; De Keyser, F.; Cutolo, M. 2013: OP0225Do worsening scleroderma capillaroscopic patterns predict novel future severe organ involvement in systemic sclerosis? A pilot study. Annals of the Rheumatic Diseases 71(Suppl 3): 131.3-132

Rossato, M.; Broen, J. C.; Rossen, N. P.; van Bon, L.; Radstake, T. R. 2013: OP0225Micrornas Underlie Plasmacytoid Dentritic Cell Dysfunction in Systemic Sclerosis. Annals of the Rheumatic Diseases 72(Suppl 3): A128.3-A128

Spadoni, T.; svegliati, S.; pezone, A.; marrone, G.; grieco, A.; moroncini, G.; Jüngel, A.; distler, O.; avvedimento, E.; gabrielli, A. 2013: OP0226WIF1, a WNT Pathway Inhibitor, is Silenced in Systemic Sclerosis by DNA Damage: A Mechanism Linking DNA Damage to WNT and Fibrosis. Annals of the Rheumatic Diseases 72(Suppl 3): A128.4-A129

Avouac, J.; Elhai, M.; Tomcik, M.; Friese, M.; Colonna, M.; Bernhardt, G.; Kahan, A.; Chiocchia, G.; Distler, J.; Allanore, Y. 2013: OP0227Critical Role of the Adhesion Receptor DNAX Accessory Molecule-1 (DNAM-1) in the Development of Inflammation-Driven Dermal Fibrosis in Mouse Model of Systemic Sclerosis. Annals of the Rheumatic Diseases 72(Suppl 3): A129.1-A129

Codullo, V.; Caporali, R.; Cuomo, G.; D'Alto, M.; Pazzano, A.S.; Camporotondo, R.; Fusetti, C.; Borgogno, E.; Montecucco, C.; Valentini, G. 2013: OP0227Features and longitudinal analysis of systemic sclerosis patients with inappropriate exercise-induced increase in pulmonary artery pressure estimated by echocardiography. Annals of the Rheumatic Diseases 71(Suppl 3): 132.2-133

Abignano, G.; Aydin, S.; Castillo-Gallego, C.; Woods, D.; Meekings, A.; McGonagle, D.; Emery, P.; Del Galdo, F. 2013: OP0228Optical coherence tomography validation: A new quantitative imaging biomarker for affected skin in scleroderma. Annals of the Rheumatic Diseases 71(Suppl 3): 133.1-133

Illiano, S.; Ledein, L.; Bidouard, J.-P.; Schaefer, M.; Ruetten, H.; Janiak, P.; Beyer, C.; Distler, A.; Dees, C.; Distler, J. H.; Distler, O. 2013: OP0228Protective Effect of LPA1 and 3 Receptor Antagonism in Experimental Skin Fibrosis is Linked to LPA Activity in Dermal Fibroblasts of SSC Patients. Annals of the Rheumatic Diseases 72(Suppl 3): A129.2-A129

Jordan, S.; Distler, J.; Maurer, B.; Walker, U.; Huscher, D.; Riemenkasten, G.; Distler, O. 2013: OP0229Effect of endothelin-1 receptor antagonists on skin fibrosis in scleroderma patients a EUSTAR analysis. Annals of the Rheumatic Diseases 71(Suppl 3): 133.2-133

Iwamoto, N.; Vettori, S.; Maurer, B.; Brock, M.; Jüngel, A.; Calcagni, M.; Gay, R. E.; Distler, J. H.; Gay, S.; Kawakami, A.; Distler, O. 2013: OP0229MIR-193B Induces uPA in SSC and Contributes to the Proliferative Vasculopathy Via uPAR Independent Pathways. Annals of the Rheumatic Diseases 72(Suppl 3): A130.1-A130

Stanmore, E. K.; Oldham, J.; Skelton, D. A.; O'Neill, T.; Todd, C. 2013: OP0230-HPRFalls, Fear of Falling and Risk Factors in Adults with Rheumatoid Arthritis: A Prospective Study. Annals of the Rheumatic Diseases 72(Suppl 3): A130.2-A130

Yang, L.; Serada, S.; Fujimoto, M.; Murota, H.; Kotobuki, Y.; Kitaba, S.; Naka, T.; Katayama, I. 2013: OP0230Periostin, a novel matricellular protein, is required for cutaneous sclerosis in a mouse model of scleroderma. Annals of the Rheumatic Diseases 71(Suppl 3): 133.3-134

Venalis, P.; Kumánovics, G.; Schulze-Koops, H.; Akhmetshina, A.; Dees, C.; Zerr, P.; Cziriak, L.; Mackevic, Z.; Lundberg, I.E.; Distler, O.; Schett, G.; Distler, J.H. 2013: OP0231Heart involvement in scleroderma patients and mice models. Annals of the Rheumatic Diseases 71(Suppl 3): 134.1-134

Beasley, M.; Prescott, G.; McBeth, J.; Scotland, G.; Lovell, K.; Keeley, P.; Hannaford, P.; McNamee, P.; Symmons, D. P. M.; Woby, S.; Gkazinou, C.; Macfarlane, G. J. 2013: OP0232Long-Term Effects of Cognitive Behaviour Therapy and Exercise for Chronic Widespread Pain. Annals of the Rheumatic Diseases 72(Suppl 3): A131.1-A131

Volkov, A.; Osipyants, R.; Panasyuk, E.; Smirnov, A.; Lukina, G.; Gluchova, S.; Aleksandrova, E.; Karateev, D.; Nasonov, E. 2013: OP0232Monitoring anti-interleukin 6 receptor antibody treatment in rheumatoid arthritis and prediction progressive structural damage of the wrist joints by ultrasonography:. Annals of the Rheumatic Diseases 71(Suppl 3): 134.2-134

Lowitz, T.; Museyko, O.; Laouisset, L.; Laredo, J.-D.; Bousson, V.D.; Kalender, W.A.; Engelke, K. 2013: OP0233QCT indicates locally increased bone mineral density (BMD) in regions of bone marrow lesions (BML) segmented on MR images. Annals of the Rheumatic Diseases 71(Suppl 3): 134.3-135

Andersen, M.; Ellegaard, K.; Hebsgaard, J.; Christensen, R.; Kvist, P.H.; Vendel, N.; Rømer, J.; Søe, N.; Bliddal, H. 2013: OP0234Association between ultrasound colour doppler activity and synovial pathology in biopsies from small hand joints in patients with rheumatoid arthritis: A cross sectional study. Annals of the Rheumatic Diseases 71(Suppl 3): 135.1-135

Soubrier, M.; Perrodeau, E.; Gaudin, P.; Cantagrel, A.; Le Loët, X.; Flipo, R.; Guis, S.; Combe, B.; Euller-Ziegler, L.; Schaeverbeke, T.; Fautrel, B.; Saraux, A.; Chary-Valckenaere, I.; Chales, G.; Dernis, E.; Richette, P.; Mariette, X.; Berenbaum, F.; Sibilia, J.; Ravaud, P.; Dougados, M. 2013: OP0234Impact of a Nurse Led Program on the Management of Comorbidities in Rheumatoid Arthritis (RA). Results of a Prospective, Multicentre, Randomized, Controlled Trial (Comedra). Annals of the Rheumatic Diseases 72(Suppl 3): A131.3-A131

Larsen, J. L.; Nordin, H. 2013: OP0235-HPRTargeted Information on Methotrexate and Lifting Alcohol Restrictions in Patients with RA and PSA is Safe and Reduces Patients Negative Beliefs. Annals of the Rheumatic Diseases 72(Suppl 3): A132.1-A132

Gent, Y.; Weijers, K.; Molthoff, C.; Windhorst, A.; de Greeuw, I.; Al, M.; Bergstra, R.; Verlaan, M.; Kassiou, M.; Lammertsma, A.; Jansen, G.; van der Laken, C. 2013: OP0235Pet high affinity translocator protein ligands as a novel modality for macrophage targeting in arthritis. Annals of the Rheumatic Diseases 71(Suppl 3): 135.2-135

Keenan, A.-M.; White, J.; Pearson, D.; McSorely, P.; Andrews, J.; Taylor, Y.; Emery, P. 2013: OP0236-HPRThe Implementation of a Novel Software Application (Midatabank) to Record, Triage and Manage Telephone Calls to the Leeds Rheumatology Outpatients Department. Annals of the Rheumatic Diseases 72(Suppl 3): A132.2-A132

Manning, V.; Hurley, M.; Scott, D. L.; Choy, E.; Bearne, L. 2013: OP0237-HPRUpper Limb Exercise, Education and Self Management in Early Rheumatoid Arthritis (The Extra Programme)- Results from a Randomised Controlled Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A132.3-A133

Gargani, L.; Barskova, T.; Conforti, M.L.; Guiducci, S.; Bruni, C.; Moggi Pignone, A.; Picano, E.; Matucci Cerinic, M. 2013: OP0237Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. Annals of the Rheumatic Diseases 71(Suppl 3): 136.1-136

Hamdi, W.; Ghannouchi, M.M.; Bouaziz, M.; Ladeb, F.M.; Kchir, M.M. 2013: OP0238Hand joint ultrasound assessment shows more erosion in elderly onset recent rheumatoid arthritis (RA) patients compared to young onset recent RA:. Annals of the Rheumatic Diseases 71(Suppl 3): 136.2-136

Wright, P. B.; Utriainen, L.; Firmin, D.; Aumeunier, A.; McEntegart, A.; McCarey, D.; McInnes, I. B.; Milling, S. 2013: OP0238Patients with Ankylosing Spondylitis Have an Increased Proportion of CD16+ Dendritic Cells, Able to Induce CCR6-Expression on CD4+ T Cells. Annals of the Rheumatic Diseases 72(Suppl 3): A133.1-A133

Hreggvidsdottir, H. S.; Mjosberg, J.; Bernink, J.; Baeten, D.; Spits, H. 2013: OP0239Phenotypic and Molecular Profile of Innate Lymphoid Cells in Chronic Synovial Inflammation. Annals of the Rheumatic Diseases 72(Suppl 3): A133.2-A133

Weber, U.; Pedersen, S.J.; Zubler, V.; Rufibach, K.; Chan, S.; Lambert, R.G.; Ostergaard, M.; Maksymowych, W.P. 2013: OP0239What constitutes the characteristic fat lesion on MRI of the sacroiliac joints in early spondyloarthritis?:. Annals of the Rheumatic Diseases 71(Suppl 3): 136.3-137

Cauli, A.; Dessole, G.; Porru, G.; Cassotta, A.; Piga, M.; Vacca, A.; Ibba, V.; Garau, P.; Fiorillo, M. T.; Sorrentino, R.; Mathieu, A. 2013: OP0240 Higher Expression of TNFR1 and IL-1R2 on Cell Surface of B*2705 Ankylosing Spondylitis Patients Vs B*2705 and B*2709 Healthy Subjects. Influence of Erap1 Polymorphism. Annals of the Rheumatic Diseases 72(Suppl 3): A133-A134

Dachicourt, J.-N.; Grange, L.; Gossec, L. 2013: OP0240-PAREAnnounce and explain ankylosing spondylitis, creation of a patient tool. Annals of the Rheumatic Diseases 71(Suppl 3): 137.1-137

Wallis, D.; Weisman, M.; Haroon, N.; Anton, A.; Mc Govern, D.; Targan, S.; Inman, R. 2013: OP0241 Anti-Flagellin Antibodies in Ankylosing Spondylitis (AS) Implicate Subclinical Bowel Inflammation and Differentiate as from Mechanical Back Pain Patients. Annals of the Rheumatic Diseases 72(Suppl 3): A134-A134

Filippopoulou, A.; Daoussis, D.; Liossis, S.-N.; Bouris, P.; Klavdianou, K.; Karamanos, N.; Andonopoulos, A. 2013: OP0242Serum Indian Hedgehog (IHH) Levels Are Increased in Patients with Ankylosing Spondylitis (AS). Anti-TNF a Treatment Decreases Serum IHH Levels in Patients with as and Affects the Expression of Functional Target Genes in a Cell Line Model. Annals of the Rheumatic Diseases 72(Suppl 3): A134.2-A134

Pitsillidou, I. 2013: OP0243-PAREThe significant benefits from creative activities for patients with rheumatic disease. Annals of the Rheumatic Diseases 71(Suppl 3): 138.1-138

Magrey, M. N.; Haqqi, T.; Haseeb, A. 2013: OP0243Microrna Expression Profile in Patients with Spondyloarthritis- a Pilot Study. Annals of the Rheumatic Diseases 72(Suppl 3): A134.3-A135

Mateus, E. 2013: OP0244-PAREImpatients: Discussing agency, empowerment and its impacts on rheumatic patients. Annals of the Rheumatic Diseases 71(Suppl 3): 138.2-138

Bleil, J.; Appel, H.; Maier, R.; Sieper, J.; Syrbe, U. 2013: OP0244High Expression of Prostaglandin E2 in Zygapophyseal Joints of Patients with Ankylosing Spondylitis and Osteoarthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A135.1-A135

Cumming, J.; Gilbert, K. 2013: OP0245-PAREThe emotional and information support needs of people living with polymyalgia rheumatica. Annals of the Rheumatic Diseases 71(Suppl 3): 138.3-138

Ochi, K.; Furuya, T.; Inoue, E.; Ishida, O.; Yano, K.; Sakuma, Y.; Yoshida, S.; Ikari, K.; Taniguchi, A.; Yamanaka, H.; Momohara, S. 2013: OP0245Sites, Frequencies, and Causes of Fractures in Patients with Rheumatoid Arthritis: A Large Prospective Observational Cohort Study in Japan. Annals of the Rheumatic Diseases 72(Suppl 3): A135.2-A135

Carlsson, A. 2013: OP0246-PAREFrom research to action! physical activity and exercise in rheumatic diseases. Annals of the Rheumatic Diseases 71(Suppl 3): 138.4-139

Bultink, I. E.; Harvey, N. C.; Lalmohamed, A.; Cooper, C.; Lems, W. F.; van Staa, T. P.; de Vries, F. 2013: OP0246Incidence of and Risk Factors for Clinical Fractures in Patients with Systemic Lupus Erythematosus and Matched Controls: A Population-Based Study in the United Kingdom. Annals of the Rheumatic Diseases 72(Suppl 3): A135.3-A136

Palacios, S.; Bonnick, S.; De Villiers, T.; Chapurlat, R.; Odio, A.; Scott, B.; Le Bailly De Tilleghem, C.; DaSilva, C.; Leung, A.; Gurner, D. 2013: OP0247Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate a Randomized Placebo-Controlled Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A136.1-A136

Poddubnyy, D.; Haibel, H.; Listing, J.; Märker-Hermann, E.; Zeidler, H.; Braun, J.; Rudwaleit, M.; Sieper, J. 2013: OP0247Reduction of radiographic spinal progression in patients with ankylosing spondylitis treated with non-steroidal anti-inflammatory drugs is most evident in the presence of syndesmophytes and active systemic inflammation. Annals of the Rheumatic Diseases 71(Suppl 3): 139.1-139

McClung, M. R.; Grauer, A.; Boonen, S.; Brown, J. P.; Diez-Perez, A.; Langdahl, B. L.; Reginster, J.-Y.; Zanchetta, J. R.; Katz, L.; Maddox, J.; Yang, Y.-C.; Libanati, C.; Bone, H. G. 2013: OP0248Inhibition of Sclerostin with Romosozumab in Postmenopausal Women with Low Bone Mineral Density: Phase 2 Trial Results. Annals of the Rheumatic Diseases 72(Suppl 3): A136.2-A137

Pavlov-Dolijanovic, S.R.; Damjanov, N.; Vujasinovic Stupar, N.; Babic, D. 2013: OP0248The prognostic value of scleroderma pattern capillary changes, aticentromere antibodies and anti-topo I antibodies for the development of very early systemic sclerosis - a follow-up study of 497 patients with raynauds phenomenon. Annals of the Rheumatic Diseases 71(Suppl 3): 139.2-140

Evstigneyeva, L.; Kozhemyakina, E.; Lesnyak, O.; Negodaeva, E.; Guselnikova, G.; Belkin, A.; Leskovetc, E. 2013: OP0249Effect of Exercise for Patient with Osteoporotic Vertebral Fractures. Annals of the Rheumatic Diseases 72(Suppl 3): A137.1-A137

Juszkiewicz, A.; Kisiel, B.; Kruszewski, R.; Bachta, A.; Kłos, K.; Saracyn, M.; Duda, K.; Staniszewska-Varga, J.; Bogusławska, R.; Młoźniak-Cieśla, A.; Grabowska-Jodkowska, A.; Olesińska, M.; Niemczyk, S.; Płoski, R.; Tłustochowicz, W. 2013: OP0249Ultrasound evaluation of carotid and femoral arteries in systemic lupus erythematosus: Is a combined carotid and femoral ultrasonography better than carotid ultrasonography in determining atherosclerotic burden?. Annals of the Rheumatic Diseases 71(Suppl 3): 140.1-140

Roux, C.; Lippuner, K.; Bone, H. G.; Zapalowski, C.; Minisola, S.; Franek, E.; Lakatos, P.; Kendler, D.; Lewiecki, E. M.; Mautalen, C.; Jensen, S.; Wang, A.; Daizadeh, N.; Wagman, R. B.; Boonen, S. 2013: OP0250Denosumab Treatment of Postmenopausal Women with Osteoporosis for 7 Years: Clinical Fracture Results from the First 4 Years of the Freedom Extension. Annals of the Rheumatic Diseases 72(Suppl 3): A137.2-A137

Lie, E.; Woodworth, T.G.; Christensen, R.; Bykerk, V.; Bingham, C.O.; Furst, D.E.; Choy, E.H. 2013: OP0250Exploration of omeract preliminary rheumatoid arthritis (RA) flare domains in a longitudinal observational study:. Annals of the Rheumatic Diseases 71(Suppl 3): 140.2-140

Brown, J. P.; Wagman, R. B.; Dempster, D. W.; Kendler, D.; Miller, P.; Bolognese, M.; Valter, I.; Beck Jensen, J.-E.; Zerbini, C.; Zanchetta, J. R.; Daizadeh, N.; Reid, I. 2013: OP0251Bone Histology and Histomorphometry: Effects of 5 Years of Denosumab in the Freedom Study Extension. Annals of the Rheumatic Diseases 72(Suppl 3): A137.3-A138

Tatem, A.; Kovac, J.R. 2017: External penile prosthesis as a novel approach to the treatment of erectile dysfunction. Translational Andrology and Urology 6(Suppl 5): S795-S796

Xu, T.; Zhang, X. 2013: OP0252Effect of Glucocorticoids and Bisphosphonates on PPAR-Gamma and Hedgehog Pathway in Glucocorticoid-Induced Osteoporosis. Annals of the Rheumatic Diseases 72(Suppl 3): A138.1-A138

Boyle, D. L.; Wei, N.; Singhal, A. K.; Rosengren, S.; Kaplan, I.; Soma, K.; Hodge, J.; Luo, Z.; Krishnaswami, S.; Gruben, D.; Zwillich, S. H.; Bradley, J.; Firestein, G. S. 2013: OP0253 The JAK Inhibitor Tofacitinib Suppresses Synovial JAK1-STAT1 Signalling in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A138-A139

El Miedany, Y.; El Gaafary, M.; Youssef, S.; Palmer, D. 2013: OP0253-PCTraining for general practitioners: Does an education program and a diagnostic algorithm improve referral reliability?. Annals of the Rheumatic Diseases 71(Suppl 3): 141.3-142

Grabiec, A. M.; Angiolilli, C.; Hartkamp, L. M.; van Baarsen, L. G.; Tak, P. P.; Baeten, D. L.; Reedquist, K. A. 2013: OP0254Cytokine-Induced JNK-Dependent Downregulation of the Forkhead Box O Transcription Factor Foxo1 Promotes Survival and Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A139.1-A139

García Manrique De Lara, M.; Gόmez Centeno, A.; Calvet Fontova, J.; Graell, E.; Galisteo, C.; Gratacos, J.; Larrosa, M. 2013: OP0254Who should control the classical cardiovascular risk factors in the rheumatoid arthritis? study on the consistency between primary care and rheumatology. Annals of the Rheumatic Diseases 71(Suppl 3): 142.1-142

Streicher, K.; Morehouse, C.; Groves, C.; Rajan, B.; Pilataxi, F.; Lehmann, K.; Brohawn, P. Z.; Higgs, B. W.; McKeever, K.; Richman, L.; Jallal, B.; Herbst, R.; Yao, Y.; Ranade, K. 2013: OP0255 Inhibition of the Plasma Cell Signature Correlates with Reduced Collagen Expression in Systemic Sclerosis. Annals of the Rheumatic Diseases 72(Suppl 3): A139-A139

Engler, A.; Gay, R. E.; Michel, B. A.; Gay, S.; Ospelt, C. 2013: OP0256SIRT1 Regulates Cigarette Smoke-Induced IL8 Expression and TNFA-Mediated Il6 Release in Rheumatoid Arthritis Synovial Fibroblasts. Annals of the Rheumatic Diseases 72(Suppl 3): A139.3-A140

Muangchant, C.; Pope, J. 2013: OP0257IL-6 in scleroderma; potential implications for targeted therapy: A systematic analysis. Annals of the Rheumatic Diseases 71(Suppl 3): 143.1-143

Balogh, E.; Biniecka, M.; Connolly, M.; McCormick, J.; Veale, D. J.; Fearon, U. 2013: OP0257Interleukin-34 Regulates Angiogenesis and Cell Proliferation in Inflammatory Arthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A140.1-A140

Sagen, J.S. 2013: OP0259-PAREMultilingual touch screen page on arthritis in children (DINFO). Annals of the Rheumatic Diseases 71(Suppl 3): 143.3-144

Austermann, J.; Fassl, S.; Holzinger, D.; Chae, J.J.; Tilmann, K.; Keitzer, R.; Roth, J.; Foell, D.; Wittkowski, H. 2013: OP0260The pathophysiology of S100A8/A9 in familial mediterranean fever (FMF). Annals of the Rheumatic Diseases 71(Suppl 3): 144.1-144

Bosworth, A.; Jacklin, C. 2013: OP0261-PAREWhat is Remission to you? Defining Remission from the Patients Perspective in Rheumatoid Arthrtis. Annals of the Rheumatic Diseases 72(Suppl 3): A141.2-A141

Carter, S.; Derese, I.; Braem, K.; Luyten, F.; Lories, R. 2013: OP0261Genetic and functional evidence for a role of the bone morphogenetic protein type 1B receptor in ankylosis in mice. Annals of the Rheumatic Diseases 71(Suppl 3): 144.2-144

Garrido-Castro, J. L.; Collantes-Estevez, E.; Gonzalez-Navas, C.; Carmona, L. 2013: OP0262-PAREWhat is the Knowledge Level that Ankylosing Spondylitis Patients Have About their Own Disease?. Annals of the Rheumatic Diseases 72(Suppl 3): A141.3-A141

van Duijn, H.; Ferwerda, M.; Tomas, M.; van Middendorp, H.; Ros, H.; Evers, A. 2013: OP0263-PAREPatient Involvement in E-Health Research and Intervention Development. Annals of the Rheumatic Diseases 72(Suppl 3): A142.1-A142

Vanhoutte, F.P.; Mazur, M.; Namour, F.; van der Aa, A.; Wigerinck, P.; van 't Klooster, G.A.E. 2013: OP0263Efficacy and safety of GLPG0634, a selective JAK1 inhibitor, after short-term treatment of rheumatoid arthritis; results of a phase IIA trial. Annals of the Rheumatic Diseases 71(Suppl 3): 145.1-145

Stancheva, L.; Bozhinova, S.; Boteva, B. 2013: OP0264-PAREWith Love and Smile - Charity Events for People with Rheumatic Diseases. Annals of the Rheumatic Diseases 72(Suppl 3): A142.2-A142

Abou-Raya, S.; Abou-Raya, A.; El Khadrawy, T.; Helmii, M. 2013: OP0264Effect of vitamin D supplementation and physical activity in preventing sarcopenia in older adults with osteoporosis: A randomized controlled trial. Annals of the Rheumatic Diseases 71(Suppl 3): 145.2-145

Carlsson, A. 2013: OP0265-PARENational Guidelines for Musculoskeletal Diseases in Sweden. Annals of the Rheumatic Diseases 72(Suppl 3): A142.3-A142

Diamantopoulos, A.P.; Hoff, M.; Hochberg, M.; Haugeberg, G. 2013: OP0265Mortality after fragility hip fracture in middle aged and elderly men and women in southern norway. Annals of the Rheumatic Diseases 71(Suppl 3): 146.1-146

Udras, E.; Karp, T. 2013: OP0266-PAREOsteoporosis Prevention Project in Estonia: Bone Density Measurements, Patient Counseling, Information Days, Lectures and Materials. Annals of the Rheumatic Diseases 72(Suppl 3): A143.1-A143

Sieper, J.; van der Heijde, D.; Elewaut, D.; Pangan, A.L.; Anderson, J. 2013: OP0266Disease burden is comparable in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: Implications for treatment:. Annals of the Rheumatic Diseases 71(Suppl 3): 146.2-146

Trippen, R.D.; Almanzar, G.; Sustal, K.; Höfner, K.; Prelog, M. 2013: OP0267The influence of latent cytomegalovirus (CMV) infection on T-cell-phenotype in children with juvenile idiopathic arthritis (JIA). Annals of the Rheumatic Diseases 71(Suppl 3): 146.3-147

Rudin, A.; Rabe, H.; Lundell, A.-C.; Adlerberth, I.; Wold, A.E. 2013: OP0268Echerichia coli expands the proportion of helios+ natural CD25+CD127low/neg regulatory T cells in newborn children. Annals of the Rheumatic Diseases 71(Suppl 3): 147.1-147

Collado, P.; Gamir, M. L.; Merino, R.; Modesto, C.; Monteagudo, I.; Lopez-Robledillo, J. C. 2013: OP0269Detection of Synovitis in Clinically Inactive Juvenile Idiopathic Arthritis Patients by Ultrasonography with Power Doppler. Annals of the Rheumatic Diseases 72(Suppl 3): A143.4-A144

Maksymowych, W.; Pedersen, S.; Østergaard, M.; Lambert, R. 2013: OP0269MRI of the spine for detection of new bone formation in ankylosing spondylitis: Does it offer any advantages over radiography?:. Annals of the Rheumatic Diseases 71(Suppl 3): 147.2-147

Sehgal, A.; Mithal, A.; Mannalithara, A.; Singh, G.; Triadafilopoulos, G. 2013: OP0270Osteoporotic Hip Fractures in Extreme Elderly Men: A Growing Problem. Annals of the Rheumatic Diseases 72(Suppl 3): A144.1-A144

Crema, M.D.; Hunter, D.J.; Burstein, D.; Li, L.; Krishna, N.; Roemer, F.W.; Eckstein, F.; Hellio le Graverand, M.-P.; Guermazi, A. 2013: OP0270The association of delayed gadolinium-enhanced MRI of cartilage (DGEMRIC) and cartilage morphometry in a sample of middle-aged women: A 2-year follow-up MRI study. Annals of the Rheumatic Diseases 71(Suppl 3): 147.3-148

Hahne, M.; Luetkecosmann, S.; Tran, C.L.; Strehl, C.; Fangradt, M.; Jakstadt, M.; Duda, G.; Hoff, P.; Gaber, T.; Burmester, G.-R.; Buttgereit, F. 2013: OP0271Differential regulatory functions of HIF-1a and HIF-2a during angiogenesis of human microvascular endothelial cells (HMECS). Annals of the Rheumatic Diseases 71(Suppl 3): 148.1-148

van den Berg, R.; de Hooge, M.; Navarro Compán, V.; Reijnierse, M.; van Gaalen, F.; Fagerli, K.; Turina, M.; van Oosterhout, M.; Punzi, L.; Huizinga, T.; van der Heijde, D. 2013: OP0271Prevalence of Structural Lesions on MRI of the Sacroiliac Joints in Patients with Early Axial Spondyloarthritis and Patients with Back Pain. Annals of the Rheumatic Diseases 72(Suppl 3): A144.2-A145

Patakas, A.; Nadler, S.G.; Brewer, J.M.; McInnes, I.B.; Garside, P. 2013: OP0272Abatacept is highly effective in inhibiting T cell priming but fails to induce T cell tolerance after primary antigen encounter. Annals of the Rheumatic Diseases 71(Suppl 3): 148.2-148

De Hooge, M.; Van Den Berg, R.; Navarro Compán, V.; Reijnierse, M.; van Gaalen, F.; Fagerli, K. M.; Turina, M.; van Oosterhout, M.; Lorenzin, M.; Huizinga, T.; Van Der Heijde, D. 2013: OP0272Prevalence of Structural Lesions MRI-Spine in Patients with (Possible) Axial Spondyloarthritis (AXSPA) Included in the Space-Cohort. Annals of the Rheumatic Diseases 72(Suppl 3): A145.1-A145

Weber, U.; Zubler, V.; Zhao, Z.; Lambert, R. G.; Chan, S. M.; Pedersen, S. J.; Ostergaard, M.; Maksymowych, W. P. 2013: OP0273Does Spinal MRI Add Incremental Diagnostic Value to MRI of the Sacroiliac Joints Alone in Non-Radiographic Axial Spondyloarthritis?. Annals of the Rheumatic Diseases 72(Suppl 3): A145.2-A146

Sieger, N.; Fleischer, S.; Mei, H.E.; Reiter, K.; Shock, A.; Burmester, G.R.; Daridon, C.; Dörner, T. 2013: OP0273Inhibition of B cell receptor signaling with epratuzumab and the effects of alpha-2,6-sialic acid removal. Annals of the Rheumatic Diseases 71(Suppl 3): 149.1-149

Khanna, D.; Gladue, H.; Fitzgerald, J.; Channick, R.; Chung, L.; Distler, O.; Furst, D.; Hachulla, E.; Humbert, M.; Langelben, D.; Mathai, S.; Saggar, R.; Visovatti, S.; McLaughlin, V. 2013: OP0274Recommendations for Screening and Detection of Connective-Tissue Disease Associated Pulmonary Arterial Hypertension. Annals of the Rheumatic Diseases 72(Suppl 3): A146.1-A146

Haavardsholm, E.A.; Gandjbakhch, F.; Conaghan, P.; Ejbjerg, B.J.; Foltz, V.; Brown, A.; Døhn, U.M.; Lassere, M.; Freeston, J.; Bøyesen, P.; Bird, P.; Fautrel, B.; Hetland, M.L.; Emery, P.; Bourgeois, P.; Hørslev-Petersen, K.; Olsen, I.C.; Østergaard, M. 2013: OP0274Towards imaging remission: Determining a MRI inflammatory activity acceptable state in rheumatoid arthritis:. Annals of the Rheumatic Diseases 71(Suppl 3): 149.2-149

Cutolo, M.; Herrick, A.; Distler, O.; Becker, M.; Beltran, E.; Carpentier, P.; Ferri, C.; Inanç, M.; Vlachoyiannopoulos, P.; Chadha-Boreham, H.; Cottreel, E.; Pfister, T.; Rosenberg, D.; Torres, J.; Smith, V. 2013: OP0275Nailfold Videocapillaroscopy and Other Predictive Factors Associated with New Digital Ulcers in Systemic Sclerosis: Data from the Cap Study. Annals of the Rheumatic Diseases 72(Suppl 3): A146.2-A147

Zufferey, P.; Möller, B.; Brulhart, L.; Tamborrini, G.; Scherer, A.; Ziswiler, H.R. 2013: OP0275Persistence of ultrasound synovitis in the patients fullfiling the DAS and/or the new ACR/EULAR RA remission definitions: Results of the sonar score applied to the patients of the SCQM cohort. Annals of the Rheumatic Diseases 71(Suppl 3): 149.3-150

Ursum, J.; Nielen, M.; Twisk, J.; Peters, M.; Schellevis, F.; Nurmohamed, M.; Korevaar, J. 2013: OP0276-PCHigh Risk for Anaemia, Osteoporosis and Copd After the Onset of Inflammatory Arthritis: Results from a Population-Based Study. Annals of the Rheumatic Diseases 72(Suppl 3): A147.1-A147

Falcini, F.; Masi, L.; Franceschelli, F.; Leoncini, G.; Ciuffi, S.; Rigante, D.; La Torre, F.; Matucci Cerinic, M.; Brandi, M.L. 2013: OP0276Fibroblast growth factor (FGF23) gene polymorphism in kawasaki disease: A risk of coronary damage. Annals of the Rheumatic Diseases 71(Suppl 3): 150.1-150

Iolascon, G.; Capaldo, A.; Orlando, V.; Menditto, E. 2013: OP0277-PCPersistence with Antiosteoporotic Drugs: A Retrospective Population-Based Cohort Study. Annals of the Rheumatic Diseases 72(Suppl 3): A147.2-A147

Cunin, P.; Kumar, R.; Chen, M.; Monach, P. A.; Nigrovic, P. A. 2013: OP0280Complex Basis for Divergent Arthritis Susceptibility in Mast Cell-Deficient Mice. Annals of the Rheumatic Diseases 72(Suppl 3): A148.3-A148

Mannion, M.; Xie, F.; Curtis, J. R.; Beukelman, T. 2013: OP0281Recent Trends in Medication Usage for the Treatment of Juvenile Idiopathic Arthritis in the United States and the Influence of Tnf Inhibitors. Annals of the Rheumatic Diseases 72(Suppl 3): A149.1-A149

Ndosi, M.; Bremander, A.; Hamnes, B.; Horton, M.; Kukkurainen, M. L.; Machado, P.; Marques, A.; Meesters, J.; Stamm, T.; Tennant, A.; Torre-Aboki, J. D. L.; Vliet Vlieland, T.; Zangi, H.; Hill, J. 2013: OP0283Validation of the Educational Needs Assessment Tool as a Generic Instrument for Rheumatic Diseases in 7 European Countries. Annals of the Rheumatic Diseases 72(Suppl 3): A149.3-A150

Dougados, M.; Perrodeau, E.; Fayet, F.; Gaudin, P.; Cerato, M.-H.; le Loet, X.; Flipo, R.-M.; Chabrefy, L.; Mouterde, G.; Euller-Ziegler, L.; Schaeverbeke, T.; Fautrel, B.; Saraux, A.; Valckaenaere, I.; Chales, G.; Dernis, E.; Richette, P.; Mariette, X.; Berenbaum, F.; Sibilia, J.; Ravaud, P. 2013: OP0284Impact of a Nurse Led Program of Patient Self-Assessment of Disease Activity on the Management of Rheumatoid Arthritis: Results of a Prospective, Multicentre, Randomized, Controlled Trial (Comedra). Annals of the Rheumatic Diseases 72(Suppl 3): A150.1-A150

Pfeffer, L.; Janoly-Dumenil, A.; Donjon, A.; Ouagne, V.; Tebib, J. G.; Piperno, M. 2013: OP0286Effects of an Educational Program on the Safety Knowledge and Skills of Patients with Rheumatoid Arthritis Treated by Biologics. Annals of the Rheumatic Diseases 72(Suppl 3): A150.3-A151

Ciechomska, A.; Dale, J.; McKay, N.; Turner, D.; Youssef, H. 2013: OP0288Lessons Learned from the Scottish Rheumatology Ultrasound Mentoring Network Project. Annals of the Rheumatic Diseases 72(Suppl 3): A151.2-A151

sunmboye, K. O.; moorthy, A. 2013: OP0289Comparative Knowledge and Perception of Two Chronic Diseases Rheumatoid Arthritis and Diabetes Mellitus in Primary Care: Testing Waters Locally. Annals of the Rheumatic Diseases 72(Suppl 3): A151.3-A152

Mateus, E. 2013: OP0290-PAREFamily Planning and JIA: Infertility and Parenthood. Annals of the Rheumatic Diseases 72(Suppl 3): A152.1-A152

Wesseling, J.; Bastick, A. N.; Bierma-Zeinstra, S. M.; Bijlsma, J. W. 2013: OP0292Different Pain Trajectories in Early Symptomatic Knee OA; 5 Year Follow-Up of Check (Cohort Hip & Cohort Knee) Study. Annals of the Rheumatic Diseases 72(Suppl 3): A152.3-A153

Stoppiello, L. A.; Mapp, P.; Hill, R.; Wilson, D.; Scammell, B.; Walsh, D. 2013: OP0293Increased Nerve Growth Factor in the Synovium of People with Painful Knee Osteoarthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A153.1-A153

Todorov, P. T.; Batalov, A.; Kanev, P.; Shejtanov, I. 2013: OP0294Ultrasonographic Study of Erector Spinae Caudal Enthesopathy - Could Nonspecific Low Back Pain Become More Specific. Annals of the Rheumatic Diseases 72(Suppl 3): A153.2-A153

Tung, C. H.; Lai, N.-S. 2013: OP0296Hepatic Complication in Autoimmune Rheumatic Diseases: A Nationwide Cohort Study in Taiwan. Annals of the Rheumatic Diseases 72(Suppl 3): A154.1-A154

Otten, M. H.; Anink, J.; Prince, F. H.; Twilt, M.; Vastert, S. J.; ten Cate, R.; Hoppenreijs, E. P.; Armbrust, W.; Gorter, S. L.; van Pelt, P. A.; Kamphuis, S.; Dolman, K. M.; Swart, J. F.; van den Berg, J. M.; Koopman-Keemink, Y.; van Rossum, M. A.; Wulffraat, N. M.; van Suijlekom-Smit, L. W. 2013: OP0297Trends in Prescription of Biologics and Outcomes of Juvenile Idiopathic Arthritis; Results of the Dutch National Arthritis and Biologicals in Children Register. Annals of the Rheumatic Diseases 72(Suppl 3): A154.2-A154

Helliwell, T.; Muller, S.; Hider, S. L.; Mallen, C. D. 2013: OP0298-PCHow General Practitioners Diagnose Polymyalgia Rheumatica. Annals of the Rheumatic Diseases 72(Suppl 3): A155.1-A155

Van Lent, P.; Schelbergen, R.; Huurne, M. T.; Blom, A.; Roth, J.; Vogl, T.; Jorgensen, C.; Berg, W. V. D. 2013: OP0299Synovial Activation in Experimental OA Drives Rapid Suppressive Effects of Adipose-Derived Stem Cells after Local Administration and Protects Against Development of Ligament Damage. Annals of the Rheumatic Diseases 72(Suppl 3): A155.2-A155

Ludlow, J.; Moses, F.; Wong, C.; Pelosi, M.; de Vries, B.; Black, K. 2013: OP03.02: The success rate of medical management of miscarriage and its impact on the choice of miscarriage management. Ultrasound in Obstetrics and Gynecology 42(S1): 53-54

Stamatopoulos, N.; Lu, C.; Infante, F.; Menakaya, U.; Casikar, I.; Reid, S.; Mongelli, M.; Condous, G. 2013: OP03.03: Does the presence of subchorionic haematoma increase the risk of miscarriage?. Ultrasound in Obstetrics and Gynecology 42(S1): 54-54

Olowu, O.; Janga, D.; Chandrasekar, D.; Odejinmi, F. 2013: OP03.06: Laparoscopic management of ectopic pregnancy: 12 year experience. Ultrasound in Obstetrics and Gynecology 42(S1): 55-55

Stamatopoulos, N.; Lu, C.; Infante, F.; Menakaya, U.; Casikar, I.; Reid, S.; Mongelli, M.; Condous, G. 2013: OP03.09: Can miscarriage be predicted in women who present with a viable pregnancy at the first early pregnancy scan?. Ultrasound in Obstetrics and Gynecology 42(S1): 56-56

Allipour-Birgani, S.; Dietrich, H.; Gruber, J.; Distler, O.; Zisch, A.; Sgonc, R. 2013: OP0300Effect of VEGF121-Fibrin on the Expression of VEGF Receptors in Ischemic Lesions of UCD-206 Chickens, an Animal Model for Systemic Sclerosis. Annals of the Rheumatic Diseases 72(Suppl 3): A155.3-A156

Rosenblatt, L.; Curtis, J. R.; Yang, A.; Hebden, T. 2013: OP0301Outcomes of Patients with Rheumatoid Arthritis and Comorbid Hyperlipidaemia. Annals of the Rheumatic Diseases 72(Suppl 3): A156.1-A156

Labitigan, M.; Shrestha, A.; Jordan, N.; Reed, G.; Magner, R.; Bahce-Altuntas, A.; Broder, A. 2013: OP0302Moderate to High Disease Activity in Psoriatic Arthritis is Associated with Elevated Total Cholesterol and Triglycerides. Annals of the Rheumatic Diseases 72(Suppl 3): A156.2-A156

Bombardieri, M.; Rocher, V.; Mittereder, N.; Carlesso, G.; Herbst, R.; Sleeman, M.; Pitzalis, C. 2013: OP0303Mavrilimumab Reduces Pro-Inflammatory Cytokines and CD68 Positive Macrophages in Synovial Explants from Rheumatoid Arthritis Subjects Engrafted Into SCID/Beige Mice. Annals of the Rheumatic Diseases 72(Suppl 3): A156.3-A157

Hartkamp, L. M.; van Es, I. E.; Fine, J. S.; Smith, M.; Woods, J.; Narula, S.; DeMartino, J.; Tak, P. P.; Reedquist, K. A. 2013: OP0304BTK Inhibition Suppresses Inflammatory Cytokine Production and Affects Gene Expression in Human Macrophages and RA Synovial Tissue Explants. Annals of the Rheumatic Diseases 72(Suppl 3): A157.1-A157

Pazzola, G.; Magnani, L.; Boiardi, L.; Pipitone, N.; Muratore, F.; Versari, A.; Formisano, D.; Addimanda, O.; Meliconi, R.; Pulsatelli, L.; Bajocchi, G.; Catanoso, M.; Padovano, I.; Possemato, N.; Lo Gullo, A.; Salvarani, C. 2013: OP0306Evaluation of Disease Activity Using FDG PET-CT in Patients with Large Vessel Vasculitis. Annals of the Rheumatic Diseases 72(Suppl 3): A158.1-A158

Kondo, M.; Yamaoka, K.; Sonomoto, K.; Fukuyo, S.; Oshita, K.; Okada, Y.; Saito, K.; Tanaka, Y. 2013: OP0307Inhibitory Effects of IL-17 on Chondrogenic Differentiation of Human Mesenchymal Stem Cells Through the Phosphorylation of Sox9. Annals of the Rheumatic Diseases 72(Suppl 3): A158.2-A158

Kuttapitiya, A.; Davis, A.; Hing, C.; Dennis, J.; Sofat, N. 2013: OP0308Identifying Target Molecules Mediating Pain Processing in Osteoarthritis: Assessing TRPV1, TRPA1 and TRPM8 Expression in Joint Tissue. Annals of the Rheumatic Diseases 72(Suppl 3): A158.3-A159

Knoop, J.; Dekker, J.; van der Leeden, M.; van der Esch, M.; Thorstensson, C. A.; Gerritsen, M.; Voorneman, R. E.; Peter, W. F.; de Rooij, M.; Romviel, S.; Lems, W. F.; Roorda, L. D.; Steultjens, M. P. 2013: OP0309-HPRKnee Joint Stabilization Therapy in Patients with Osteoarthritis of the Knee: A Randomized, Controlled Trial. Annals of the Rheumatic Diseases 72(Suppl 3): A159.1-A159

Carlsson, A. 2013: OP0310-PAREFrom One-Way Communication to Dialogue, Facebook and Twitter. Annals of the Rheumatic Diseases 72(Suppl 3): A159.2-A159

Hussain, S. M.; Wang, Y.; Cicuttini, F.; Simpson, J. A.; Giles, G.; Graves, S.; Wluka, A. 2013: OP0311Incidence of Severe Knee and Hip Osteoarthritis in Relation to the Metabolic Syndrome and its Components: A Prospective Cohort Study. Annals of the Rheumatic Diseases 72(Suppl 3): A159.3-A160

Perez-Ruiz, F. 2013: OP0312Association of Insuline Resistance and Hypertension with Renal Clearance of Uric Acid in Males with Gout and Normal Renal Function. Annals of the Rheumatic Diseases 72(Suppl 3): A160.1-A160

Ferraz-Amaro, I.; Delgado-Frías, E.; Hernández-Hernández, V.; Muñiz-Montes, J. R.; González-Díaz, A.; Gómez Rodríguez-Bethencourt, A.; Díaz-González, F. 2013: OP0314Body Composition and Abdominal Adiposity in Rheumatoid Arthritis Patients: Cross-Sectional Study of Patients and Controls. Annals of the Rheumatic Diseases 72(Suppl 3): A160.3-A160

Hall, M. C.; Courtney, P.; Doherty, S.; Latief, K.; Zhang, W.; Doherty, M. 2013: OP0315Ultrasound Features of Inflammation in the Knee Joint and its Relationship to Pain and Radiographic Osteoarthritis. Annals of the Rheumatic Diseases 72(Suppl 3): A161.1-A161

Eathakkattu Antony, B. S.; Jones, G.; Venn, A.; Cicuttini, F.; March, L.; Blizzard, L.; Dwyer, T.; Cross, M.; Ding, C. 2013: OP0316The Association Between Childhood Obesity Measures and Adulthood Knee Pain, Stiffness and Physical Dysfunction: A 25-Year Cohort Study. Annals of the Rheumatic Diseases 72(Suppl 3): A161.2-A161

Ding, C.; Han, W.; Cai, S.; Liu, Z.; Jin, X.; Antony, B.; Jones, G. 2013: OP0317Infrapatellar Fat Pad Area is Associated with Reduced Knee Symptomatic and Structural Abnormalities in Older Adults: A Cross-Sectional Study. Annals of the Rheumatic Diseases 72(Suppl 3): A161.3-A162

Reddy, V.; Cambridge, G.; Isenberg, D.; Cragg, M.; Leandro, M. 2013: OP0318Use of an in Vitro Whole Blood Depletion Assay to Compare the Efficacy of B Cell Depleting Agents in Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases 72(Suppl 3): A162.1-A162

Jacobsen, S.; Tanha, N.; Troelsen, L.; Hermansen, M.-L. F.; Kjær, L.; Faurschou, M.; Garred, P. 2013: OP0319Genetically Determined Mannose-Binding Lectin Deficiency Increases Risk of Nephritis in Danish Patients with Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases 72(Suppl 3): A162.2-A162

Müllern-Aspegren, A. 2013: OP0320-PAREBe Welcome, A Project About the Medical Consultation. Annals of the Rheumatic Diseases 72(Suppl 3): A162.3-A163

Shen, X; Carlström, M; Borniquel, S; Jädert, C; Kevil, C G.; Lundberg, J 2013: OP04 Microbiota regulation of host hydrogen sulfide bioavailability and metabolism. Nitric Oxide 31: S20-S21

Kuleva, M.; Decaudin, A.; Le Bidois, J.; Villain, E.; Ville, Y.; Salomon, L. J. 2013: OP04.02: Clinical course and outcome of antenatally detected atrioventricular block: experience of single tertiary centre and review of the literature. Ultrasound in Obstetrics and Gynecology 42(S1): 57-57

Kurihara, Y.; Tachibana, D.; Yanai, S.; Kitada, K.; Sano, M.; Wada, N.; Yamamoto, H.; Hamasaki, S.; Terada, H.; Nakano, A.; Koyama, M. 2013: OP04.05: Time interval assessment of ventricular inflow patterns in normal singleton fetuses. Ultrasound in Obstetrics and Gynecology 42(S1): 57-58

Kawataki, M. 2013: OP04.06: The new application of dual Doppler to the flow of SVC and AO. Ultrasound in Obstetrics and Gynecology 42(S1): 58-58

Henry, A.; Meriki, N.; Mahajan, A.; Sanderson, J.; Wu, L.; Welsh, A. W. 2013: OP04.08: Delta-MPI in pathological versus uncomplicated pregnancy: a value-add to right and left mod-MPI?. Ultrasound in Obstetrics and Gynecology 42(S1): 58-59

Meriki, N.; Henry, A.; Sanderson, J.; Mahajan, A.; Wu, L.; Welsh, A. W. 2013: OP04.09: Normal ranges for the right modified myocardial performance index (RMPI) in the Australian population using three alternative caliper placements. Ultrasound in Obstetrics and Gynecology 42(S1): 59-59

Moody, A; Scholes, S; Mindell, J 2013: OP04Airway Obstruction and All-Cause and Respiratory Mortality: Exploring the Relationship between three Definitions of Obstruction, Smoking using Healths Survey for England and Scottish Health Survey Data. Journal of Epidemiology and Community Health 67(Suppl 1): A5.1-A5

Martillotti, G.; Rypens, F.; David, M.; Desilets, V.; Dubé, J.; Audibert, F. 2013: OP05.01: Correlation between isolated fetal cerebral ventriculomegaly and fetal and neonatal alloimmune thrombocytopenia. Ultrasound in Obstetrics and Gynecology 42(S1): 59-60

Pugash, D.; Dunham, C. P.; Mayer, C.; Hendson, G.; Gagnon, A. 2013: OP05.02: Corroboration of normal and abnormal fetal cerebral lamination on postmortem sonography with neuropathological examination. Ultrasound in Obstetrics and Gynecology 42(S1): 60-60

Haratz, K. K.; Feit, H.; Lerman-Sagie, T.; Lev, D.; Nardozza, L. M.; Moron, A. F.; Malinger, G. 2013: OP05.04: Nomograms for the fetal optic nerve sheath diameter. Ultrasound in Obstetrics and Gynecology 42(S1): 60-61

Lv, G.; Xu, W. 2013: OP05.05: The clinical value of the three-dimensional ultrasonography in measurement of fetal choroid plexus and lateral ventricle volume. Ultrasound in Obstetrics and Gynecology 42(S1): 61-61

Xie, H.; Lei, T.; Du, L. 2013: OP05.08: Prenatal evaluation of the conus medullaris position in normal fetuses and fetuses with spina bifida occulta with three-dimensional ultrasound. Ultrasound in Obstetrics and Gynecology 42(S1): 61-62

Develay-Morice, J.; Frandji-Barbier, N.; Mousty, E.; Haddad, G.; d'Ercole, C.; Mares, P. 2013: OP05.09: Spina bifida: don't forget the fibers! A new sign when it's difficult. Ultrasound in Obstetrics and Gynecology 42(S1): 62-62

Kampanellou, E 2013: OP05From Industries to Services: Occupational Mobility and Health in Scotland. Journal of Epidemiology and Community Health 67(Suppl 1): A5.2-A6

Brancaleone, V; Flower, R J.; Cirino, G; Perretti, M 2013: OP06 Annexin A1 (AnxA1) mediates hydrogen sulfide (H2S) effects in the control of inflammation. Nitric Oxide 31: S21-S22

Pascual, M.; Graupera, B.; Hereter, L.; Alcazar, J.; Fernández-Cid, M.; Simon, M.; Rodríguez, I. 2013: OP06.02: Evaluation of uterine transverse diameter in Müllerian duct anomalies. Ultrasound in Obstetrics and Gynecology 42(S1): 62-63

Baumgarten, M. N.; Polanski, L. T.; Campbell, B.; Raine-Fenning, N. J. 2013: OP06.03: Fundal length decreases in first trimester pregnancies of women undergoing in vitro fertilization treatment. Ultrasound in Obstetrics and Gynecology 42(S1): 63-63

Lerner, J. P. 2013: OP06.06: Evaluation of intrauterine adhesions by SIS prior to operative hysteroscopy. Ultrasound in Obstetrics and Gynecology 42(S1): 63-64

Pascual, M.; Alcazar, J.; Graupera, B.; Hereter, L.; Pedrero, C.; Rodríguez, I. 2013: OP06.07: The role of uterine transverse diameter in the diagnostic of septate uterus in clinic practice. Ultrasound in Obstetrics and Gynecology 42(S1): 64-64

Green, M J; Leyland, A H; Sweeting, H; Benzeval, M 2013: OP06Opposing Processes Contingent on Early Smoking: A Cross-Cohort Comparison of Socioeconomic Inequalities in Alcohol use Across the Youth-To-Adult Transition. Journal of Epidemiology and Community Health 67(Suppl 1): A6.1-A6

Roy-Lacroix, M.; Moretti, F.; Brosseau, L.; Hwang, A.; Clancy, J.; Fung Kee Fung, K. 2013: OP07.01: A comparison of three-dimensional volume sonography to two-dimensional second trimester anatomic surveys in a Canadian healthcare context. Ultrasound in Obstetrics and Gynecology 42(S1): 65-65

Alberry, M.; Fanelli, T.; Hassan, W. A.; Brockelsby, J.; Lees, C. 2013: OP07.04: The transverse septum lingual view on 2D ultrasound for the detection of cleft palate. Ultrasound in Obstetrics and Gynecology 42(S1): 66-66

Ochoa, J. H.; Colubriale, A.; Defago, V.; Mangupli, P.; Lovagnini Frutos, M. G. 2013: OP07.07: Subdiaphragmatic echogenic masses: prenatal diagnosis and outcome. Ultrasound in Obstetrics and Gynecology 42(S1): 66-67

Soto-Chacon, E.; Ville, Y.; Yamamoto, M. 2013: OP07.08: Case of velamental vessels in an amniotic band: a not to touch case. Ultrasound in Obstetrics and Gynecology 42(S1): 67-67

Harvey, K; Muniz, G; Kuh, D; Stafford, M 2013: OP07The Association between Socioeconomic Position and Longitudinal Adult Social Integration in a British Birth Cohort. Journal of Epidemiology and Community Health 67(Suppl 1): A6.2-A7

Jorm, L. R.; Randall, D. A.; Falster, M. O.; Leyland, A. H. 2013: OP08 Using Linked Administrative Data and Multilevel Modelling to Identify Targets for Interventions to Tackle Health Disparities. Journal of Epidemiology and Community Health 67(Suppl 1): A7-A7

Pagani, G.; D'Antonio, F.; Khalil, A.; Akolekar, R.; Papageorghiou, A. T.; Bhide, A.; Thilaganathan, B. 2013: OP08.03: Reduced fetal movements at term: association to second trimester uterine artery Doppler assessment. Ultrasound in Obstetrics and Gynecology 42(S1): 67-68

Rencoret, G. I.; Figueroa Poblete, J.; Leiva, J. 2013: OP08.04: Uterine artery Doppler in predicting pregnancy outcome in women with chronic hypertension. Ultrasound in Obstetrics and Gynecology 42(S1): 68-68

Everett, T. R.; Mahendru, A.; McEniery, C. M.; Wilkinson, I. B.; Lees, C. 2013: OP08.06: The effects of S-nitrosoglutathione on maternal and fetal Doppler in early-onset pre-eclampsia. Ultrasound in Obstetrics and Gynecology 42(S1): 69-69

Diemert, A. M.; Pagenkemper, M.; Wilhelm, S.; Hartwig, I.; Arck, P.; Hecher, K. 2013: OP08.09: The challenge to measure the fetal thymus and the adrenal gland-learning curve and reproducibility in the PRINCE prospective birth cohort. Ultrasound in Obstetrics and Gynecology 42(S1): 69-70

Henry, A.; Shand, A.; Crowther, C.; Palmer, A.; Wang, Y. A.; Welsh, A. W. 2013: OP08.10: Comprehensive ultrasound evaluation of short-term fetal effects of dexamethasone and betamethasone. Ultrasound in Obstetrics and Gynecology 42(S1): 70-70

Nanan, R. 2013: OP08.12: Towards a better understanding of the developmental origins of disease. Ultrasound in Obstetrics and Gynecology 42(S1): 70-71

Graupera, B.; Pascual, M.; Hereter, L.; Tresserra, F.; Pedrero, C.; Fernández-Cid, M. 2013: OP09.01: Decidualization of endometrioma during pregnancy mimicking a malignant ovarian tumor. Ultrasound in Obstetrics and Gynecology 42(S1): 71-71

Virgilio, B.; Ludovisi, M.; Di Legge, A.; Mascilini, F.; Moruzzi, M.; Giansiracusa, C.; De Blasis, I.; Guastafierro, F.; Testa, A. 2013: OP09.03: Ultrasound characteristics of ovarian cystoadenofibromas. Ultrasound in Obstetrics and Gynecology 42(S1): 72-72

Alcazar, J.; Utrilla-Layna, J.; Olartecoechea, B.; Aubá, M.; Ruiz-Zambrana, A.; Pineda, L.; Juez, L.; Ajossa, S.; Guerriero, S. 2013: OP09.06: Predicting malignancy in entirely solid-appearing adnexal masses on gray-scale ultrasound based on additional ultrasound findings, clinical complaints and biochemical parameters: a retrospective study. Ultrasound in Obstetrics and Gynecology 42(S1): 73-73

Engels, A.; Van Calster, B.; Richter, J.; DeKoninck, P.; Lewi, L.; De Catte, L.; Devlieger, R.; Deprest, J. 2013: OP10.02: Sealing of iatrogenic fetal membrane defects after fetoscopic surgery for congenital diaphragmatic hernia by collagen plugs. Ultrasound in Obstetrics and Gynecology 42(S1): 74-74

Preis, K.; Swiatkowska-Freund, M.; Pankrac, Z. 2013: OP10.05: Impact of the gestational age at the TTTS diagnosis and laser treatment on the pregnancy outcome: a modified Quintero staging. Ultrasound in Obstetrics and Gynecology 42(S1): 75-75

Kim, S.; Shin, J. 2013: OP10.08: Effect of cervical cerclage on labor course and obstetric outcome. Ultrasound in Obstetrics and Gynecology 42(S1): 76-76

Zaman, S; Fouad, F; Pless-Mulloli, T; White, M; Ahmad, B 2013: OP10How do Women Living in Socioeconomically Contrasting Neighbourhoods Perceive the Relationship between their Neighbourhoods and Health? A Qualitative Study in Aleppo, Syria. Journal of Epidemiology and Community Health 67(Suppl 1): A8.1-A8

Picard, A.; Boucoiran, I.; Wavrant, S.; Dubé, J.; Bujold, E.; Audibert, F. 2013: OP11.03: Intra-amniotic sludge observed at cervical ultrasound and the risk of preterm delivery. Ultrasound in Obstetrics and Gynecology 42(S1): 77-77

Kim, E.; Kim, J. 2013: OP11.06: Sonographic funneling of uterine cervix as predictor for success of labor induction. Ultrasound in Obstetrics and Gynecology 42(S1): 77-78

Cordoba, M.; Monteagudo, A.; Jadhav, A. R.; Joo, L.; Timor-Tritsch, I. E. 2013: OP11.07: Pre and post-ripening sonographic assessment of cervix for predicting successful induction of labor. Ultrasound in Obstetrics and Gynecology 42(S1): 78-78

Eremina, O. V.; Shifman, E. M.; Voevodin, S.; Gus, A.; Bayev, O. R. 2013: OP11.08: Relationship between ultrasound and Dopplerometry in labor and fetal hypoxia. Ultrasound in Obstetrics and Gynecology 42(S1): 78-79

Pennington, A J; Orton, L; Ring, A; Fox, D; Petticrew, M; White, M; Sowden, A; Whitehead, M M 2013: OP11Missing Women? The Health Inequalities Impact of Low Control and Gender Discrimination: A Theory-Led Systematic Review of Observational Studies. Journal of Epidemiology and Community Health 67(Suppl 1): A8.2-A8

Su, H.; Chen, X.; Hu, J.; Li, J.; Xu, P.; Wang, Z.; Sun, Y. 2013: OP12.01: The relationship of multiple peri-conception risk factors and congenital heart disease: a retrospective study with 975 cases. Ultrasound in Obstetrics and Gynecology 42(S1): 79-79

Votino, C.; Condorelli, M.; Votino, R.; Bessieres, B.; Dessy, H.; Cos, T. 2013: OP12.03: Early evaluation of fetal heart anatomy: a prospective study from 6 to 10 weeks' gestation. Ultrasound in Obstetrics and Gynecology 42(S1): 79-80

Yazicioglu, H. F.; Gul, A.; Vuruskan, E.; Karahasanoglu, A.; Uzun, I. 2013: OP12.04: Fetal heart anomalies detected during first trimester screening test in a mixed population. Ultrasound in Obstetrics and Gynecology 42(S1): 80-80

Kim, S.; Kang, M.; Kim, E.; Lee, J.; Park, J. S.; Jun, J. K. 2013: OP12.06: Antenatal accuracy of fetal echocardiography in the diagnosis of fetal coarctation of aorta. Ultrasound in Obstetrics and Gynecology 42(S1): 80-81

Mori, N.; Mashima, M.; Ito, M.; Uketa, E.; Hanaoka, U.; Kanenishi, K.; Tanaka, H.; Hata, T. 2013: OP12.08: HDlive rendering images of the fetal heart. Ultrasound in Obstetrics and Gynecology 42(S1): 81-81

Kou, K.; Leung, K.; Poon, C.; Lee, S. 2013: OP12.10: Fetal heart disease: impact of prenatal counseling by paediatric cardiologists on the pregnancy outcomes. Ultrasound in Obstetrics and Gynecology 42(S1): 81-82

Brantberg, A.; Loraas, L.; Tegnander, E.; Moholdt, T.; Garnaes, K. K.; Eik-Nes, S.; Ingul, C. B. 2013: OP12.11: Reduced fetal cardiac function in obese pregnant women. Ultrasound in Obstetrics and Gynecology 42(S1): 82-82

Wardle, H; Hall, J; Graham, H; Law, C; McAloney, K; Platt, L 2013: OP12The Health Behaviours of Mothers in England: A Latent Class Analysis. Journal of Epidemiology and Community Health 67(Suppl 1): A8.3-A9

Emmanule di Villa Bianca, R d'; Mitidieri, E; Dario Di Minno, M Nicola; Kirkby, N S.; Warner, T D.; Di Minno, G; Cirino, G; Sorrentino, R 2013: OP13 The hydrogen sulfide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia. Nitric Oxide 31: S24-S25

Fu, J. 2013: OP13.02: Does maternal psychological status affect placental-fetal blood flow circulation during pregnancy: a pilot study. Ultrasound in Obstetrics and Gynecology 42(S1): 82-83

Vale, F.; Oliveira, C. A.; Silva, F. C.; Sa, R. A. 2013: OP13.03: Cerebral arteries Doppler indices in mild chronic hypertensive pregnant women. Ultrasound in Obstetrics and Gynecology 42(S1): 83-83

Pagani, G.; D'Antonio, F.; Khalil, A.; Akolekar, R.; Papageorghiou, A. T.; Bhide, A.; Thilaganathan, B. 2013: OP13.05: Reduced fetal movements at term: association to first trimester PAPP-A level. Ultrasound in Obstetrics and Gynecology 42(S1): 83-84

Visentin, S.; Londero, A. P.; Bellamio, B.; Giunta, G.; Nika, R.; Cosmi, E. 2013: OP13.06: Fetal ultrasound examinations in women affected by late gestational hypertension and third trimester ultrasound growth scan values to predict the onset of late gestational hypertension. Ultrasound in Obstetrics and Gynecology 42(S1): 84-84

OBrien, C.; Arbuckle, S.; Thomas, S.; Rode, J.; Jeffery, H. 2013: OP13.08: Histological chorioamnionitis in the Northern Territory is associated with rural and remote residence rather than ethnicity. Ultrasound in Obstetrics and Gynecology 42(S1): 84-85

Mantovani, E.; Pagani, G.; Thilaganathan, B.; Bhide, A.; Khalil, A. 2013: OP13.09: Cardiovascular indices in the early identification of pre-eclampsia in women presenting with gestational hypertension. Ultrasound in Obstetrics and Gynecology 42(S1): 85-85

Capewell, S; Collins, M; Mason, H; O'Flaherty, M; Guzman-Castillo, M; Critchley, J 2013: OP13An Economic Evaluation of Salt Reduction Policies to Reduce Cardiovascular Disease in England: A Policy Modelling Study. Journal of Epidemiology and Community Health 67(Suppl 1): A9.1-A9

Zhang, X.; Zheng, R.; Huang, D.; Zheng, Z.; He, X.; Mao, Y.; Cao, J. 2013: OP14.01: The value of contrast-enhanced ultrasound for differential diagnosis of subserous myoma and ovarian fibroma. Ultrasound in Obstetrics and Gynecology 42(S1): 85-86

Moschos, E.; Bailey, A. A.; Twickler, D. M. 2013: OP14.02: Saline-infusion sonography compared with saline-infusion sonography endometrial sampling in diagnosing endometrial pathology. Ultrasound in Obstetrics and Gynecology 42(S1): 86-86

Dueholm, M.; Rydbjerg, S.; Holm, J. W.; Hansen, E.; Ørtoft, G. 2013: OP14.04: 3- and 2 dimensional transvaginal ultrasound with power Doppler and gel infusion for diagnosis of malignancy in women with postmenopausal bleeding. Ultrasound in Obstetrics and Gynecology 42(S1): 86-87

Czekierdowski, A.; Poziemski, P.; Borowski, D.; Chrosciel, M.; Stachowicz, N.; Kraczkowski, J. 2013: OP14.05: Prediction of benign and malignant endometrial changes with the use of IETA group descriptors. Ultrasound in Obstetrics and Gynecology 42(S1): 87-87

Jäger, L.; Lindqvist, P. G.; Flöter Rådestad, A.; Dueholm, M.; Fischerova, D.; Franchi, D.; Jokubkiene, L.; Leone, F.; Savelli, L.; Sladkevicius, P.; Testa, A.; Van den Bosch, T.; Epstein, E. 2013: OP14.07: Transvaginal ultrasound assessment of myometrial and cervical stroma invasion in endometrial cancer: can any gynecologist do the job?. Ultrasound in Obstetrics and Gynecology 42(S1): 87-88

Harb, W.; Oboleviciute, L.; Kruminis, V.; Vaitkiene, D.; Cizauskas, A.; Gaurilcikas, A. 2013: OP14.08: Diagnostic performance of transvaginal sonography for the assessment of myometrial invasion in cases of endometrial cancer. Ultrasound in Obstetrics and Gynecology 42(S1): 88-88

Wilcox, M; Mason, H; Fouad, F M; Rastam, S; Ali, R Al; Capwell, S; O'Flaherty, M; Page, T F; Maziak, W 2013: OP14Cost Effectiveness Analysis of Salt Reduction Policies to Reduce Coronary Heart Disease in Syria. Journal of Epidemiology and Community Health 67(Suppl 1): A9.2-A10

Lloyd-Williams, F.; Bromley, H.; Orton, L.; Taylor-Robinson, D.; O'Flaherty, M.; Moonan, M.; McGill, R.; Calder, N.; Anwar, E.; Castillo, M. G.; Rayner, M.; Capewell, S. 2013: OP15 Identifying the most effective public health nutrition policies: The views of policy-makers and thought-leaders across 14 EU countries. Journal of Epidemiology and Community Health 67(Suppl 1): A10-A10

Verburg, B.; Fink, A.; Reidy, K.; Palma-Dias, R. 2013: OP15.01: Evaluation of the additional value of fetal MRI in fetal anomalies diagnosed by ultrasound and postnatal correlation of the findings. Ultrasound in Obstetrics and Gynecology 42(S1): 88-89

Maraci, M.; Napolitano, R.; Papageorghiou, A. T.; Noble, J. A. 2013: OP15.02: Automatic fetal head detection on video clips from a low-cost portable USB ultrasound (US) device. Ultrasound in Obstetrics and Gynecology 42(S1): 89-89

Mantovani, E.; Thilaganathan, B.; Pagani, G.; Bhide, A.; Khalil, A. 2013: OP15.04: Inotropy index and ratio of potential to kinetic energy: two novel parameters derived from continuous-wave Doppler ultrasound. Ultrasound in Obstetrics and Gynecology 42(S1): 89-90

Arthuis, C.; Perrotin, F.; Simon, E.; Novell, A.; Escoffre, J.; Bouakaz, A. 2013: OP15.05: New quantitative analysis of uteroplacental perfusion using Doppler and contrast-enhanced ultrasound imaging. Ultrasound in Obstetrics and Gynecology 42(S1): 90-90

Miyague, A. H.; Soares, C. A.; Teixeira, D. M.; Nastri, C. O.; Martins, W. P. 2013: OP15.07: Influence of pulse repetition frequency adjustment on three-dimensional power Doppler indices and STIC volumetric pulsatility index using an in vivo model. Ultrasound in Obstetrics and Gynecology 42(S1): 90-91

Sabiani, L.; Haumonte, J.; Loundou, A.; D'ercole, C.; Bretelle, F. 2013: OP15.08: Quantification of cervix's elastography in assessing the risk of preterm delivery. Ultrasound in Obstetrics and Gynecology 42(S1): 91-91

D'Antonio, F.; Iacovella, C.; Bhide, A. 2013: OP15.10: Magnetic resonance imaging (MRI) signs of invasive placenta: systematic review and meta analysis. Ultrasound in Obstetrics and Gynecology 42(S1): 91-92

Reid, S.; Lu, C.; Casikar, I.; Menakaya, U.; Condous, G. 2013: OP16.01: The use of the soft marker, site-specific tenderness at TVS, in the pre-operative mapping of peritoneal endometriosis. Ultrasound in Obstetrics and Gynecology 42(S1): 92-92

León, M.; Alcazar, J.; Vaccaro, H.; Martinez, J.; Gutierrez, J.; Iturra, A.; Amor, F.; Sovino, H. 2013: OP16.03: Extended transvaginal ultrasound in deep endometriosis: use of bowel preparation and acoustic window with intravaginal gel. Ultrasound in Obstetrics and Gynecology 42(S1): 92-93

Deka, D.; Malhotra, N. 2013: OP16.04: Ultrasound diagnosis of anomalies of uterine cervix and uterus for cervical reconstruction. Ultrasound in Obstetrics and Gynecology 42(S1): 93-93

Reid, S.; Lu, C.; Casikar, I.; Phua, C.; Menakaya, U.; Condous, G. 2013: OP16.06: Is there a relationship between the position of the uterus and the presence of deep infiltrating endometriosis?. Ultrasound in Obstetrics and Gynecology 42(S1): 93-94

Ludlow, J.; Dorney, E.; Lanzarone, V.; Cooper, M. 2013: OP16.07: Same day ultrasound imaging and laparoscopic surgery for the diagnosis of deep infiltrating endometriosis. Ultrasound in Obstetrics and Gynecology 42(S1): 94-94

Bromley, H; Williams, F Lloyd; Orton, L; McGill, R; Anwar, E; Moonan, M; Robinson, D Taylor; Calder, N; O'Flaherty, M; Castillo, M Guzman; Hawkes, C; M, R; Capewell, S 2013: OP16Utilising a Novel Framework to Assess Public Health Nutrition Actions Across 30 European Countries (Euro Heart II Project). Journal of Epidemiology and Community Health 67(Suppl 1): A10.2-A11

Coletta, C; Chao, C; Módis, K; Papapetropoulos, A; Hellmich, M; Szabo, C 2013: OP17 Cystathionine-β-synthase (CBS) is upregulated in colorectal cancer cells and promotes their proliferation. Nitric Oxide 31: S26-S27

Ekelund, C. K.; Petersen, O.; Ball, S.; Hyett, J.; Tabor, A.; Vogel, I. 2013: OP17.01: Nuchal translucency measurements in fetuses according to karyotype in a low risk population. Ultrasound in Obstetrics and Gynecology 42(S1): 94-95

Wulff, C. B.; Ball, S.; Rode, L.; Pinborg, A.; Loft, A.; Tabor, A. 2013: OP17.02: Are ART women at increased risk of miscarriage and stillbirth following first trimester risk assessment compared to spontaneously pregnant women?. Ultrasound in Obstetrics and Gynecology 42(S1): 95-95

Alberry, M.; Hassan, W. A.; Goodburn, S.; Brockelsby, J.; Wladimiroff, J. W.; Nash, R.; Lees, C. 2013: OP17.04: Unintended consequences of UK guidance for anomaly screening and invasive testing. Ultrasound in Obstetrics and Gynecology 42(S1): 95-96

Deloison, B.; Muller, F.; Dreux, S.; Czerkiewicz, I.; Sokolov, D.; Oury, J.; Ville, Y.; Salomon, L. J. 2013: OP17.05: Outcomes in case of low PAPP-A and free β-HCG in maternal serum at first trimester screening. Ultrasound in Obstetrics and Gynecology 42(S1): 96-96

Ekelund, C. K.; Wulff, C. B.; Ball, S.; Wright, D.; Tabor, A. 2013: OP17.06: First trimester biochemical markers in oocyte donated women. Ultrasound in Obstetrics and Gynecology 42(S1): 96-97

Pincham, V.; McLennan, A.; Hyett, J.; Schluter, P.; Pollard, K. 2013: OP17.07: Development of auditable standards in the first trimester ultrasound assessment of fetal blood flow through the ductus venosus and the tricuspid valve. Ultrasound in Obstetrics and Gynecology 42(S1): 97-97

Dhaifalah, I.; Andrys, C.; Drahosova, M.; Musilova, I.; Lesko, D.; Adamik, Z.; Kacerovsky, M. 2013: OP17.10: Azurocidin in maternal serum in the first trimester and preterm delivery. Ultrasound in Obstetrics and Gynecology 42(S1): 98-98

Murray, E T; Hardy, R; Tilling, K; Southall, H; Aucott, P; Kuh, D; Ben-Shlomo, Y; Richards, M 2013: OP17Area Deprivation Across the Life Course and Cognitive Capability in Mid-Life: Findings from the 1946 British Birth Cohort. Journal of Epidemiology and Community Health 67(Suppl 1): A11.1-A11

Shek, C.; Wong, V.; Krause, H.; Goh, J.; Dietz, H. P. 2013: OP18.03: Pelvic organ support in nulliparous Africans and Caucasians: a comparative study using 4D pelvic floor ultrasound. Ultrasound in Obstetrics and Gynecology 42(S1): 99-99

Wang, H. 2013: OP18.06: Study of correlation between anterior compartment prolapse quantification through transperineal ultrasonography and POP-Q examination. Ultrasound in Obstetrics and Gynecology 42(S1): 100-100

Caudwell- Hall, J.; Shek, C.; Guzman Rojas, R. A.; Kamisan Atan, I.; Dietz, H. P. 2013: OP18.09: Delivery-related pelvic floor trauma: does birth position matter?. Ultrasound in Obstetrics and Gynecology 42(S1): 100-101

Russ, T C; Kivimaki, M; Stamatakis, E; Starr, J; Batty, G D 2013: OP18Does Dementia Risk Begin in Early Life? Examining the Relationship Between Height and Dementia Mortality in an Individual Participant Meta-analysis of 181,800 People from Eighteen Prospective Cohort Studies. Journal of Epidemiology and Community Health 67(Suppl 1): A11.2-A11

Napolitano, R.; Ohuma, E.; Dhami, J.; Ioannou, C.; Conde-Agudelo, A.; Kennedy, S.; Villar, J.; Papageorghiou, A. T. 2013: OP19.01: Systematic review of the methodology used for creating dating charts based on fetal crown-rump length. Ultrasound in Obstetrics and Gynecology 42(S1): 101-101

McLennan, A.; Mogra, R.; Murphy, K.; Schluter, P.; Hyett, J. 2013: OP19.03: Assessment of crown-rump length measurement variability. Ultrasound in Obstetrics and Gynecology 42(S1): 102-102